References

Crippa, J. A., Zuardi, A. W., Martín-Santos, R., Bhattacharyya, S., Atakan, Z., McGuire, P., & Fusar-Poli, P. (2009). Cannabis and anxiety: A critical review of the evidence. Human Psychopharmacology, 24(7), 515-523. https://doi.org/10.1002/hup.1048(https://doi.org/10.1002/hup.1048) Darkovska-Serafimovska, M., Serafimovska, T., Arsova-Sarafinovska, Z., Stefanoski, S., Keskovski, Z., & Balkanov, T. (2018). Pharmacotherapeutic considerations for use of cannabinoids to relieve pain in patients with malignant diseases. Journal of Pain Research, 11, 837-842. https://doi.org/10.2147/JPR.S160556(https://doi.org/10.2147/JPR.S160556) Government of Canada. (2018, October 17). About cannabis. https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/about.html(https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/about.html) Grinspoon, P. (2020, September 24). Cannabidiol (cbd)-What we know and what we don’t. Harvard Health Publishing. https://www.health.harvard.edu/blog/cannabidiol-cbd-what-we-know-and-what-we-dont-2(https://www.health.harvard.edu/blog/cannabidiol-cbd-what-we-know-and-what-we-dont-2018082414476)018082414476(https://www.health.harvard.edu/blog/cannabidiol-cbd-what-we-know-and-what-we-dont-2018082414476) Guimarães, F. S., Chiaretti, T. M., Graeff, F. G., and Zuardi, A. W. (1990). Antianxiety effect of cannabidiol in the elevated plus-maze. Psychopharmacology, 100(4), 558–559. https://doi.org/10.1007/BF02244012(https://doi.org/10.1007/BF02244012) How cbd can be taken: 4 different delivery methods. (2020). Phytoextractum. https://www.phytoextractum.com/resources/how-cbd-can-be-taken-4-different-delivery-m(https://www.phytoextractum.com/resources/how-cbd-can-be-taken-4-different-delivery-methods/)ethods/(https://www.phytoextractum.com/resources/how-cbd-can-be-taken-4-different-delivery-methods/) Leweke, F. M., Piomelli, D., Pahlisch, F., Muhl, D., Gerth, C. W., Hoyer, C., Klosterkötter, J., Hellmich, M., & Koethe, D. (2012). Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia. Translational Psychiatry, 2(3), e94-e94. https://doi.org/10.1038/tp.2012.15(https://doi.org/10.1038/tp.2012.15) Lowe, D. J. E., Sasiadek, J. D., Coles, A. S., & George, T. P. (2019). Cannabis and mental illness: A review. European Archives of Psychiatry and Clinical Neuroscience, 269(1), 107-120. https://doi.org/10.1007/s00406-018-0970-7(https://doi.org/10.1007/s00406-018-0970-7) McGuire, P., Robson, P., Cubala, W. J., Vasile, D., Morrison, P. D., Barron, R., Taylor, A., & Wright, S. (2018). Cannabidiol (cbd) as an adjunctive therapy in schizophrenia: A multicenter randomized controlled trial. The American Journal of Psychiatry, 175(3), 225-231. https://doi.org/10.1176/appi.ajp.2017.17030325(https://doi.org/10.1176/appi.ajp.2017.17030325) Pearson, J., Martin, A., Horgan, K., Wittreich, J., Gertz, B., & Lindley, C. (2000). Vomiting-and nausea-specific quality of life in patients with acute and delayed chemotherapy-induced emesis. Quality of Life Research, 9(3), 296-296. https://www.jstor.org/stable/4036294(https://www.jstor.org/stable/4036294) Rexaline, S. (2019, March 7). Cbd vs. thc: The science behind most popular cannabinoids. Benzinga. https://www.benzinga.com/markets/cannabis/19/03/13312269/cbd-vs-thc-the-science-behi(https://www.benzinga.com/markets/cannabis/19/03/13312269/cbd-vs-thc-the-science-behind-the-most-popular-cannabinoids?utm_sq=g0v89su8hc&utm_source=Twitter&utm_medium=social&utm_campaign=ParkAmerican&utm_content=NewsArticles)nd-the-most-popular-cannabinoids?utm_sq=g0v89su8hc&utm_source=Twitter&utm_med(https://www.benzinga.com/markets/cannabis/19/03/13312269/cbd-vs-thc-the-science-behind-the-most-popular-cannabinoids?utm_sq=g0v89su8hc&utm_source=Twitter&utm_medium=social&utm_campaign=ParkAmerican&utm_content=NewsArticles)ium=social&utm_campaign=ParkAmerican&utm_content=NewsArticles(https://www.benzinga.com/markets/cannabis/19/03/13312269/cbd-vs-thc-the-science-behind-the-most-popular-cannabinoids?utm_sq=g0v89su8hc&utm_source=Twitter&utm_medium=social&utm_campaign=ParkAmerican&utm_content=NewsArticles) Shannon, S., & Opila-Lehman, J. (2016). Effectiveness of cannabidiol oil for pediatric anxiety and insomnia as part of posttraumatic stress disorder: A case report. Permanente Journal, 20(4), 16-005. https://doi.org/10.7812/TPP/16-005(https://doi.org/10.7812/TPP/16-005)

Anthony J. C., Warner L. A., Kessler R. C. (1994). Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: Basic findings from the national comorbidity survey. Experimental and Clinical Psychopharmacology, 2(3), 244–268. https://doi.org/10.1037/1064-1297.2.3.244(https://doi.org/10.1037/1064-1297.2.3.244) Arendt, M., Rosenberg, R., Foldager, L., Perto, G., & Munk-Jørgensen, P. (2005). Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: Follow-up study of 535 incident cases. British Journal of Psychiatry, 187(6), 510-515. https://doi.org/10.1192/bjp.187.6.510(https://doi.org/10.1192/bjp.187.6.510) Arkowitz, H., & Lilienfeld, S. (2021, March 1). Experts tell the truth about pot. Scientific American. https://www.scientificamerican.com/article/the-truth-about-pot/(https://www.scientificamerican.com/article/the-truth-about-pot/) Bab, I., Zimmer, A., & Melamed, E. (2009). Cannabinoids and the skeleton: From marijuana to reversal of bone loss. Annals of Medicine (Helsinki), 41(8), 560-567. https://doi.org/10.1080/07853890903121025(https://doi.org/10.1080/07853890903121025) Canadian Centre on Substance Use and Addiction. (2019). 7 things about edible cannabis. https://www.ccsa.ca/sites/default/files/2019-06/CCSA-7-Things-About-Edible-Cannabis-2(https://www.ccsa.ca/sites/default/files/2019-06/CCSA-7-Things-About-Edible-Cannabis-2019-en.pdf)019-en.pdf(https://www.ccsa.ca/sites/default/files/2019-06/CCSA-7-Things-About-Edible-Cannabis-2019-en.pdf) Corey-Bloom, J., Wolfson, T., Gamst, A., Jin, S., Marcotte, T. D., Bentley, H., & Gouaux, B. (2012). Smoked cannabis for spasticity in multiple sclerosis: A randomized, placebo-controlled trial. Canadian Medical Association Journal (CMAJ), 184(10), 1143-1150. https://doi.org/10.1503/cmaj.110837(https://doi.org/10.1503/cmaj.110837) Crane, M. (2021). Dangers of marijuana: Long-term effects of pot on the brain and body. American Addiction Centers. https://americanaddictioncenters.org/marijuana-rehab/long-term-effects(https://americanaddictioncenters.org/marijuana-rehab/long-term-effects) Freeman, T. P., & Winstock, A. R. (2015). Examining the profile of high-potency cannabis and its association with severity of cannabis dependence. Psychological Medicine, 45(15), 3181-3189. https://doi.org/10.1017/S0033291715001178(https://doi.org/10.1017/S0033291715001178) Government of Canada. (2019). Cannabis: Lower your risks. https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/resources/low(https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/resources/lower-your-risks.html)er-your-risks.html(https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/resources/lower-your-risks.html) Government of Canada. (2020). Canadian cannabis survey 2020: Summary. https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/research-data(https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/research-data/canadian-cannabis-survey-2020-summary.html#a4)/canadian-cannabis-survey-2020-summary.html#a4(https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/research-data/canadian-cannabis-survey-2020-summary.html#a4) Greco, R., Gasperi, V., Maccarrone, M., & Tassorelli, C. (2010). The endocannabinoid system and migraine. Experimental Neurology, 224(1), 85-91. https://doi.org/10.1016/j.expneurol.2010.03.029(https://doi.org/10.1016/j.expneurol.2010.03.029) Green, B., Kavanagh, D., & Young, R. (2003). Being stoned: A review of self-reported cannabis effects. Drug and Alcohol Review, 22(4), 453-460. https://doi.org/10.1080/09595230310001613976(https://doi.org/10.1080/09595230310001613976) Grewal, J. K., & Loh, L. C. (2020). Health considerations of the legalization of cannabis edibles. Canadian Medical Association Journal (CMAJ), 192(1), E1-E2. https://doi.org/10.1503/cmaj.191217(https://doi.org/10.1503/cmaj.191217) Grewal. S., & George. T. (2017). Cannabis-induced psychosis: A review. Psychiatric Times, 34(7). https://www.psychiatrictimes.com/view/cannabis-induced-psychosis-review(https://www.psychiatrictimes.com/view/cannabis-induced-psychosis-review) Hall, W. (2015). What has research over the past two decades revealed about the adverse health effects of recreational cannabis use? Addiction (Abingdon, Endlang), 110(1), 19-35. https://doi.org/10.1111/add.12703(https://doi.org/10.1111/add.12703) Hamilton, H. A., Brands, B., Ialomiteanu, A. R., & Mann, R. E. (2017). Therapeutic use of cannabis: Prevalence and characteristics among adults in ontario, canada. Canadian Journal of Public Health, 108(3), e282-e287. https://doi.org/10.17269/CJPH.108.6130(https://doi.org/10.17269/CJPH.108.6130) Hasin, D. S., Saha, T. D., Kerridge, B. T., Goldstein, R. B., Chou, S. P., Zhang, H., Jung, J., Pickering, R. P., Ruan, W. J., Smith, S. M., Huang, B., & Grant, B. F. (2015). Prevalence of marijuana use disorders in the united states between 2001-2002 and 2012-2013. JAMA Psychiatry, 72(12), 1235-1242. https://doi.org/10.1001/jamapsychiatry.2015.1858(https://doi.org/10.1001/jamapsychiatry.2015.1858) Holt. J. (2021, January 18). The pros and cons of using marijuana recreationally. Grow Diaries. https://growdiaries.com/journal/the-pros-and-cons-of-using-cannabis-recreationally(https://growdiaries.com/journal/the-pros-and-cons-of-using-cannabis-recreationally) Jones, K. A., Blagrove, M., & Parrott, A. C. (2009). Cannabis and ecstasy/mdma: Empirical measures of creativity in recreational users. Journal of Psychoactive Drugs, 41(4), 323-329. https://doi.org/10.1080/02791072.2009.10399769(https://doi.org/10.1080/02791072.2009.10399769) Joy, J. E., Watson, S. J., Benson, J. A., NetLibrary, I., Institute of Medicine (U.S.). Division of Neuroscience and Behavioral Health, & Institute of Medicine. (1999;2000;2005;). In Janet E. Joy, John A. Benson J. and Stanley J. Watson J.(Eds.), Marijuana and medicine: Assessing the science base. National Academy Press. https://doi.org/10.17226/6376(https://doi.org/10.17226/6376) Kouri, E., Pope, H. G., Yurgelun-Todd, D., & Gruber, S. (1995). Attributes of heavy vs. occasional marijuana smokers in a college population. Biological Psychiatry (1969), 38(7), 475-481. https://doi.org/10.1016/0006-3223(94)00325-W(https://doi.org/10.1016/0006-3223(94)00325-W) Ksir, C., & Hart, C. L. (2016). Cannabis and psychosis: A critical overview of the relationship. Current Psychiatry Reports, 18(2), 1-11. https://doi.org/10.1007/s11920-015-0657-y(https://doi.org/10.1007/s11920-015-0657-y) Lachenmeier, D. W., & Rehm, J. (2015). Comparative risk assessment of alcohol, tobacco, cannabis and other illicit drugs using the margin of exposure approach. Scientific Reports, 5(1), 8126. https://doi.org/10.1038/srep08126(https://doi.org/10.1038/srep08126) Liu, Q., Wu, Z., Liu, Y., Chen, L., Zhao, H., Guo, H., Zhu, K., Wang, W., Chen, S., Zhou, N.,Li, Y., & Shi, B. (2020). Cannabinoid receptor 2 activation decreases severity of cyclophosphamide‐ induced cystitis via regulating autophagy. Neurourology and Urodynamics, 39(1), 158-169. https://doi.org/10.1002/nau.24205(https://doi.org/10.1002/nau.24205) Long and short-term effects of cannabis. (2018, June 21). Portage. https://portage.ca/en/blog/long-and-short-term-effects-of-cannabis/(https://portage.ca/en/blog/long-and-short-term-effects-of-cannabis/) MacCallum, C.A., & Russo, E. B. (2018). Practical considerations in medical cannabis administration and dosing. European Journal of Internal Medicine, 49, 12-19. https://doi.org/10.1016/j.ejim.2018.01.004(https://doi.org/10.1016/j.ejim.2018.01.004) Mundell, E., J. (2020, March 18). One joint may cause psychotic symptoms: Study. A Family Pharmacy Apple Valley. https://www.afamilypharmacy.com/patient-resources/article/755848/one-joint-may-cause-(https://www.afamilypharmacy.com/patient-resources/article/755848/one-joint-may-cause-psychotic-symptoms-study)psychotic-symptoms-study(https://www.afamilypharmacy.com/patient-resources/article/755848/one-joint-may-cause-psychotic-symptoms-study) National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice; Committee on the Health Effects of Marijuana: An Evidence Review and Research Agenda. (2017). The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. Washington (DC): National Academies Press (US); 2017 Jan 12.  https://doi.org/10.17226/24625(https://doi.org/10.17226/24625) Peki, W. (2021). 61 potential benefits of marijuana and its cannabinoids that are backed by scientific research. Herbonaut. https://www.herbonaut.com/benefits-of-marijuana/(https://www.herbonaut.com/benefits-of-marijuana/) Ramo, D. E., Delucchi, K. L., Hall, S. M., Liu, H., & Prochaska, J. J. (2013). Marijuana and tobacco co-use in young adults: Patterns and thoughts about use. Journal of Studies on Alcohol and Drugs, 74(2), 301-310. https://doi.org/10.15288/jsad.2013.74.301(https://doi.org/10.15288/jsad.2013.74.301) Ramos Barreda, A., De Leon, K., & Urmas, S. (2018). A simple guide to pot, thc and how much is too much. LA Times. https://www.latimes.com/projects/la-me-weed-101-thc-calculator/(https://www.latimes.com/projects/la-me-weed-101-thc-calculator/) Reiman, A. (2009). Cannabis as a substitute for alcohol and other drugs. Harm Reduction Journal, 6(1), 35-35. https://doi.org/10.1186/1477-7517-6-35(https://doi.org/10.1186/1477-7517-6-35) Rosenberg, E. C., Tsien, R. W., Whalley, B. J., & Devinsky, O. (2015). Cannabinoids and epilepsy. Neurotherapeutics, 12(4), 747-768. https://doi.org/10.1007/s13311-015-0375-5(https://doi.org/10.1007/s13311-015-0375-5) Rubinstein, M. L., Rait, M. A., & Prochaska, J. J. (2014). Frequent marijuana use is associated with greater nicotine addiction in adolescent smokers. Drug and Alcohol Dependence, 141, 159-162. https://doi.org/10.1016/j.drugalcdep.2014.05.015(https://doi.org/10.1016/j.drugalcdep.2014.05.015) Szaflarski, Jerzy P., MD, PhD, & Devinsky, O. (2017). Cannabinoids and epilepsy —introduction. Epilepsy & Behavior, 70(Pt B), 277-277. https://doi.org/10.1016/j.yebeh.2017.01.015(https://doi.org/10.1016/j.yebeh.2017.01.015) Wall, J., Davis, S., & Ridgway, S. (2001). Cannabis: Its therapeutic use. Nursing Standard, 16(10), 39-44. https://doi.org/10.7748/ns2001.11.16.10.39.c3123(https://doi.org/10.7748/ns2001.11.16.10.39.c3123) Ware, M. A., Wang, T., Shapiro, S., Robinson, A., Ducruet,T., Huynh, T., Gamsa, A., Bennett, G. J., & Collet, J. (2010). Smoked cannabis for chronic neuropathic pain: A randomized controlled trial. Canadian Medical Association Journal (CMAJ), 182(14), E694-E701. https://doi.org/10.1503/cmaj.091414(https://doi.org/10.1503/cmaj.091414) Watkins. M., (2020, August 17). Marijuana (weed, cannabis) overdose symptoms, signs & treatment. American Addictions Centers. https://drugabuse.com/drugs/marijuana/overdose/(https://drugabuse.com/drugs/marijuana/overdose/) Webb, C. W., & Webb, S. M. (2014). Therapeutic benefits of cannabis: A patient survey.Hawai'i Journal of Medicine & Public Health, 73(4), 109-111. https://pubmed.ncbi.nlm.nih.gov/24765558/(https://pubmed.ncbi.nlm.nih.gov/24765558/) Weckowicz, T. E. (1975). Effect of marijuana on divergent and convergent production cognitive tests. Journal of Abnormal Psychology (1965), 84(4), 386-398. https://doi.org/10.1037/0021-843X.84.4.386(https://doi.org/10.1037/0021-843X.84.4.386) World Health Organization. (2016). The health and social effects of nonmedical cannabis use. https://apps.who.int/iris/handle/10665/251056(https://apps.who.int/iris/handle/10665/251056)

Armstrong, M. J. (2018, October 16). Legal cannabis vs. black market: Can it compete? The Conversation. Retrieved February 1, 2020, from https://theconversation.com/legal-cannabis-vs-black-market-can-it-compete-104915.(https://theconversation.com/legal-cannabis-vs-black-market-can-it-compete-104915) Ashton, C. H. (2001). Pharmacology and effects of cannabis: A brief review. British Journal of Psychiatry, 178(2), 101-106. https://doi.org/10.1192/bjp.178.2.101(https://doi.org/10.1192/bjp.178.2.101) Beirness, D. J., & Porath-Waller, A. J. (2019). Clearing the smoke on cannabis: Cannabis use and driving -an update. Canadian Centre on Substance Abuse. https://www.ccsa.ca/sites/default/files/2019-10/CCSA-Cannabis-Use-Driving-Report-2019(https://www.ccsa.ca/sites/default/files/2019-10/CCSA-Cannabis-Use-Driving-Report-2019-en_1.pdf)-en_1.pdf(https://www.ccsa.ca/sites/default/files/2019-10/CCSA-Cannabis-Use-Driving-Report-2019-en_1.pdf) Berghaus, G., & Guo, B.L. (1995). Medicines and driver fitness—findings from a meta-analysis of experimental studies as basic information to patients, physicians, and experts. Transportation Research Board. https://trid.trb.org/view/470158(https://trid.trb.org/view/470158) Bjorge, P. (2020, March 4). Cannabis tinctures 101: How to make, consume, and dose them. Leafly.https://www.leafly.ca/news/cannabis-101/cannabis-tinctures-101-what-are-they-how-to-ma(https://www.leafly.ca/news/cannabis-101/cannabis-tinctures-101-what-are-they-how-to-m)ke-them-and-how-to(https://www.leafly.ca/news/cannabis-101/cannabis-tinctures-101-what-are-they-how-to-make-them-and-how-to) Boone, S. (2021, April 16). Curious about the indica vs. sativa debate? Learn the real difference. Scary Mommy. https://www.scarymommy.com/indica-vs-sativa/#:~:text=Indica%20plants%20are%20short%20and%20stocky%20with%20broad,written%20records%20of%20their%20distinct%20genetics%20and%20evolution.(https://www.scarymommy.com/indica-vs-sativa/#:~:text=Indica%20plants%20are%20short%20and%20stocky%20with%20broad,written%20records%20of%20their%20distinct%20genetics%20and%20evolution) Borodovsky, J. T., Crosier, B. S., Lee, D. C., Sargent, J. D., & Budney, A. J. (2016). Smoking, vaping, eating: Is legalization impacting the way people use cannabis? The International Journal of Drug Policy, 36, 141-147. https://doi.org/10.1016/j.drugpo.2016.02.022(https://doi.org/10.1016/j.drugpo.2016.02.022) Boshkova, M., (2018). Why do people smoke weed? The top 12 reasons. Higher Mentality. https://www.highermentality.com/why-people-smoke-weed/(https://www.highermentality.com/why-people-smoke-weed/) Capler, R. (2009). Why people use cannabis. Visions: BC’s Mental Health and Substance Use Journal, 5(4), 9. https://www.heretohelp.bc.ca/why-people-use-cannabis(https://www.heretohelp.bc.ca/why-people-use-cannabis) Duvall, C., S, (2019). “Decriminalization doesn’t erase marijuana’s class and race problems.” Opposing viewpoints online collection, Gale, 2019. www.gale.com. Originally published as “Decriminalization doesn’t address marijuana’s standing as a drug of the poor,” The Conversation, 31 Mar. 2015. https://www.gale.com/open-access/marijuana(https://www.gale.com/open-access/marijuana) Fataar, F., Goodman, S., Wadsworth, E., & Hammond, D. (2021). Consumer perceptions of ‘legal’ and ‘illegal’ cannabis in us states with legal cannabis sales. Addictive Behaviors, 112, 106563-106563. https://doi.org/10.1016/j.addbeh.2020.106563(https://doi.org/10.1016/j.addbeh.2020.106563) Franciosi, A. (2017). THC patch: The ultimate guide to thc transdermal patches. Honest Marijuana. https://honestmarijuana.com/thc-patch/(https://honestmarijuana.com/thc-patch/) Fraser, G., A., (2009). The use of a synthetic cannabinoid in the management of treatment-resistant nightmares in posttraumatic stress disorder (PTSD). CNS Neuroscience & Therapeutics, 15(1), 84-88. https://doi.org/10.1111/j.1755-5949.2008.00071.x(https://doi.org/10.1111/j.1755-5949.2008.00071.x) Gilbert, A. N., & DiVerdi, J. A. (2018). Consumer perceptions of strain differences in cannabis aroma. PloS One, 13(2), e0192247-e0192247. https://doi.org/10.1371/journal.pone.0192247(https://doi.org/10.1371/journal.pone.0192247) Government of Canada. (2019). What you need to know before you choose to consume cannabis. https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/resources/wH(https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/resources/what-you-need-to-know-if-you-choose-to-consume-cannabis.html)at-you-need-to-know-if-you-choose-to-consume-cannabis.html(https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/resources/what-you-need-to-know-if-you-choose-to-consume-cannabis.html) Government of Canada. (2020). Canadian Cannabis Survey 2020: Summary. https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/research-data(https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/research-data/canadian-cannabis-survey-2020-summary.html#a2)/canadian-cannabis-survey-2020-summary.html#a2(https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/research-data/canadian-cannabis-survey-2020-summary.html#a2) Government of Canada. (2020). What you need to know about cannabis. https://www.canada.ca/en/services/health/campaigns/cannabis/canadians.html#a7(https://www.canada.ca/en/services/health/campaigns/cannabis/canadians.html#a7) Government of Ontario. (2021). Cannabis and driving. Learn about the laws and penalties, and how cannabis affects your driving. https://www.ontario.ca/page/cannabis-and-driving(https://www.ontario.ca/page/cannabis-and-driving) Hartman, R. L., Brown, T. L., Milavetz, G., Spurgin, A., Pierce, R. S., Gorelick, D. A., Gaffney, G., & Huestis, M. A. (2015). Cannabis effects on driving lateral control with and without alcohol. Drug and Alcohol Dependence, 154, 25-37. https://doi.org/10.1016/j.drugalcdep.2015.06.015(https://doi.org/10.1016/j.drugalcdep.2015.06.015) Hartman, R. L., & Huestis, M. A. (2013). Cannabis effects on driving skills. Clinical Chemistry (Baltimore, Md.), 59(3), 478-492. https://doi.org/10.1373/clinchem.2012.194381(https://doi.org/10.1373/clinchem.2012.194381) Hartogsohn, I. (2017). Constructing drug effects: A history of set and setting. Drug Science, Policy and Law. https://doi.org/10.1177/2050324516683325(https://doi.org/10.1177/2050324516683325) Holland, K. (2021). Sativa vs. indica: What to expect across cannabis types and strains. Healthline. https://www.healthline.com/health/sativa-vs-indica(https://www.healthline.com/health/sativa-vs-indica) Huestis, M. A. (2007). Human cannabinoid pharmacokinetics. Chemistry & Biodiversity, 4(8), 1770- 1804. https://doi.org/10.1002/cbdv.200790152(https://doi.org/10.1002/cbdv.200790152) Legal vs. illegal: Inside canada’s marketplace. (2020). Responsible Cannabis Use. https://thercu.org/blogs/blog/legal-vs-illegal-inside-canada-s-cannabis-marketplace(https://thercu.org/blogs/blog/legal-vs-illegal-inside-canada-s-cannabis-marketplace) Livingston, L., (2018). 6 uses for indica cannabis strains. Buy My Weed Online. https://buymyweedonline.com/marijuana/6-uses-for-indica/(https://buymyweedonline.com/marijuana/6-uses-for-indica/) MADD. (n.d.). Cannabis and driving. https://madd.ca/pages/impaired-driving/overview/cannabis-and-driving/(https://madd.ca/pages/impaired-driving/overview/cannabis-and-driving/) Martin, T. L., Solbeck, P. A. M., Mayers, D. J., Langille, R. M., Buczek, Y., & Pelletier, M. R. (2013). A review of alcohol-impaired driving: The role of blood alcohol concentration and complexity of the driving task. Journal of Forensic Sciences, 58(5), 1238-1250. https://doi.org/10.1111/1556-4029.12227(https://doi.org/10.1111/1556-4029.12227) McPartland, J. M., & Small, E. (2020). A classification of endangered high-thc cannabis (cannabis sativa subsp. indica) domesticates and their wild relatives. Phytokeys, 144(2), 81-112. https://doi.org/10.3897/phytokeys.144.46700(https://doi.org/10.3897/phytokeys.144.46700) Moore, T. R. (2002). A primer of drug action: A concise nontechnical guide to the actions, uses, and side effects of psychoactive drugs, ninth edition. American Journal of Health-System Pharmacy, 59(11), 1130-1131. https://doi.org/10.1093/ajhp/59.11.1130a(https://doi.org/10.1093/ajhp/59.11.1130a) National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice; Committee on the Health Effects of Marijuana: An Evidence Review and Research Agenda. (2017). The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. Washington (DC): National Academies Press (US); 2017 Jan 12. https://doi.org/10.17226/24625(https://doi.org/10.17226/24625) Parnes, J. E., Bravo, A. J., Conner, B. T., & Pearson, M. R. (2018). A burning problem:Cannabis lessons learned from Colorado. Addiction Research & Theory, 26(1), 3-10. https://doi.org/10.1080/16066359.2017.1315410(https://doi.org/10.1080/16066359.2017.1315410) Ramaekers, J. G., Robbe, H. W. J., & O'Hanlon, J. F. (2000). Marijuana, alcohol and actual driving performance. Human Psychopharmacology, 15(7), 551-558. https://doi.org/10.1002/1099-1077(200010)15:7<551::AID-HUP236>3.0.CO;2-P(https://doi.org/10.1002/1099-1077(200010)15:7%3C551::AID-HUP236%3E3.0.CO;2-P) Rosado, J., (2019). Cannabis hybrids. Marijuana Doctors. https://www.marijuanadoctors.com/resources/cannabis-hybrids/(https://www.marijuanadoctors.com/resources/cannabis-hybrids/) Rotermann, M. (2019). National cannabis survey 2nd quarter. Statistics Canada. https://www150.statcan.gc.ca/n1/en/catalogue/11-627-M2019057(https://www150.statcan.gc.ca/n1/en/catalogue/11-627-M2019057) Safe Cannabis Guide. (n.d.). Methods of cannabis consumption. https://www.safecannabisuse.com/dosing/(https://www.safecannabisuse.com/dosing/) Society for the Study of Ingestive Behavior. (2018, July 17). How cannabis affects appetite: brain changes. ScienceDaily. Retrieved June 27, 2021 from www.sciencedaily.com/releases/2018/07/180717094747.htm(http://www.sciencedaily.com/releases/2018/07/180717094747.htm) Statistics Canada. (2019, October 30). National cannabis survey, third quarter 2019. https://www150.statcan.gc.ca/n1/daily-quotidien/191030/dq191030a-eng.htm(https://www150.statcan.gc.ca/n1/daily-quotidien/191030/dq191030a-eng.htm) The Cannabis Advisory. (n.d.). How soon after using cannabis can you drive? https://www.thecannabisadvisory.com/cannabis-news/after-using-cannabis-can-drive/(https://www.thecannabisadvisory.com/cannabis-news/after-using-cannabis-can-drive/) Tringale, R., & Jensen, C. (2011). Cannabis and insomnia. http://files7.webydo.com/92/9209805/UploadedFiles/5E9EC245-448E-17B2-C7CA-21C6(http://files7.webydo.com/92/9209805/UploadedFiles/5E9EC245-448E-17B2-C7CA-21C6BDC6852D.pdf)BDC6852D.pdf(http://files7.webydo.com/92/9209805/UploadedFiles/5E9EC245-448E-17B2-C7CA-21C6BDC6852D.pdf) Vincent, P. C., Collins, R. L., Liu, L., Yu, J., De Leo, J. A., & Earleywine, M. (2017). Theeffects of perceived quality on behavioral economic demand for marijuana: A web-based experiment. Drug and Alcohol Dependence, 170, 174-180. https://doi.org/10.1016/j.drugalcdep.2016.11.013(https://doi.org/10.1016/j.drugalcdep.2016.11.013) Volkow, N. (2015). The biology and potential therapeutic effects of cannabidiol. National Institute on Drug Abuse. https://archives.drugabuse.gov/testimonies/2015/biology-potential-therapeutic-effects-cann(https://archives.drugabuse.gov/testimonies/2015/biology-potential-therapeutic-effects-cannabidiol#:~:text=CBD%20has%20shown%20therapeutic%20efficacy,measures%20of%20stress%20and%20anxiety.&text=In%20addition%2C%20CBD%20has%20shown,human%20laboratory%20and%20clinical%20trials)abidiol#:~:text=CBD%20has%20shown%20therapeutic%20efficacy,measures%20of%20(https://archives.drugabuse.gov/testimonies/2015/biology-potential-therapeutic-effects-cannabidiol#:~:text=CBD%20has%20shown%20therapeutic%20efficacy,measures%20of%20stress%20and%20anxiety.&text=In%20addition%2C%20CBD%20has%20shown,human%20laboratory%20and%20clinical%20trials)stress%20and%20anxiety.&text=In%20addition%2C%20CBD%20has%20shown,human(https://archives.drugabuse.gov/testimonies/2015/biology-potential-therapeutic-effects-cannabidiol#:~:text=CBD%20has%20shown%20therapeutic%20efficacy,measures%20of%20stress%20and%20anxiety.&text=In%20addition%2C%20CBD%20has%20shown,human%20laboratory%20and%20clinical%20trials)%20laboratory%20and%20clinical%20trials.(https://archives.drugabuse.gov/testimonies/2015/biology-potential-therapeutic-effects-cannabidiol#:~:text=CBD%20has%20shown%20therapeutic%20efficacy,measures%20of%20stress%20and%20anxiety.&text=In%20addition%2C%20CBD%20has%20shown,human%20laboratory%20and%20clinical%20trials) White, J, (n.d.). Cannabis Sativa - What is Cannabis Sativa? A guide to sativa marijuana strains, their effects and medical uses, and how they work. CNBS. https://www.cnbs.org/cannabis-types/cannabis-sativa/(https://www.cnbs.org/cannabis-types/cannabis-sativa/)

Abdallah, S. J., Smith, B. M., Ware, M. A., Moore, M., Li, P. Z., Bourbeau, J., & Jensen, D. (2018). Effect of vaporized cannabis on exertional breathlessness and exercise endurance in advanced chronic obstructive pulmonary disease: A randomized controlled trial. Annals of the American Thoracic Society, 15(10), 1146-1158. https://doi.org/10.1513/AnnalsATS.201803-198OC(https://doi.org/10.1513/AnnalsATS.201803-198OC) Agrawal, A., Budney, A. J., & Lynskey, M. T. (2012). The co-occurring use and misuse of cannabis and tobacco: A review. Addiction (Abingdon, England), 107(7), 1221-1233. https://doi.org/10.1111/j.1360-0443.2012.03837.x(https://doi.org/10.1111/j.1360-0443.2012.03837.x) Allen, J. A., Davis, K. C., Duke, J. C., Nonnemaker, J. M., Bradfield, B. R., & Farrelly, M. C. (2017). New product trial, use of edibles, and unexpected highs among marijuana and hashish users in colorado. Drug and Alcohol Dependence, 176, 44-47. https://doi.org/10.1016/j.drugalcdep.2017.03.006(https://doi.org/10.1016/j.drugalcdep.2017.03.006) Al-Zouabi, I., Stogner, J. M., Miller, B. L., & Lane, E. S. (2018). Butane hash oil and dabbing: insights into use, amateur production techniques, and potential harm mitigation. Substance Abuse and Rehabilitation, 9, 91–101. https://doi.org/10.2147/SAR.S135252(https://doi.org/10.2147/SAR.S135252) Anderson, R. P., & Zechar, K. (2019). Lung injury from inhaling butane hash oil mimics pneumonia. Respiratory Medicine Case Reports, 26, 171-173. https://doi.org/10.1016/j.rmcr.2019.01.002(https://doi.org/10.1016/j.rmcr.2019.01.002) Baron, E. P. (2015). Comprehensive review of medicinal marijuana, cannabinoids, and therapeutic implications in medicine and headache: What a long strange trip it's been. Headache, 55(6), 885-916. https://doi.org/10.1111/head.12570(https://doi.org/10.1111/head.12570) Blake, A., & Nahtigal, I. (2019). The evolving landscape of cannabis edibles. Current Opinion in Food Science, 28, 25-31. https://doi.org/10.1016/j.cofs.2019.03.009(https://doi.org/10.1016/j.cofs.2019.03.009) Calapai, F., Cardia, L., Sorbara, E. E., Navarra, M., Gangemi, S., Calapai, G., & Mannucci, C. (2020). Cannabinoids, Blood-Brain Barrier, and Brain Disposition. Pharmaceutics, 12(3), 265. https://doi.org/10.3390/pharmaceutics12030265(https://doi.org/10.3390/pharmaceutics12030265) Cannabis-based medicines -Gw pharmaceuticals: High cbd, high thc, medicinal cannabis -Gw pharmaceuticals, thc:cbd. (2003). Drugs in R&D, 4(5), 306-309. https://doi.org/10.2165/00126839-200304050-00005(https://doi.org/10.2165/00126839-200304050-00005) Chelliah, M. P., Zinn, Z., Khuu, P., & Teng, J. M. (2018). Self‐initiated use of topical cannabidiol oil for epidermolysis bullosa. Pediatric Dermatology, 35(4), e224-e227. https://doi.org/10.1111/pde.13545(https://doi.org/10.1111/pde.13545) Cinnamon Bidwell, L., YorkWilliams, S. L., Mueller, R. L., Bryan, A. D., & Hutchison, K. E. (2018). Exploring cannabis concentrates on the legal market: User profiles, product strength, and health-related outcomes. Addictive Behaviors Reports, 8, 102-106. https://doi.org/10.1016/j.abrep.2018.08.004(https://doi.org/10.1016/j.abrep.2018.08.004) Cozzi, N. V. (1993). Effects of water filtration on marijuana smoke: A literature review. MAPS Bull, 4(2), 4-6. https://maps.org/news/bulletin/effects-of-water-filtration-on-marijuana-smoke/(https://maps.org/news/bulletin/effects-of-water-filtration-on-marijuana-smoke/) Craft, S., Winstock, A., Ferris, J., Mackie, C., Lynskey, M. T., & Freeman, T. P. (2020;2019;). Characterising heterogeneity in the use of different cannabis products: Latent class analysis with 55 000 people who use cannabis and associations with severity of cannabis dependence. Psychological Medicine, 50(14), 2364-2373. https://doi.org/10.1017/S0033291719002460(https://doi.org/10.1017/S0033291719002460) Earleywine, M., & Barnwell, S. S. (2007). Decreased respiratory symptoms in cannabis users who vaporize. Harm Reduction Journal, 4(1), 1-4. https://doi.org/10.1186/1477-7517-4-11(https://doi.org/10.1186/1477-7517-4-11) Gaffal, E., Cron, M., Glodde, N., & Tüting, T. (2013). Anti‐inflammatory activity of topical thc in dnfb‐mediated mouse allergic contact dermatitis independent of cb1 and cb2 receptors. Allergy, 68(8), 994-1000. https://doi.org/10.1111/all.12183(https://doi.org/10.1111/all.12183) Gates, P., Jaffe, A., & Copeland, J. (2014). Cannabis smoking and respiratory health: Consideration of the literature. Respirology (Carlton, Vic.), 19(5), 655-662. https://doi.org/10.1111/resp.12298(https://doi.org/10.1111/resp.12298) Gieringer, D. (1996). Marijuana water pipe and vaporizer study. MAPS Bull, 6(3), 59-66. https://maps.org/news-letters/v06n3/06359mj1.html(https://maps.org/news-letters/v06n3/06359mj1.html) Gieringer, D. H. (2001). Cannabis "vaporization": A promising strategy for smoke harm reduction. Journal of Cannabis Therapeutics, 1(3-4), 153-170. https://doi.org/10.1300/J175v01n03_10(https://doi.org/10.1300/J175v01n03_10) Government of Canada. (2019). Canadian cannabis survey 2019 –Summary.https://www.canada.ca/en/health-canada/services/publications/drugs-health-products/canad(https://www.canada.ca/en/health-canada/services/publications/drugs-health-products/canadian-cannabis-survey-2019-summary.html)ian-cannabis-survey-2019-summary.html(https://www.canada.ca/en/health-canada/services/publications/drugs-health-products/canadian-cannabis-survey-2019-summary.html) Government of Canada. (2019). Final regulations: Edible cannabis, cannabis extracts, cannabis topicals. https://www.canada.ca/content/dam/hc-sc/documents/services/drugs-medication/cannabis/(https://www.canada.ca/content/dam/hc-sc/documents/services/drugs-medication/cannabis/resources/final-regulations-edible-cannabis-extracts-topical-eng.pdf)resources/final-regulations-edible-cannabis-extracts-topical-eng.pdf(https://www.canada.ca/content/dam/hc-sc/documents/services/drugs-medication/cannabis/resources/final-regulations-edible-cannabis-extracts-topical-eng.pdf) Government of Canada. (2020). Canadian cannabis survey 2020: Summary. https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/research-data(https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/research-data/canadian-cannabis-survey-2020-summary.html#a2)/canadian-cannabis-survey-2020-summary.html#a2(https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/research-data/canadian-cannabis-survey-2020-summary.html#a2) Government of Canada. (2021, February 3). Cannabis legalization and regulation. https://www.justice.gc.ca/eng/cj-jp/cannabis/(https://www.justice.gc.ca/eng/cj-jp/cannabis/) Grof, C. P. L. (2018). Cannabis, from plant to pill. British Journal of Clinical Pharmacology, 84(11), 2463-2467. https://doi.org/10.1111/bcp.13618(https://doi.org/10.1111/bcp.13618) Grotenhermen, F. (2001). Harm reduction associated with inhalation and oral administration of cannabis and thc. Journal of Cannabis Therapeutics, 1(3-4), 133-152. https://doi.org/10.1300/J175v01n03_09(https://doi.org/10.1300/J175v01n03_09) Grotenhermen, F. (2003). Pharmacokinetics and pharmacodynamics of cannabinoids. Clinical Pharmacokinetics, 42(4), 327-360. https://doi.org/10.2165/00003088-200342040-00003(https://doi.org/10.2165/00003088-200342040-00003) Grotenhermen, F., Russo, E., & Zuardi, A. W. (2017). Even high doses of oral cannabidiol do not cause thc-like effects in humans: Comment on merrick et al. cannabis and cannabinoid research 2016; 1 (1): 102–112; DOI: 10.1089/can. 2015.0004. Cannabis and Cannabinoid Research, 2(1), 1-4. https://doi.org/10.1089/can.2016.0036(https://doi.org/10.1089/can.2016.0036) Guy, G. W., Flint, M. E., Robson, P. J., & Whittle, B. A. (2000). A phase one study of sublingual cannabis-based medicine extract. Journal of Pharmacy and Pharmacology,52(9; SUPP/1), 294-294. https://eurekamag.com/research/034/314/034314323.php(https://eurekamag.com/research/034/314/034314323.php) Guy, R. H. (1996). Current status and future prospects of transdermal drug delivery. Pharmaceutical Research, 13(12), 1765-1769. https://doi.org/10.1023/a:1016060403438(https://doi.org/10.1023/a:1016060403438) GW Pharmaceuticals. (2012). Sativex Product Monograph, Salisbury, Wiltshire, UK. https://pdf.hres.ca/dpd_pm/00016162.PDF(https://pdf.hres.ca/dpd_pm/00016162.PDF) Hakkarainen, P. (2016). Vaporizing the pot world –easy, healthy, and cool. Drugs and Alcohol Today, 16(3), 185-193. https://doi.org/10.1108/DAT-10-2015-0062(https://doi.org/10.1108/DAT-10-2015-0062) Hancox, R. J., Poulton, R., Ely, M., Welch, D., Taylor, D. R., McLachlan, C. R., Greene, J. M., Moffitt, T. E., Caspi, A., & Sears, M. R. (2010). Effects of cannabis on lung function: a population-based cohort study. The European Respiratory Journal, 35(1), 42–47. https://doi.org/10.1183/09031936.00065009(https://doi.org/10.1183/09031936.00065009) Happyana, N., Agnolet, S., Muntendam, R., Van Dam, A., Schneider, B., & Kayser, O. (2013). Analysis of cannabinoids in laser-microdissected trichomes of medicinal cannabis sativa using lcms and cryogenic nmr. Phytochemistry (Oxford), 87, 51-59. https://doi.org/10.1016/j.phytochem.2012.11.001(https://doi.org/10.1016/j.phytochem.2012.11.001) Hash. (2021, June 28). https://weedmaps.com/learn/dictionary/hash(https://weedmaps.com/learn/dictionary/hash) Hawley, D., Graham, T., Stasiak, M., & Dixon, M. (2018). Improving cannabis bud quality and yield with subcanopy lighting. Hortscience, 53(11), 1593-1599. https://doi.org/10.21273/HORTSCI13173-18(https://doi.org/10.21273/HORTSCI13173-18) Hazekamp, A., Ruhaak, R., Zuurman, L., van Gerven, J., & Verpoorte, R. (2006). Evaluation of a vaporizing device (volcano®) for the pulmonary administration of tetrahydrocannabinol. Journal of Pharmaceutical Sciences, 95(6), 1308-1317. https://doi.org/10.1002/jps.20574(https://doi.org/10.1002/jps.20574) He, T., Oks, M., Esposito, M., Steinberg, H., & Makaryus, M. (2017). “Tree-in-bloom”: Severe acute lung injury induced by vaping cannabis oil. Annals of the American Thoracic Society, 14(3). https://doi.org/10.1513/AnnalsATS.201612-974LE(https://doi.org/10.1513/AnnalsATS.201612-974LE) Hess, C., Krämer, M., & Madea, B. (2017). Topical application of thc containing products is not able to cause positive cannabinoid finding in blood or urine. Forensic Science International, 272, 68-71. https://doi.org/10.1016/j.forsciint.2017.01.008(https://doi.org/10.1016/j.forsciint.2017.01.008) Hosseini, A.,McLachlan, A. J., & Lickliter, J. D. (2021). A phase I trial of the safety, tolerability and pharmacokinetics of cannabidiol administered as single‐dose oil solution and single and multiple doses of a sublingual wafer in healthy volunteers. British Journal of Clinical Pharmacology, 87(4), 2070-2077. https://doi.org/10.1111/bcp.14617(https://doi.org/10.1111/bcp.14617) Howie, N., Trigkas, T., Cruchley, A., Wertz, P., Squier, C., & Williams, D. (2001). Short-term exposure to alcohol increases the permeability of human oral mucosa. Oral Diseases, 7(6), 349-354. https://doi.org/10.1034/j.1601-0825.2001.00731.x(https://doi.org/10.1034/j.1601-0825.2001.00731.x) Huestis M. A. (2007). Human cannabinoid pharmacokinetics. Chemistry & Biodiversity, 4(8), 1770–1804. https://doi.org/10.1002/cbdv.200790152(https://doi.org/10.1002/cbdv.200790152) Jackson, D. K. & Hyatt, K. (2013). Silicone and hyaluronic acid (hla) delivery systems for products by sustainable processes for medical uses including wound management. (US Patent No. US2013/0184354 A1). https://patents.google.com/patent/US20130184354A1/en(https://patents.google.com/patent/US20130184354A1/en) Jin, D., Jin, S., & Chen, J. (2019). Cannabis indoor growing conditions, management practices, and post-harvest treatment: a review. American Journal of Plant Sciences, 10(6), 925. https://doi.org/10.4236/ajps.2019.106067(https://doi.org/10.4236/ajps.2019.106067) Johnson, J. R., Lossignol, D., Burnell-Nugent, M., & Fallon, M. T. (2013). An open-label extension study to investigate the long-term safety and tolerability of thc/cbd oromucosal spray and oromucosal thc spray in patients with terminal cancer-related pain refractory to strong opioid analgesics. Journal of Pain and Symptom Management, 46(2), 207-218. https://doi.org/10.1016/j.jpainsymman.2012.07.014(https://doi.org/10.1016/j.jpainsymman.2012.07.014) Joshi, M., Joshi, A., & Bartter, T. (2014). Marijuana and lung diseases. Current Opinion in Pulmonary Medicine, 20(2), 173-179. https://doi.org/10.1097/MCP.0000000000000026(https://doi.org/10.1097/MCP.0000000000000026) Kado, J. (2020). Topical formulation for binding to dermatological cannabinoid receptors. (US Patent No. 10543176). https://patents.google.com/patent/US10543176B2/en?oq=U.S.+Patent+No.+10%2c543%2(https://patents.google.com/patent/US10543176B2/en?oq=U.S.+Patent+No.+10%2c543%2c176)c176(https://patents.google.com/patent/US10543176B2/en?oq=U.S.+Patent+No.+10%2c543%2c176) Kamel, R. (2015). Transdermal drug delivery: Benefits and challenges. Journal of Applied Pharmacy, 8(1). https://doi.org/10.4172/1920-4159.1000e103(https://doi.org/10.4172/1920-4159.1000e103) Kawahara, K., & Tojo, K. (2007). Skin irritation in transdermal drug delivery systems: A strategy for its reduction. Pharmaceutical Research, 24(2), 399-408. https://doi.org/10.1007/s11095-006-9165-4(https://doi.org/10.1007/s11095-006-9165-4) Kliuk-Ben Bassat, O., Brill, S., Vaisman, N., Schechter, M., Ashtamker, N., Hirshberg, B., & Mosenzon, O. (2021). Pos-676 exploratory study to assess the safety of sublingual oil based medical cannabis bol-dp-o-04 in dialysis patients who have chronic pain. Kidney International Reports, 6(4), S295-S295. https://doi.org/10.1016/j.ekir.2021.03.707(https://doi.org/10.1016/j.ekir.2021.03.707) Klumpers, L. E., Beumer, T. L., van Hasselt, J. G., Lipplaa, A., Karger, L. B., Kleinloog, H.D., Freijer, J. I., de Kam, M. L., & van Gerven, J. M. (2012). Novel Δ9‐tetrahydrocannabinol formulation Namisol® has beneficial pharmacokinetics and promising pharmacodynamic effects. British Journal of Clinical Pharmacology, 74(1), 42-53. https://doi.org/10.1111/j.1365-2125.2012.04164.x(https://doi.org/10.1111/j.1365-2125.2012.04164.x) Lamy, F. R., Daniulaityte, R., Zatreh, M.,Nahhas, R. W., Sheth, A., Martins, S. S., Boyer, E. W., & Carlson, R. G. (2018). "You got to love rosin: Solventless dabs, pure, clean, natural medicine." Exploring twitter data on emerging trends in rosin tech marijuana concentrates. Drug and Alcohol Dependence, 183, 248-252. https://doi.org/10.1016/j.drugalcdep.2017.10.039(https://doi.org/10.1016/j.drugalcdep.2017.10.039) Lee, M. H. S., & Hancox, R. J. (2011). Effects of smoking cannabis on lung function. Expert Review of Respiratory Medicine, 5(4), 537-547. https://doi.org/10.1586/ers.11.40(https://doi.org/10.1586/ers.11.40) Loflin, M., & Earleywine, M. (2014). A new method of cannabis ingestion: The dangers of dabs? Addictive Behaviors, 39(10), 1430-1433. https://doi.org/10.1016/j.addbeh.2014.05.013(https://doi.org/10.1016/j.addbeh.2014.05.013) Maida, V., & Corban, J. (2017). Topical medical cannabis: A new treatment for wound pain—Three cases of pyoderma gangrenosum. Journal of Pain and Symptom Management, 54(5), 732-736. https://doi.org/10.1016/j.jpainsymman.2017.06.005(https://doi.org/10.1016/j.jpainsymman.2017.06.005) Maida, V., Shi, R. B., Fazzari, F. G. T., & Zomparelli, L. (2021). Topical cannabis-based medicines -A novel adjuvant treatment for venous leg ulcers: An open-label trial. Experimental Dermatology, 30(9), 1258-1267. https://doi.org/10.1111/exd.14395(https://doi.org/10.1111/exd.14395) Mariani, J. J., Brooks, D., Haney, M., & Levin, F. R. (2011). Quantification and comparison of marijuana smoking practices: Blunts, joints, and pipes. Drug and Alcohol Dependence, 113(2-3), 249-251. https://doi.org/10.1016/j.drugalcdep.2010.08.008(https://doi.org/10.1016/j.drugalcdep.2010.08.008) Marsot, A., Audebert, C., Attolini, L., Lacarelle, B., Micallef, J., & Blin, O. (2017). Population pharmacokinetics model of thc used by pulmonary route in occasional cannabis smokers. Journal of Pharmacological and Toxicological Methods, 85, 49-54. https://doi.org/10.1016/j.vascn.2017.02.003(https://doi.org/10.1016/j.vascn.2017.02.003) McInnis, O. A., & Plecas, D. (2016). Clearing the smoke on cannabis: Respiratory effects of cannabis smoking: An update. Canadian Centre on Substance Abuse. https://www.ccsa.ca/sites/default/files/2019-04/CCSA-Cannabis-Use-Respiratory-Effects-(https://www.ccsa.ca/sites/default/files/2019-04/CCSA-Cannabis-Use-Respiratory-Effects-Report-2016-en.pdf)Report-2016-en.pdf(https://www.ccsa.ca/sites/default/files/2019-04/CCSA-Cannabis-Use-Respiratory-Effects-Report-2016-en.pdf) Meier, M. H. (2017). Associations between butane hash oil use and cannabis-related problems. Drug and Alcohol Dependence, 179, 25-31. https://doi.org/10.1016/j.drugalcdep.2017.06.015(https://doi.org/10.1016/j.drugalcdep.2017.06.015) Michael G. DeGroote Centre for Medicinal Cannabis Research. (2018).What effects does smoking cannabis have on the respiratory system? McMaster University MDCMCR. https://cannabisresearch.mcmaster.ca/news/2018/04/27/cannabis-smoking-and-effects-on-t(https://cannabisresearch.mcmaster.ca/news/2018/04/27/cannabis-smoking-and-effects-on-)he-respiratory-system(https://cannabisresearch.mcmaster.ca/news/2018/04/27/cannabis-smoking-and-effects-on-the-respiratory-system) National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice; Committee on the Health Effects of Marijuana: An Evidence Review and Research Agenda. (2017). The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. Washington (DC): National Academies Press (US); 2017 Jan 12. https://doi.org/10.17226/24625(https://doi.org/10.17226/24625) National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health. (2014). The health consequences of smoking—50 years of progress: A report of the surgeon general. Centers for Disease Control and Prevention (US). https://pubmed.ncbi.nlm.nih.gov/24455788/(https://pubmed.ncbi.nlm.nih.gov/24455788/) OCS. (n.d.-a). Cannabis basics: Methods of consumption. https://ocs.ca/blogs/cannabis-basics/methods-of-consumption(https://ocs.ca/blogs/cannabis-basics/methods-of-consumption) OCS. (n.d.-b). Choosing cannabis products: Vaporizers vs. vapes: What’s the difference? https://ocs.ca/blogs/choosing-cannabis-products/vaporizers-vs-vapes-what-s-the-difference(https://ocs.ca/blogs/choosing-cannabis-products/vaporizers-vs-vapes-what-s-the-difference?index=ocs_articles&objectIDs=30531815244&queryID=f702b092338baed61343af5ee7bf3590)?index=ocs_articles&objectIDs=30531815244&queryID=f702b092338baed61343af5ee7(https://ocs.ca/blogs/choosing-cannabis-products/vaporizers-vs-vapes-what-s-the-difference?index=ocs_articles&objectIDs=30531815244&queryID=f702b092338baed61343af5ee7bf3590)bf3590(https://ocs.ca/blogs/choosing-cannabis-products/vaporizers-vs-vapes-what-s-the-difference?index=ocs_articles&objectIDs=30531815244&queryID=f702b092338baed61343af5ee7bf3590) OCS. (n.d.-c). Extracts: Deep dive. https://ocs.ca/blogs/choosing-cannabis-products/extracts-deep-dive?index=ocs_articles&o(https://ocs.ca/blogs/choosing-cannabis-products/extracts-deep-dive?index=ocs_articles&objectIDs=30529587020&queryID=c9d2d3b11ba2c0bc47edc49ebc255f20)bjectIDs=30529587020&queryID=c9d2d3b11ba2c0bc47edc49ebc255f20(https://ocs.ca/blogs/choosing-cannabis-products/extracts-deep-dive?index=ocs_articles&objectIDs=30529587020&queryID=c9d2d3b11ba2c0bc47edc49ebc255f20) OCS. (n.d.-d). How to clean a bong. https://ocs.ca/blogs/cannabis-how-tos/how-to-clean-a-bong?index=ocs_articles&objectIDs(https://ocs.ca/blogs/cannabis-how-tos/how-to-clean-a-bong?index=ocs_articles&objectIDs=30530701132&queryID=eababca6199dae7967fd91ecb3dc398e)=30530701132&queryID=eababca6199dae7967fd91ecb3dc398e(https://ocs.ca/blogs/cannabis-how-tos/how-to-clean-a-bong?index=ocs_articles&objectIDs=30530701132&queryID=eababca6199dae7967fd91ecb3dc398e) OCS. (n.d.-e). Intro to live resin. https://ocs.ca/blogs/cannabis-basics/intro-to-live-resin?index=ocs_articles&objectIDs=305(https://ocs.ca/blogs/cannabis-basics/intro-to-live-resin?index=ocs_articles&objectIDs=30554556236&queryID=e8c384c1145b55517aa47e40466943e9)54556236&queryID=e8c384c1145b55517aa47e40466943e9(https://ocs.ca/blogs/cannabis-basics/intro-to-live-resin?index=ocs_articles&objectIDs=30554556236&queryID=e8c384c1145b55517aa47e40466943e9) OCS. (n.d.-f). Intro to shatter. https://ocs.ca/blogs/cannabis-basics/intro-to-shatter?index=ocs_articles&objectIDs=30551(https://ocs.ca/blogs/cannabis-basics/intro-to-shatter?index=ocs_articles&objectIDs=30551541580&queryID=fbfee6a5e73dae7cb6619237e3d5d2a4)541580&queryID=fbfee6a5e73dae7cb6619237e3d5d2a4(https://ocs.ca/blogs/cannabis-basics/intro-to-shatter?index=ocs_articles&objectIDs=30551541580&queryID=fbfee6a5e73dae7cb6619237e3d5d2a4) OCS. (n.d.-g). Intro to topicals. https://ocs.ca/blogs/cannabis-basics/intro-to-topicals(https://ocs.ca/blogs/cannabis-basics/intro-to-topicals) OCS. (n.d.-h). Rolling papers.https://ocs.ca/collections/rolling-papers?product=1314114307916&sort_by=products_priC(https://ocs.ca/collections/rolling-papers?product=1314114307916&sort_by=products_price_per_uom_asc)e_per_uom_asc(https://ocs.ca/collections/rolling-papers?product=1314114307916&sort_by=products_price_per_uom_asc) Papaseit, E., Pérez-Mañá, C., Pérez-Acevedo, A. P., Hladun, O., Torres-Moreno, M. C., Muga, R., Torrens, M., & Farré, M. (2018). Cannabinoids: from pot to lab. International Journal of Medical Sciences, 15(12), 1286–1295. https://doi.org/10.7150/ijms.27087(https://doi.org/10.7150/ijms.27087) Papatheodorou, S. I., Buettner, H., Rice, M. B., & Mittleman, M. A. (2016). Recent marijuana use and associations with exhaled nitric oxide and pulmonary function in adults in the united states. Chest, 149(6), 1428-1435. https://doi.org/10.1016/j.chest.2015.12.033(https://doi.org/10.1016/j.chest.2015.12.033) Peschel, W. (2016). Quality control of traditional cannabis tinctures: Pattern, markers, and stability. Scientia Pharmaceutica, 84(3), 567-584. https://doi.org/10.3390/scipharm84030567(https://doi.org/10.3390/scipharm84030567) Pierre, J. M., Gandal, M., & Son, M. (2016). Cannabis-induced psychosis associated with high potency “wax dabs”. Schizophrenia Research, 172(1-3), 211-212. https://doi.org/10.1016/j.schres.2016.01.056(https://doi.org/10.1016/j.schres.2016.01.056) Pomahacova, B., Van der Kooy, F., & Verpoorte, R. (2009). Cannabis smoke condensate III: The cannabinoid content of vaporised cannabis sativa. Inhalation Toxicology, 21(13), 1108-1112. https://doi.org/10.3109/08958370902748559(https://doi.org/10.3109/08958370902748559) Raber, J. C., Elzinga, S., & Kaplan, C. (2015). Understanding dabs: Contamination concerns of cannabis concentrates and cannabinoid transfer during the act of dabbing. The Journal of Toxicological Sciences, 40(6), 797-803. https://doi.org/10.2131/jts.40.797(https://doi.org/10.2131/jts.40.797) Riboulet-Zemouli, K. (2020). ‘Cannabis’ ontologies I: Conceptual issues with cannabis and cannabinoids terminology. Drug Science, Policy and Law, 6. https://doi.org/10.1177/2050324520945797(https://doi.org/10.1177/2050324520945797) Ruchlemer, R., Amit-Kohn, M., Raveh, D., & Hanuš, L. (2015). Inhaled medicinal cannabis and the immunocompromised patient. Supportive Care in Cancer, 23(3), 819-822. https://doi.org/10.1007/s00520-014-2429-3(https://doi.org/10.1007/s00520-014-2429-3) Russo E. B. (2011). Taming thc: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. British Journal of Pharmacology, 163(7), 1344–1364. https://doi.org/10.1111/j.1476-5381.2011.01238.x(https://doi.org/10.1111/j.1476-5381.2011.01238.x) Sagar, K. A., Lambros, A. M., Dahlgren, M. K., Smith, R. T., & Gruber, S. A. (2018). Made from concentrate? A national web survey assessing dab use in the united states. Drug and Alcohol Dependence, 190, 133-142. https://doi.org/10.1016/j.drugalcdep.2018.05.022(https://doi.org/10.1016/j.drugalcdep.2018.05.022) Scully, C. (2007). Cannabis; adverse effects from an oromucosal spray. British Dental Journal, 203(6), E12-E37. https://doi.org/10.1038/bdj.2007.749(https://doi.org/10.1038/bdj.2007.749) Seltenrich, N. (2019). Cannabis contaminants: Regulating solvents, microbes, and metals in legal weed. Environmental Health Perspectives, 127(8), 82001. https://doi.org/10.1289/EHP5785(https://doi.org/10.1289/EHP5785) Shakya, P., Madhav, N. V. S., Shakya, A. K., & Singh, K. (2011). Palatal mucosa as a route for systemic drug delivery: A review. Journal of Controlled Release, 151(1), 2-9. https://doi.org/10.1016/j.jconrel.2010.11.003(https://doi.org/10.1016/j.jconrel.2010.11.003) Skalicky, J., Husek, J., Hofbauerova, J., & Dittrich, M. (2012). A composition for the treatment of inflammatory diseases comprising boswellic acids and cannabidiol. (European Patent Application No. 2444081A1). https://patents.google.com/patent/EP2444081A1/en(https://patents.google.com/patent/EP2444081A1/en) Stephens D, Patel JK, Angelo D, Frunzi J. (2020). Cannabis butane hash oil dabbing induced lung injury mimicking atypical pneumonia. Cureus, 12(2), e7033. https://doi.org/10.7759/cureus.7033(https://doi.org/10.7759/cureus.7033) Stinchcomb, A. L., Valiveti, S., Hammell, D. C., & Ramsey, D. R. (2004;2010;). Human skin permeation of Δ8-tetrahydrocannabinol, cannabidiol and cannabinol. Journal of Pharmacy and Pharmacology, 56(3), 291-297. https://doi.org/10.1211/0022357022791(https://doi.org/10.1211/0022357022791) Stockburger, S. (2016). Forms of administration of cannabis and their efficacy. Journal of Pain Management, 9(4), 381. https://www.researchgate.net/publication/316546304_Forms_of_administration_of_cannabis_and_their_efficacy(https://www.researchgate.net/publication/316546304_Forms_of_administration_of_cannabis_and_their_efficacy) Stogner, J. M., & Miller, B. L. (2015). The dabbing dilemma: A call for research on butane hash oil and other alternate forms of cannabis use. Substance Abuse, 36(4), 393-395. https://doi.org/10.1080/08897077.2015.1071724(https://doi.org/10.1080/08897077.2015.1071724) Taylor, D. R., Fergusson, D. M., Milne, B. J., Horwood, L. J., Moffitt, T. E., Sears, M. R., & Poulton, R. (2002). A longitudinal study of the effects of tobacco and cannabis exposure on lung function in young adults. Addiction (Abingdon, England), 97(8), 1055-1061. https://doi.org/10.1046/j.1360-0443.2002.00169.x(https://doi.org/10.1046/j.1360-0443.2002.00169.x) Tetrault, J.M., Crothers, K., Moore, B.A., Mehra, R., Concato, & J., Fiellin, D.A. (2007). Effects of marijuana smoking on pulmonary function and respiratory complications: A systematic review. Archives of Internal Medicine, 167(3), 221-228. https://doi.org/10.1001/archinte.167.3.221(https://doi.org/10.1001/archinte.167.3.221) Thu, K., Hayes, M., Miles, S., Tierney, L., & Foy, A. (2013). Marijuana ‘bong’ smoking and tuberculosis. Internal Medicine Journal, 43(4), 456-458. https://doi.org/10.1111/imj.12089(https://doi.org/10.1111/imj.12089) Tijani, A. O., Thakur, D., Mishra, D., Frempong, D., Chukwunyere, U. I., & Puri, A. (2021). Delivering therapeutic cannabinoids via skin: Current state and future perspectives. Journal of Controlled Release, 334, 427-451. https://doi.org/10.1016/j.jconrel.2021.05.005(https://doi.org/10.1016/j.jconrel.2021.05.005) Touitou, E., Fabin, B., Dany, S., & Almog, S. (1988). Transdermal delivery of tetrahydrocannabinol. International Journal of Pharmaceutics, 43(1-2), 9-15. https://doi.org/10.1016/0378-5173(88)90052-X(https://doi.org/10.1016/0378-5173(88)90052-X) Trofin, I. G., Dabija, G., Vaireanu, D. I., & Filipescu, L. (2012). Long-term storage and cannabis oil stability. Revista de Chimie, 63(3), 293-297. https://www.academia.edu/20127134/Long_term_Storage_and_Cannabis_Oil_Stability(https://www.academia.edu/20127134/Long_term_Storage_and_Cannabis_Oil_Stability) Van Dam, N. T., & Earleywine, M. (2010). Pulmonary function in cannabis users: Support for a clinical trial of the vaporizer. International Journal on Drug Policy, 21(6), 511–513. https://doi.org/10.1016/j.drugpo.2010.04.001(https://doi.org/10.1016/j.drugpo.2010.04.001) Volkow, N. D., Baler, R. D., Compton, W. M., & Weiss, S. R. (2014). Adverse health effects of marijuana use. The New England Journal of Medicine, 370(23), 2219-2227. https://doi.org/10.1056/NEJMra1402309(https://doi.org/10.1056/NEJMra1402309) Weed Maps. (n.d.-a). Bongs. https://weedmaps.com/learn/dictionary/bong(https://weedmaps.com/learn/dictionary/bong) Weed Maps. (n.d.-b). Pipes. https://weedmaps.com/learn/dictionary/pipe(https://weedmaps.com/learn/dictionary/pipe) Weed Maps. (n.d.-c). What is distillate? https://weedmaps.com/learn/dictionary/distillate(https://weedmaps.com/learn/dictionary/distillate) Wu, T. C., Tashkin, D. P., Djahed, B., & Rose, J. E. (1988). Pulmonary hazards of smoking marijuana as compared with tobacco. The New England Journal of Medicine, 318(6), 347–351. https://doi.org/10.1056/NEJM198802113180603(https://doi.org/10.1056/NEJM198802113180603) Zhao, T., Cheng, K., Ott, W. R., Wallace, L., & Hildemann, L. M. (2020). Characteristics of secondhand cannabis smoke from common smoking methods: Calibration factor, emission rate, and particle removal rate. Atmospheric Environment (1994), 242, 117731. https://doi.org/10.1016/j.atmosenv.2020.117731(https://doi.org/10.1016/j.atmosenv.2020.117731) Zig Zag. (n.d.). Cigarette roller 78 mm. https://zigzag.com/products/78mm-cigarette-roller(https://zigzag.com/products/78mm-cigarette-roller)

Asbridge, M., Hayden, J. A., & Cartwright, J. L. (2012). Acute cannabis consumption and motor vehicle collision risk: Systematic review of observational studies and meta-analysis. BMJ (Online), 344, e536. https://doi.org/10.1136/bmj.e536(https://doi.org/10.1136/bmj.e536) Asbridge, M., Mann, R., Cusimano, M. D., Trayling, C., Roerecke, M., Tallon, J. M., Whipp, A., & Rehm, J. (2014). Cannabis and traffic collision risk: Findings from a case- crossover study of injured drivers presenting to emergency departments. International Journal of Public Health, 59(2), 395-404. https://doi.org/10.1007/s00038-013-0512-z(https://doi.org/10.1007/s00038-013-0512-z) Ball, A. L. (2007). Hiv, injecting drug use and harm reduction: A public health response. Addiction (Abingdon, England), 102(5), 684-690. https://doi.org/10.1111/j.1360-0443.2007.01761.x(https://doi.org/10.1111/j.1360-0443.2007.01761.x) Barrus, D. G., Capogrossi, K. L., Cates, S. C., Gourdet, C. K., Peiper, N. C., Novak, S. P., Lefever, T. W., & Wiley, J. L. (2016). Tasty thc: Promises and challenges of cannabis edibles. Methods Report (RTI Press), 2016, 10.3768/rtipress.2016.op.0035.1611. https://doi.org/10.3768/rtipress.2016.op.0035.1611(https://doi.org/10.3768/rtipress.2016.op.0035.1611) Batalla, A., Bhattacharyya, S., Yuecel, M., Fusar-Poli, P., Crippa, J. A., Nogue, S., Torrens, M., Pujol, J., Farre, M., & Martin-Santos, R. (2013). Structural and functional imaging studies in chronic cannabis users: A systematic review of adolescent and adult findings. PloS One, 8(2), e55821. https://doi.org/10.1371/journal.pone.0055821(https://doi.org/10.1371/journal.pone.0055821) Bédard, M., Dubois, S., & Weaver, B. (2007). The impact of cannabis on driving. Canadian Journal of Public Health, 98(1), 6-11. https://doi.org/10.1007/BF03405376(https://doi.org/10.1007/BF03405376) Bhattacharyya, S., Fusar-Poli, P., Borgwardt, S., Martin-Santos, R., O'Carroll, C., Crippa, J., Atakan, Z., & McGuire, P. (2009). P. 3.02 opposite neural effects of the main psychoactive ingredients of cannabis—Implications for therapeutics. European Neuropsychopharmacology, 19, S63-S64. https://doi.org/10.1016/S0924-977X(09)70072-0(https://doi.org/10.1016/S0924-977X(09)70072-0) Blake, A., & Nahtigal, I. (2019). The evolving landscape of cannabis edibles. Current Opinion in Food Science, 28, 25-31. https://doi.org/10.1016/j.cofs.2019.03.009(https://doi.org/10.1016/j.cofs.2019.03.009) Canadian Nurses Association. (2017). Harm reduction for non-medical cannabis use. https://hl-prod-ca-oc-download.s3-ca-central-1.amazonaws.com/CNA/2f975e7e-4a40-45c(https://hl-prod-ca-oc-download.s3-ca-central-1.amazonaws.com/CNA/2f975e7e-4a40-45ca-863c-5ebf0a138d5e/UploadedImages/documents/Harm_Reduction_for_Non_Medical_Cannabis_Use.pdf)a-863c-5ebf0a138d5e/UploadedImages/documents/Harm_Reduction_for_Non_Medical_(https://hl-prod-ca-oc-download.s3-ca-central-1.amazonaws.com/CNA/2f975e7e-4a40-45ca-863c-5ebf0a138d5e/UploadedImages/documents/Harm_Reduction_for_Non_Medical_Cannabis_Use.pdf)Cannabis_Use.pdf(https://hl-prod-ca-oc-download.s3-ca-central-1.amazonaws.com/CNA/2f975e7e-4a40-45ca-863c-5ebf0a138d5e/UploadedImages/documents/Harm_Reduction_for_Non_Medical_Cannabis_Use.pdf) Cannabis Regulations (SOR/2018-144). https://laws-lois.justice.gc.ca/eng/regulations/sor-2018-144/(https://laws-lois.justice.gc.ca/eng/regulations/sor-2018-144/) Coffey, C., Carlin, J. B., Degenhardt, L., Lynskey, M., Sanci, L., & Patton, G. C. (2002). Cannabis dependence in young adults: An australian population study. Addiction (Abingdon, England), 97(2), 187-194. https://doi.org/10.1046/j.1360-0443.2002.00029.x(https://doi.org/10.1046/j.1360-0443.2002.00029.x) D'Souza, D. C., Perry, E., MacDougall, L., Ammerman, Y., Cooper, T., Braley, G., Gueorguieva, R., & Krystal, J. H. (2004). The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacology, 29(8), 1558-1572. https://doi.org/10.1038/sj.npp.1300496(https://doi.org/10.1038/sj.npp.1300496) D’Souza, D. C., Sewell, R. A., & Ranganathan, M. (2009). Cannabis and psychosis/schizophrenia: Human studies. European Archives of Psychiatry and Clinical Neuroscience, 259(7), 413-431. https://doi.org/10.1007/s00406-009-0024-2(https://doi.org/10.1007/s00406-009-0024-2) Earleywine, M., & Barnwell, S. S. (2007). Decreased respiratory symptoms in cannabis users who vaporize. Harm Reduction Journal, 4(1), 11. https://doi.org/10.1186/1477-7517-4-11(https://doi.org/10.1186/1477-7517-4-11) Einstein, S. (2007). Harm and risk reduction: History, theories, issues, and implications. Substance Use & Misuse, 42(2-3), 257-265. https://doi.org/10.1080/10826080601141990(https://doi.org/10.1080/10826080601141990) Fischer, B., Russell, C., Sabioni, P., Van Den Brink, W., Le Foll, B., Hall, W., Rehm, J. & Room, R. (2017). Lower-risk cannabis use guidelines: A comprehensive update of evidence and recommendations. American Journal of Public Health, 107(8), e1-e12. https://doi.org/10.2105/AJPH.2017.303818(https://doi.org/10.2105/AJPH.2017.303818) Fontes, M. A., Bolla, K. I., Cunha, P. J., Almeida, P. P., Jungerman, F., Laranjeira, R. R., Bressan, R. A., & Lacerda, A. L. (2011). Cannabis use before age 15 and subsequent executive functioning. The British Journal of Psychiatry : The Journal of Mental Science, 198(6), 442–447. https://doi.org/10.1192/bjp.bp.110.077479(https://doi.org/10.1192/bjp.bp.110.077479) Freeman, T. P., & Winstock, A. R. (2015). Examining the profile of high-potency cannabis and its association with severity of cannabis dependence. Psychological Medicine, 45(15), 3181-3189. https://doi.org/10.1017/S0033291715001178(https://doi.org/10.1017/S0033291715001178) Ganzer, F., Bröning, S., Kraft, S., Sack, P. M., & Thomasius, R. (2016). Weighing the evidence: A systematic review on long-term neurocognitive effects of cannabis use in abstinent adolescents and adults. Neuropsychology Review, 26(2), 186–222. https://doi.org/10.1007/s11065-016-9316-2(https://doi.org/10.1007/s11065-016-9316-2) Gieringer, D. H. (2001). Cannabis “vaporization” a promising strategy for smoke harm reduction. Journal of Cannabis Therapeutics, 1(3-4), 153-170. https://doi.org/10.1300/J175v01n03_10(https://doi.org/10.1300/J175v01n03_10) Goldschmidt, L., Richardson, G. A., Larkby, C., & Day, N. L. (2016). Early marijuana initiation: The link between prenatal marijuana exposure, early childhood behavior, and negative adult roles. Neurotoxicology and Teratology, 58, 40-45. https://doi.org/10.1016/j.ntt.2016.05.011(https://doi.org/10.1016/j.ntt.2016.05.011) Government of Canada. (2019). Cannabis: Lower your risks. https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/resources/loW(https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/resources/lower-your-risks.html)er-your-risks.html(https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/resources/lower-your-risks.html) Government of Canada. (2021). Don’t drive high. https://www.canada.ca/en/campaign/don-t-drive-high.html(https://www.canada.ca/en/campaign/don-t-drive-high.html) Gray, T. R., Eiden, R. D., Leonard, K. E., Connors, G. J., Shisler, S., & Huestis, M. A. (2010). Identifying prenatal cannabis exposure and effects of concurrent tobacco exposure on neonatal growth. Clinical Chemistry, 56(9), 1442–1450. https://doi.org/10.1373/clinchem.2010.147876(https://doi.org/10.1373/clinchem.2010.147876) Grotenhermen, F. (2003). Pharmacokinetics and pharmacodynamics of cannabinoids. Clinical Pharmacokinetics, 42(4), 327-360. https://doi.org/10.2165/00003088-200342040-00003(https://doi.org/10.2165/00003088-200342040-00003) Hall, W., & Degenhardt, L. (2008). Cannabis use and the risk of developing a psychotic disorder. World Psychiatry, 7(2), 68-71. https://doi.org/10.1002/j.2051-5545.2008.tb00158.x(https://doi.org/10.1002/j.2051-5545.2008.tb00158.x) Hartman, R. L., & Huestis, M. A. (2013). Cannabis effects on driving skills. Clinical Chemistry, 59(3), 478–492. https://doi.org/10.1373/clinchem.2012.194381(https://doi.org/10.1373/clinchem.2012.194381) Hartogsohn, I. (2017). Constructing drug effects: A history of set and setting. Drug Science, Policy and Law, 3. https://doi.org/10.1177/2050324516683325(https://doi.org/10.1177/2050324516683325) Hawk, M., Coulter, R.W. S., Egan, J. E., Fisk, S., Reuel Friedman, M., Tula, M., & Kinsky, S. (2017). Harm reduction principles for healthcare settings. Harm Reduction Journal, 14(1), 70. https://doi.org/10.1186/s12954-017-0196-4(https://doi.org/10.1186/s12954-017-0196-4) Hawke, L. D., Wilkins, L., & Henderson, J. (2020). Early cannabis initiation: Substance use and mental health profiles of service-seeking youth. Journal of Adolescence, 83, 112–121. https://doi.org/10.1016/j.adolescence.2020.06.004(https://doi.org/10.1016/j.adolescence.2020.06.004) Hazekamp, A., Ruhaak, R., Zuurman, L., van Gerven, J., & Verpoorte, R. (2006). Evaluation of a vaporizing device (Volcano®) for the pulmonary administration of tetrahydrocannabinol. Journal of Pharmaceutical Sciences, 95(6), 1308-1317. https://doi.org/10.1002/jps.20574(https://doi.org/10.1002/jps.20574) Hines, L. A., Freeman, T. P., Gage, S. H., Zammit, S., Hickman, M., Cannon, M., Munafo, M., MacLeod, J., & Heron, J. (2020). Association of high-potency cannabis use with mental health and substance use in adolescence. JAMA Psychiatry, 77(10), 1044-1051. https://doi.org/10.1001/jamapsychiatry.2020.1035(https://doi.org/10.1001/jamapsychiatry.2020.1035) Hosseini, S., & Oremus, M. (2019). The effect of age of initiation of cannabis use on psychosis, depression, and anxiety among youth under 25 years. The Canadian Journal of Psychiatry, 64(5), 304-312. https://doi.org/10.1177/0706743718809339(https://doi.org/10.1177/0706743718809339) Hurd, Y. L., Manzoni, O. J.,Pletnikov, M. V., Lee, F. S., Bhattacharyya, S., & Melis, M. (2019). Cannabis and the developing brain: Insights into its long-lasting effects. Journal of Neuroscience, 39(42), 8250-8258. https://doi.org/10.1523/JNEUROSCI.1165-19.2019(https://doi.org/10.1523/JNEUROSCI.1165-19.2019) Institute of Medicine (US) Committee to Assess the Science Base for Tobacco Harm Reduction, Stratton, K., Shetty, W., Wallace, R., Bondurant, S. (Eds.). (2001). Clearing the smoke: Assessing the science base for tobacco harm reduction. National Academies Press (US). https://doi.org/10.17226/10029(https://doi.org/10.17226/10029) Koskinen, J., Lohonen, J., Koponen, H., Isohanni, M., & Miettunen, J. (2010). Rate of cannabis use disorders in clinical samples of patients with schizophrenia: A meta-analysis. Schizophrenia Bulletin, 36(6), 1115-1130. https://doi.org/10.1093/schbul/sbp031(https://doi.org/10.1093/schbul/sbp031) Lau, N., Sales, P., Averill, S., Murphy, F., Sato, S. O., & Murphy, S. (2015). Responsible and controlled use: Older cannabis users and harm reduction. International Journal of Drug Policy, 26(8), 709-718. https://doi.org/10.1016/j.drugpo.2015.03.008(https://doi.org/10.1016/j.drugpo.2015.03.008) Lev-Ran, S., Roerecke, M., Le Foll, B., George, T. P., McKenzie, K., & Rehm, J. (2014). The association between cannabis use and depression: A systematic review and meta-analysis of longitudinal studies. Psychological Medicine, 44(4), 797–810. https://doi.org/10.1017/S0033291713001438(https://doi.org/10.1017/S0033291713001438) Li, M. C., Brady, J. E., DiMaggio, C. J., Lusardi, A. R., Tzong, K. Y., & Li, G. (2012). Marijuana use and motor vehicle crashes. Epidemiologic Reviews, 34(1), 65-72. https://doi.org/10.1093/epirev/mxr017(https://doi.org/10.1093/epirev/mxr017) Looby, A., & Earleywine, M. (2007). Negative consequences associated with dependence in daily cannabis users. Substance Abuse Treatment, Prevention, and Policy, 2(1), 3. https://doi.org/10.1186/1747-597X-2-3(https://doi.org/10.1186/1747-597X-2-3) MacCallum, C. A., & Russo, E. B. (2018). Practical considerations in medical cannabis administration and dosing. European Journal of Internal Medicine, 49, 12-19. https://doi.org/10.1016/j.ejim.2018.01.004(https://doi.org/10.1016/j.ejim.2018.01.004) MacMaster, S. A. (2004). Harm reduction: A new perspective on substance abuse services. Social Work, 49(3), 356-363. https://doi.org/10.1093/sw/49.3.353(https://doi.org/10.1093/sw/49.3.353) Marconi, A., Di Forti, M., Lewis, C. M., Murray, R. M., & Vassos, E. (2016). Meta-analysis of the association between the level of cannabis use and risk of psychosis. Schizophrenia Bulletin, 42(5), 1262-1269. https://doi.org/10.1093/schbul/sbw003(https://doi.org/10.1093/schbul/sbw003) Marlatt, G. A. (1996). Harm reduction: Come as you are. Addictive Behaviors, 21(6), 779-788. https://doi.org/10.1016/0306-4603(96)00042-1(https://doi.org/10.1016/0306-4603(96)00042-1) Moore, T. H., Zammit, S., Lingford-Hughes, A., Barnes, T. R., Jones, P. B., Burke, M., & Lewis, G. (2007). Cannabis use and risk of psychotic or affective mental health outcomes: A systematic review. Lancet (London, England), 370(9584), 319–328. https://doi.org/10.1016/S0140-6736(07)61162-3(https://doi.org/10.1016/S0140-6736(07)61162-3) Nickel J. C. (2018). Medical marijuana for urologic chronic pelvic pain. Canadian Urological Association Journal, 12(6 Suppl 3), S181–S183. https://doi.org/10.5489/cuaj.5331(https://doi.org/10.5489/cuaj.5331) Noack, R., Höfler, M., & Lüken, U. (2011). Cannabis use patterns and their association with dsm-iv cannabis dependence and gender. European Addiction Research, 17(6), 321-328. https://doi.org/10.1159/000333338(https://doi.org/10.1159/000333338) Patton, G. C., Coffey, C., Carlin, J. B., Degenhardt, L., Lynskey, M., & Hall, W. (2002). Cannabis use and mental health in young people: Cohort study. BMJ (Clinical research ed.), 325(7374), 1195–1198. https://doi.org/10.1136/bmj.325.7374.1195(https://doi.org/10.1136/bmj.325.7374.1195) Pope Jr, H. G., Gruber, A. J., Hudson, J. I., Cohane, G., Huestis, M. A., & Yurgelun-Todd, D. (2003). Early-onset cannabis use and cognitive deficits: what is the nature of the association? Drug and Alcohol Dependence, 69(3), 303-310. https://doi.org/10.1016/s0376-8716(02)00334-4(https://doi.org/10.1016/s0376-8716(02)00334-4) Rogeberg, O., & Elvik, R. (2016). The effects of cannabis intoxication on motor vehicle collision revisited and revised. Addiction (Abingdon, England), 111(8), 1348–1359. https://doi.org/10.1111/add.13347(https://doi.org/10.1111/add.13347) Ruiz-Veguilla, M., Barrigón, M. L., Hernández, L., Rubio, J. L., Gurpegui, M., Sarramea, F., Cervilla, J., Gutiérrez, B., James, A., & Ferrin, M. (2013). Dose–response effect between cannabis use and psychosis liability in a non-clinical population: Evidence from a snowball sample. Journal of Psychiatric Research, 47(8), 1036-1043. https://doi.org/10.1016/j.jpsychires.2013.03.003(https://doi.org/10.1016/j.jpsychires.2013.03.003) Schlag, A. K., Hindocha, C., Zafar, R., Nutt, D. J., & Curran, H. V. (2021). Cannabis based medicines and cannabis dependence: A critical review of issues and evidence. Journal of Psychopharmacology, 35(7), 773-785. https://doi.org/10.1177/0269881120986393(https://doi.org/10.1177/0269881120986393) Schlossarek, S., Kempkensteffen, J., Reimer, J., & Verthein, U. (2016). Psychosocial determinants of cannabis dependence: A systematic review of the literature. European Addiction Research, 22(3), 131-144. https://doi.org/10.1159/000441777(https://doi.org/10.1159/000441777) Schreiber, S., & Pick, C. G. (2019). Cannabis use during pregnancy: Are we at the verge of defining a “fetal cannabis spectrum disorder”? Medical hypotheses, 124, 53-55. https://doi.org/10.1016/j.mehy.2019.02.017(https://doi.org/10.1016/j.mehy.2019.02.017) Shewan, D., Dalgarno, P., & Reith, G. (2000). Perceived risk and risk reduction among ecstasy users: the role of drug, set, and setting. International Journal of Drug Policy, 10(6), 431-453. https://doi.org/10.1016/S0955-3959(99)00038-9(https://doi.org/10.1016/S0955-3959(99)00038-9) Solomon, C. S., Solomon, G. D., & Elliott, W. (2020). The abcs of cbd: The fundamentals of cannabidiol. Primary Care Reports, 26(8). https://www.reliasmedia.com/articles/146607-the-abcs-of-cbd-the-fundamentals-of-cannaB(https://www.reliasmedia.com/articles/146607-the-abcs-of-cbd-the-fundamentals-of-cannabidiol)idiol(https://www.reliasmedia.com/articles/146607-the-abcs-of-cbd-the-fundamentals-of-cannabidiol) Stöver, H., & Kastelic, A. (2014). 14. Drug treatment and harm reduction in prisons. Prisons and Health, 113-133. https://www.euro.who.int/__data/assets/pdf_file/0020/249203/Prisons-and-Health,-14-Dru(https://www.euro.who.int/__data/assets/pdf_file/0020/249203/Prisons-and-Health,-14-Drug-treatment-and-harm-reduction-in-prisons.pdf)g-treatment-and-harm-reduction-in-prisons.pdf(https://www.euro.who.int/__data/assets/pdf_file/0020/249203/Prisons-and-Health,-14-Drug-treatment-and-harm-reduction-in-prisons.pdf) Swift, J., Copeland, S., Lenton, W. (2000). Cannabis and harm reduction. Drug and Alcohol Review, 19(1), 101-112. https://doi.org/10.1080/09595230096200(https://doi.org/10.1080/09595230096200) Swift, W., Coffey, C., Carlin, J. B., Degenhardt, L., & Patton, G. C. (2008). Adolescent cannabis users at 24 years: Trajectories to regular weekly use and dependence in young adulthood. Addiction (Abingdon, England), 103(8), 1361-1370. https://doi.org/10.1111/j.1360-0443.2008.02246.x(https://doi.org/10.1111/j.1360-0443.2008.02246.x) Tabchi, S., & Ghosn, M. (2015). Regorafenib: start low and go slow. Targeted Oncology, 10(3), 445-447. https://doi.org/10.1007/s11523-014-0352-7(https://doi.org/10.1007/s11523-014-0352-7) Tashkin, D. P., Gliederer, F., Rose, J., Change, P., Hui, K. K., Yu, J. L., & Wu, T. C. (1991). Effects of varying marijuana smoking profile on deposition of tar and absorption of co and delta-9-thc. Pharmacology, Biochemistry, and Behavior, 40(3), 651–656. https://doi.org/10.1016/0091-3057(91)90377-e(https://doi.org/10.1016/0091-3057(91)90377-e) Van Dam, N. T., & Earleywine, M. (2010). Pulmonary function in cannabis users: Support for a clinical trial of the vaporizer. International Journal of Drug Policy, 21(6), 511-513. https://doi.org/10.1016/j.drugpo.2010.04.001(https://doi.org/10.1016/j.drugpo.2010.04.001) Willford, J. A., Chandler, L. S., Goldschmidt, L., & Day, N. L. (2010). Effects of prenatal tobacco, alcohol and marijuana exposure on processing speed, visual-motor coordination, and interhemispheric transfer. Neurotoxicology and Teratology, 32(6), 580–588. https://doi.org/10.1016/j.ntt.2010.06.004(https://doi.org/10.1016/j.ntt.2010.06.004) Winters, K. C., & Lee, C. S. (2007;2008;). Likelihood of developing an alcohol and cannabis use disorder during youth: Association with recent use and age. Drug and Alcohol Dependence, 92(1), 239-247. https://doi.org/10.1016/j.drugalcdep.2007.08.005(https://doi.org/10.1016/j.drugalcdep.2007.08.005) Zacny, J. P., & Chait, L. D. (1989). Breathhold duration and response to marijuana smoke. Pharmacology, Biochemistry, and Behavior, 33(2), 481–484. https://doi.org/10.1016/0091-3057(89)90534-0(https://doi.org/10.1016/0091-3057(89)90534-0) Zacny, J. P., & Chait, L. D. (1991). Response to marijuana as a function of potency and breathhold duration. Psychopharmacology, 103(2), 223-226. https://doi.org/10.1007/BF02244207(https://doi.org/10.1007/BF02244207) Zinberg, N. E. (1984). Drug, set, and setting: The basis for controlled intoxicant use. Yale University Press.

Browne, J. (2016). How to smoke weed for maximum enjoyment: Tips for first-timers. The Cannabist. https://www.thecannabist.co/2016/10/07/how-to-smoke-weed-tips-enjoying-first-high/603(https://www.thecannabist.co/2016/10/07/how-to-smoke-weed-tips-enjoying-first-high/60322/)22/(https://www.thecannabist.co/2016/10/07/how-to-smoke-weed-tips-enjoying-first-high/60322/) Dalgarno, P., & Shewan, D. (2005). Reducing the risks of drug use: The case for set and setting. Addiction Research & Theory, 13(3), 259-265. https://doi.org/10.1080/16066350500053562(https://doi.org/10.1080/16066350500053562) Fagan, J. (1993). Set and setting revisited: Influences of alcohol and illicit drugs on the social context of violent events. Alcohol and Interpersonal Violence: Fostering Multidisciplinary Perspectives, 93, 161-191. https://books.google.ca/books?hl=en&lr=&id=ZYNHAAAAMAAJ&oi=fnd&pg=PA161&(https://books.google.ca/books?hl=en&lr=&id=ZYNHAAAAMAAJ&oi=fnd&pg=PA161&ots=hP-mvJ4t5B&sig=ghOAlNSJ5c-515ohlb9ogd7XVxY&redir_esc=y#v=onepage&q&f=false)ots=hP-mvJ4t5B&sig=ghOAlNSJ5c-515ohlb9ogd7XVxY&redir_esc=y#v=onepage&q&(https://books.google.ca/books?hl=en&lr=&id=ZYNHAAAAMAAJ&oi=fnd&pg=PA161&ots=hP-mvJ4t5B&sig=ghOAlNSJ5c-515ohlb9ogd7XVxY&redir_esc=y#v=onepage&q&f=false)f=false(https://books.google.ca/books?hl=en&lr=&id=ZYNHAAAAMAAJ&oi=fnd&pg=PA161&ots=hP-mvJ4t5B&sig=ghOAlNSJ5c-515ohlb9ogd7XVxY&redir_esc=y#v=onepage&q&f=false) Goulding, C., Shankar, A., Elliott, R., & Canniford, R. (2009). The marketplace management of illicit pleasure. Journal of Consumer Research, 35(5), 759-771. https://doi.org/10.1086/592946(https://doi.org/10.1086/592946) Haijen, E. C., Kaelen, M., Roseman, L., Timmermann, C., Kettner, H., Russ, S., Nutt, D., Daws, R. E., Hampshire, A. D. G., Lorenz, R., & Carhart-Harris, R. L. (2018). Predicting responses to psychedelics: A prospective study. Frontiers in Pharmacology, 9, 897. https://doi.org/10.3389/fphar.2018.00897(https://doi.org/10.3389/fphar.2018.00897) Hartogsohn, I. (2017). Constructing drug effects: A history of set and setting. Drug Science, Policy and Law. https://doi.org/10.1177/2050324516683325(https://doi.org/10.1177/2050324516683325) Janikian, M. (2020). Why don’t we talk about “Set and setting” when it comes to cannabis? Merry Jane. https://merryjane.com/culture/why-dont-we-talk-about-set-and-setting-when-it-comes-to-c(https://merryjane.com/culture/why-dont-we-talk-about-set-and-setting-when-it-comes-to-cannabis)annabis(https://merryjane.com/culture/why-dont-we-talk-about-set-and-setting-when-it-comes-to-cannabis) Lau, N., Sales, P., Averill, S., Murphy, F., Sato, S., & Murphy, S. (2015a). A safer alternative: Cannabis substitution as harm reduction. Drug and Alcohol Review, 34(6), 654-659. https://doi.org/10.1111/dar.12275 (https://doi.org/10.1111/dar.12275) Lau, N., Sales, P., Averill, S., Murphy, F., Sato, S., & Murphy, S. (2015b). Responsible and controlled use: Older cannabis users and harm reduction. The International Journal of Drug Policy, 26(8), 709-718. https://doi.org/10.1016/j.drugpo.2015.03.008(https://doi.org/10.1016/j.drugpo.2015.03.008) Leary, T., Litwin, G. H., & Metzner, R. (1963). Reactions to psilocybin administered in a supportive environment. Journal of Nervous and Mental Disease, 137(6), 561-573. https://doi.org/10.1097/00005053-196312000-00007(https://doi.org/10.1097/00005053-196312000-00007) Mason, N. L., Dolder, P. C., & Kuypers, K. P. (2020). Reported effects of psychedelic use on those with low well-being given various emotional states and social contexts. Drug Science, Policy and Law, 6, 2050324519900068. https://doi.org/10.1177/2050324519900068(https://doi.org/10.1177/2050324519900068) McElrath, K., & McEvoy, K. (2002). Negative experience on ecstasy: The role of drug, set and setting. Journal of Psychoactive Drugs, 34(2), 199-208. https://doi.org/10.1080/02791072.2002.10399954(https://doi.org/10.1080/02791072.2002.10399954) Metzner, R., & Leary, T. (1967). On programming psychedelic experiences. Psychedelic Review, 9, 5-19. https://maps.org/research-archive/psychedelicreview/n09/n09005met.pdf(https://maps.org/research-archive/psychedelicreview/n09/n09005met.pdf) Monshouwer, K., Van Laar, M., Vollebergh, W. A. (2011). Buying cannabis in ‘coffee shops’. Drug and Alcohol Review, 30(2), 148–156. https://doi.org/10.1111/j.1465-3362.2010.00268.x(https://doi.org/10.1111/j.1465-3362.2010.00268.x) Neitzke-Spruill, L. (2020). Race as a component of set and setting: How experiences of race can influence psychedelic experiences. Journal of Psychedelic Studies, 4(1), 51-60. https://doi.org/10.1556/2054.2019.022(https://doi.org/10.1556/2054.2019.022) NORML. (1996). Principles of responsible cannabis use. https://norml.org/principles/(https://norml.org/principles/) Schall, M., Kemeny, A., & Maltzman, I. (1992). Factors associated with alcohol use in university students. Journal of Studies on Alcohol, 53(2), 122-136. https://doi.org/10.15288/jsa.1992.53.122(https://doi.org/10.15288/jsa.1992.53.122) Schlag, A. K., Hindocha, C., Zafar, R., Nutt, D. J., & Curran, H. V. (2021). Cannabis based medicines and cannabis dependence: A critical review of issues and evidence. Journal of Psychopharmacology, 35(7), 773-785. https://doi.org/10.1177/0269881120986393(https://doi.org/10.1177/0269881120986393) Shewan, D., Dalgarno, P., & Reith, G. (2000). Perceived risk and risk reduction among ecstasy users: The role of drug, set, and setting. International Journal of Drug Policy, 10(6), 431-453. https://doi.org/10.1016/S0955-3959(99)00038-9(https://doi.org/10.1016/S0955-3959(99)00038-9) Skliamis, K., Benschop, A., Liebregts, N., & Korf, D. J. (2021). Where, when and with whom: Cannabis use, settings and self-regulation rules. Contemporary Drug Problems, 48(3), 241-259. https://doi.org/10.1177/00914509211033921(https://doi.org/10.1177/00914509211033921) Zinberg, N. E. (1984). Drug, set, and setting: The basis for controlled intoxicant use. Yale University Press.

Cannabis Consumption Makes You Lazy and Unsuccessful Barnwell, S. S., Earleywine, M., & Wilcox, R. (2006). Cannabis, motivation, and life satisfaction in an internet sample. Substance Abuse Treatment, Prevention and Policy, 1(1), 2-2. https://doi.org/10.1186/1747-597X-1-2(https://doi.org/10.1186/1747-597X-1-2) Bloomfield, M. A. P., Morgan, C. J. A., Kapur, S., Curran, H. V., & Howes, O. D. (2014). The link between dopamine function and apathy in cannabis users: An [18f]-dopa pet imaging study. Psychopharmacology, 231(11), 2251-2259. https://doi.org/10.1007/s00213-014-3523-4(https://doi.org/10.1007/s00213-014-3523-4) Duncan, D. F. (1987). Lifetime prevalence of “Amotivational syndrome" among users and non users of hashish. Psychology of Addictive Behaviors, 1(2), 114-119. https://doi.org/10.1037/h0080444(https://doi.org/10.1037/h0080444) EMCCDA. (2006). The state of the drug problems in europe. Lisbon: EMCDDA. Gerard, A. (2014, May 21). Medical cannabis and the myth of amotivational syndrome. in-Training. https://in-training.org/medical-cannabis-myth-amotivational-syndrome-6905(https://in-training.org/medical-cannabis-myth-amotivational-syndrome-6905) Government of Canada. (2021, August 12). Canadian cannabis survey 2020: Summary. https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/research- d(https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/research-data/canadian-cannabis-survey-2020-summary.html#a2)ata/canadian-cannabis-survey-2020-summary.html (https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/research-data/canadian-cannabis-survey-2020-summary.html#a2) Joo, S. H., Durband, D. B., & Grable, J. (2008). The academic impact of financial stress on college students. Journal of College Student Retention: Research, Theory & Practice, 10(3), 287-305. https://doi.org/10.2190/CS.10.3.c(https://doi.org/10.2190/CS.10.3.c) Kouri, E., Pope Jr, H. G., Yurgelun-Todd, D., & Gruber, S. (1995). Attributes of heavy vs. occasional marijuana smokers in a college population. Biological Psychiatry, 38(7), 475-481. https://doi.org/10.1016/0006-3223(94)00325-w(https://doi.org/10.1016/0006-3223(94)00325-w) Krumrei-Mancuso, E. J., Newton, F. B., Kim, E., & Wilcox, D. (2013). Psychosocial factors predicting first-year college student success. Journal of College Student Development, 54(3), 247-266. https://doi.org/10.1353/csd.2013.0034(https://doi.org/10.1353/csd.2013.0034) Lac, A., & Luk, J. W. (2018). Testing the amotivational syndrome: Marijuana use longitudinally predicts lower self-efficacy even after controlling for demographics, personality, and alcohol and cigarette use. Prevention Science, 19(2), 117-126. https://doi.org/10.1007/s11121-017-0811-3(https://doi.org/10.1007/s11121-017-0811-3) Mattern, K. D., & Shaw, E. J. (2010). A look beyond cognitive predictors of academic success: Understanding the relationship between academic self-beliefs and outcomes. Journal of College Student Development, 51(6), 665-678. https://doi.org/10.1353/csd.2010.0017(https://doi.org/10.1353/csd.2010.0017) Mauger, C. (2020). 'Are you high?': Marijuana advocates fume over new state-backed ads. The Detroit News. https://www.detroitnews.com/story/news/politics/2020/01/17/are-you-high-marijuana-advocates-fume-over-new-state-backed-ads/4502648002/(https://www.detroitnews.com/story/news/politics/2020/01/17/are-you-high-marijuana-advocates-fume-over-new-state-backed-ads/4502648002/) Musty, R. E., & Kaback, L. (1995). Relationships between motivation and depression in chronic marijuana users. Life Sciences, 56(23-24), 2151-2158. https://doi.org/10.1016/0024-3205(95)00202-h(https://doi.org/10.1016/0024-3205(95)00202-h) Petrucci, A. S., LaFrance, E. M., & Cuttler, C. (2020). A comprehensive examination of the links between cannabis use and motivation. Substance Use & Misuse, 55(7), 1155-1164. https://doi.org/10.1080/10826084.2020.1729203(https://doi.org/10.1080/10826084.2020.1729203) Pike, G. R., Kuh, G. D., & Massa-McKinley, R. C. (2008). First-year students' employment, engagement, and academic achievement: Untangling the relationship between work and grades. NASPA Journal, 45(4), 560-582. https://doi.org/10.2202/1949-6605.2011(https://doi.org/10.2202/1949-6605.2011) Reilly, D., Didcott, P., Swift, W., & Hall, W. (1998). Long‐term cannabis use: Characteristics of users in an australian rural area. Addiction (Abingdon, England), 93(6), 837-846. https://doi.org/10.1046/j.1360-0443.1998.9368375.x(https://doi.org/10.1046/j.1360-0443.1998.9368375.x) Robb, C. A., Moody, B., & Abdel-Ghany, M. (2012). College student persistence to degree: The burden of debt. Journal of College Student Retention: Research, Theory & Practice, 13(4), 431-456. https://doi.org/10.2190/CS.13.4.b(https://doi.org/10.2190/CS.13.4.b) Suresh, K. (2011). An overview of randomization techniques: An unbiased assessment of outcome in clinical research. Journal of Human Reproductive Sciences, 4(1), 8-11. https://doi.org/10.4103/0974-1208.82352(https://doi.org/10.4103/0974-1208.82352) van Ours, J. C., & Williams, J. (2015). Cannabis use and its effects on health, education and labor market success. Journal of Economic Surveys, 29(5), 993-1010. https://doi.org/10.1111/joes.12070(https://doi.org/10.1111/joes.12070) Wahlquist, C. (2015). ‘Stoner sloth’ anti-drug campaign gets reality check as medical experts walk away. The Guardian. https://www.theguardian.com/society/2015/dec/20/stoner-sloth-anti-drug-campaign-gets-reality-check-as-medical-experts-walk-away(https://www.theguardian.com/society/2015/dec/20/stoner-sloth-anti-drug-campaign-gets-reality-check-as-medical-experts-walk-away) You Won’t Get High the First Time You Try Cannabis Becker, H. S. (1953). Becoming a marihuana user. American journal of Sociology, 59(3), 235-242. https://doi.org/10.1086/221326(https://doi.org/10.1086/221326) Grotenhermen, F. (2003). Pharmacokinetics and pharmacodynamics of cannabinoids. Clinical Pharmacokinetics, 42(4), 327-360. https://doi.org/10.2165/00003088-200342040-00003(https://doi.org/10.2165/00003088-200342040-00003) Huestis MA. (2007). Human cannabinoid pharmacokinetics. Chemistry & Biodiversity, 4(8):1770–1804. https://doi.org/10.1002/cbdv.200790152(https://doi.org/10.1002/cbdv.200790152) MacCallum, C. A., & Russo, E. B. (2018). Practical considerations in medical cannabis administration and dosing. European Journal of Internal Medicine, 49, 12-19. https://doi.org/10.1016/j.ejim.2018.01.004(https://doi.org/10.1016/j.ejim.2018.01.004) Novak, W. (1980). High culture: Marijuana in the lives of americans. Random House (NY). Cannabis is a Gateway Drug Choo, T., Roh, S., & Robinson, M. (2008). Assessing the “Gateway hypothesis” among middle and high school students in Tennessee. Journal of Drug Issues, 38(2), 467-492. https://doi.org/10.1177/002204260803800205(https://doi.org/10.1177/002204260803800205) Fergusson, D. M., Boden, J. M., & Horwood, L. J. (2006). Cannabis use and other illicit drug use: Testing the cannabis gateway hypothesis. Addiction (Abingdon, England), 101(4), 556-569. https://doi.org/10.1111/j.1360-0443.2005.01322.x(https://doi.org/10.1111/j.1360-0443.2005.01322.x) Fergusson, D. M., Boden, J. M., & Horwood, L. J. (2006). Testing the cannabis gateway hypothesis: Replies to Hall, Kandel et al. and MacCoun (2006). Addiction, 101(4), 474-476. https://doi.org/10.1111/j.1360-0443.2006.01450.x(https://doi.org/10.1111/j.1360-0443.2006.01450.x) Fergusson, D. M., & Horwood, L. J. (2000). Does cannabis use encourage other forms of illicit drug use? Addiction (Abingdon, England), 95(4), 505-520. https://doi.org/10.1046/j.1360-0443.2000.9545053.x(https://doi.org/10.1046/j.1360-0443.2000.9545053.x) Jorgensen, C., & Wells, J. (2021). Is marijuana really a gateway drug? A nationally representative test of the marijuana gateway hypothesis using a propensity score matching design. Journal of Experimental Criminology, 1-18. https://doi.org/10.1007/s11292-021-09464-z(https://doi.org/10.1007/s11292-021-09464-z) Kandel, D. (1975). Stages in adolescent involvement in drug use. Science (New York, N.Y.), 190(4217), 912-914. https://doi.org/10.1126/science.1188374(https://doi.org/10.1126/science.1188374) Kandel, D., & Faust, R. (1975). Sequence and stages in patterns of adolescent drug use. Archives of General Psychiatry, 32(7), 923-932. https://doi.org/10.1001/archpsyc.1975.01760250115013(https://doi.org/10.1001/archpsyc.1975.01760250115013) Kandel, D. B., Yamaguchi, K., & Klein, L. C. (2006). Testing the gateway hypothesis. Addiction (Abingdon, England), 101(4), 470-476. https://doi.org/10.1111/j.1360-0443.2006.01426.x(https://doi.org/10.1111/j.1360-0443.2006.01426.x) Maccoun, R. J. (2006). Competing accounts of the gateway effect: The field thins, but still no clear winner. Addiction, 101(4), 473-474. https://doi.org/10.1111/j.1360-0443.2006.01428.x(https://doi.org/10.1111/j.1360-0443.2006.01428.x) Melberg, H. O., Jones, A. M., & Bretteville-Jensen, A. L. (2010). Is cannabis a gateway to hard drugs? Empirical Economics, 38(3), 583-603. https://doi.org/10.1007/s00181-009-0280-z(https://doi.org/10.1007/s00181-009-0280-z) Miller, M. L., & Hurd, Y. L. (2017). Testing the gateway hypothesis. Neuropsychopharmacology, 42(5), 985-986. https://doi.org/10.1038/npp.2016.279(https://doi.org/10.1038/npp.2016.279) Nkansah-Amankra, S., & Minelli, M. (2016). “Gateway hypothesis” and early drug use: Additional findings from tracking a population-based sample of adolescents to adulthood. Preventive Medicine Reports, 4, 134-141. https://doi.org/10.1016/j.pmedr.2016.05.003(https://doi.org/10.1016/j.pmedr.2016.05.003) Noel, W.M. & Wang, J. (2018). Is cannabis a gateway drug? Key findings and literature review. National Institute of Justice. https://www.ojp.gov/pdffiles1/nij/252950.pdf(https://www.ojp.gov/pdffiles1/nij/252950.pdf) Robinson, M. B. (2006). Why crime?:An integrated systems theory of antisocial behavior. Recording for the blind & dyslexic. Pearson/Prentice Hall. Cannabis is So Much Stronger Today Than it Was in The 1900s Chandra, S., Radwan, M. M., Majumdar, C. G., Church, J. C., Freeman, T. P., & ElSohly, M. A. (2019). New trends in cannabis potency in USA and Europe during the last decade (2008–2017). European Archives of Psychiatry and Clinical Neuroscience, 269(1), 5-15. https://doi.org/10.1007/s00406-019-00983-5(https://doi.org/10.1007/s00406-019-00983-5) ElSohly, M. A., Mehmedic, Z., Foster, S., Gon, C., Chandra, S., & Church, J. C. (2016). Changes in cannabis potency over the last 2 decades (1995–2014): Analysis of current data in the United States. Biological Psychiatry, 79(7), 613-619. https://doi.org/10.1016/j.biopsych.2016.01.004(https://doi.org/10.1016/j.biopsych.2016.01.004) Freeman, T. P., Groshkova, T., Cunningham, A., Sedefov, R., Griffiths, P., & Lynskey, M. T. (2019). Increasing potency and price of cannabis in Europe, 2006–16. Addiction (Abingdon, Endland),114(6), 1015-1023. https://doi.org/10.1111/add.14525(https://doi.org/10.1111/add.14525) King, L. (2008). Understanding cannabis potency and monitoring cannabis products in europe. In S. R. Sznitman, B. Olsson, & R. Room (Eds.), A cannabis reader - global issues and local experiences (pp.239-259). European Monitoring Centre for Drugs and Drug Addiction. Le France, A. (2010). Was marijuana really less potent in the 1960s? The Atlantic. https://www.theatlantic.com/technology/archive/2015/03/was-marijuana-really-less-potent-in-the-1960s/387010/(https://www.theatlantic.com/technology/archive/2015/03/was-marijuana-really-less-potent-in-the-1960s/387010/) McLaren, J., Swift, W., Dillon, P., & Allsop, S. (2008). Cannabis potency and contamination: a review of the literature. Addiction (Abingdon, England), 103(7), 1100-1109. https://doi.org/10.1111/j.1360-0443.2008.02230.x(https://doi.org/10.1111/j.1360-0443.2008.02230.x) Mehmedic, Z., Chandra, S., Slade, D., Denham, H., Foster, S., Patel, A. S., Ross, S. A., Khan, I. A., & ElSohly, M. A. (2010). Potency trends of Δ9‐THC and other cannabinoids in confiscated cannabis preparations from 1993 to 2008. Journal of Forensic Sciences, 55(5), 1209-1217. https://doi.org/10.1111/j.1556-4029.2010.01441.x(https://doi.org/10.1111/j.1556-4029.2010.01441.x) The Thistle. (2000). Myths about marijuana. https://www.mit.edu/~thistle/v13/2/myths.html(https://www.mit.edu/~thistle/v13/2/myths.html) Cannabis Will Make You a Criminal Adda, J., McConnell, B., & Rasul, I. (2014). Crime and the depenalization of cannabis possession: Evidence from a policing experiment. Journal of Political Economy,122(5), 1130-1202. https://doi.org/10.1086/676932(https://doi.org/10.1086/676932) Boyd, S. (2010). Reefer madness and beyond. In M. Deflem (Ed.), Popular culture, crime and social control (pp.3-24). Emerald Group Publishing Limited. https://doi.org/10.1108/S1521-6136(2010)0000014004(https://doi.org/10.1108/S1521-6136(2010)0000014004) Brinkman, J., & Mok-Lamme, D. (2019). Not in my backyard? Not so fast. The effect of marijuana legalization on neighborhood crime. Regional Science and Urban Economics, 78, 103460. https://doi.org/10.1016/j.regsciurbeco.2019.103460(https://doi.org/10.1016/j.regsciurbeco.2019.103460) Dellazizzo, L., Potvin, S., Athanassiou, M., & Dumais, A. (2020). Violence and cannabis use: A focused review of a forgotten aspect in the era of liberalizing cannabis. Frontiers in Psychiatry, 11, 567887-567887. https://doi.org/10.3389/fpsyt.2020.567887(https://doi.org/10.3389/fpsyt.2020.567887) Denson, T. F., & Earleywine, M. (2008). Self-reported use of alcohol, marijuana, and hard drugs and aggression: A structural equation modeling analysis of an internet survey of long term marijuana users. Journal of Aggression, Maltreatment and Trauma, 16(2), 164-180. https://doi.org/10.1080/10926770801921469(https://doi.org/10.1080/10926770801921469) Drug Enforcement Administration Museum & Visitors Center (n.d.). Harry jacob anslinger 1930s. https://deamuseum.org/anslinger/in-charge/(https://deamuseum.org/anslinger/in-charge/) Freisthler, B., Gaidus, A., Tam, C., Ponicki, W. R., & Gruenewald, P. J. (2017). From medical to recreational marijuana sales: Marijuana outlets and crime in an era of changing marijuana legislation. The Journal of Primary Prevention, 38(3), 249–263. https://doi.org/10.1007/s10935-017-0472-9(https://doi.org/10.1007/s10935-017-0472-9) Green, K. M., Doherty, E. E., Stuart, E. A., & Ensminger, M. E. (2010). Does heavy adolescent marijuana use lead to criminal involvement in adulthood? Evidence from a multiwave longitudinal study of urban african americans. Drug and Alcohol Dependence, 112(1-2), 117-125. https://doi.org/10.1016/j.drugalcdep.2010.05.018(https://doi.org/10.1016/j.drugalcdep.2010.05.018) Huber III, A., Newman, R., & LaFave, D. (2016). Cannabis control and crime: Medicinal use, depenalization and the war on drugs. The BE Journal of Economic Analysis & Policy, 16(4). https://doi.org/10.1515/bejeap-2015-0167(https://doi.org/10.1515/bejeap-2015-0167) Ostrowsky, M. K. (2011). Does marijuana use lead to aggression and violent behavior? Journal of Drug Education, 41(4), 369-389. https://doi.org/10.2190/DE.41.4.c(https://doi.org/10.2190/DE.41.4.c) Pacula, R. L., & Kilmer, B. (2003). Marijuana and crime: Is there a connection beyond prohibition? National Bureau of Economic Research. https://www.nber.org/papers/w10046(https://www.nber.org/papers/w10046) Pedersen, W., & Skardhamar, T. (2010). Cannabis and crime: findings from a longitudinal study. Addiction (Abingdon, England), 105(1), 109-118. https://doi.org/10.1111/j.1360-0443.2009.02719.x(https://doi.org/10.1111/j.1360-0443.2009.02719.x) Riggs, N. R., Chou, C., & Pentz, M. A. (2009). Protecting against intergenerational problem behavior: Mediational effects of prevented marijuana use on second-generation parent child relationships and child impulsivity. Drug and Alcohol Dependence, 100(1-2), 153-160. https://doi.org/10.1016/j.drugalcdep.2008.10.003(https://doi.org/10.1016/j.drugalcdep.2008.10.003) Solomon, R. (2020). Racism and its effect on cannabis research. Cannabis and Cannabinoid Research, 5(1), 2-5. https://doi.org/10.1089/can.2019.0063(https://doi.org/10.1089/can.2019.0063) Stringer, R. J., & Maggard, S. R. (2016). Reefer madness to marijuana legalization: Media exposure and american attitudes toward marijuana (1975-2012). Journal of Drug Issues, 46(4), 428-445. https://doi.org/10.1177/0022042616659762(https://doi.org/10.1177/0022042616659762) Weed Maps. (n.d.). Does smoking weed kill brain cells? https://weedmaps.com/learn/cannabis-and-your-body/does-smoking-weed-kill-brain-cells(https://weedmaps.com/learn/cannabis-and-your-body/does-smoking-weed-kill-brain-cells) Wei, E. H., Loeber, R., & White, H. R. (2004). Teasing apart the developmental associations between alcohol and marijuana use and violence. Journal of Contemporary Criminal Justice, 20(2), 166–183.https://doi.org/10.1177/1043986204263777(https://doi.org/10.1177/1043986204263777) Smoking Cannabis Kills Brain Cells Burggren, A. C., Shirazi, A., Ginder, N., & London, E. D. (2019). Cannabis effects on brain structure, function, and cognition: Considerations for medical uses of cannabis and its derivatives. The American Journal of Drug and Alcohol Abuse, 45(6), 563-579. https://doi.org/10.1080/00952990.2019.1634086(https://doi.org/10.1080/00952990.2019.1634086) Chang, L., Yakupov, R., Cloak, C., & Ernst, T. (2006). Marijuana use is associated with a reorganized visual-attention network and cerebellar hypoactivation. Brain: A Journal of Neurology, 129(Pt 5), 1096-1112. https://doi.org/10.1093/brain/awl064(https://doi.org/10.1093/brain/awl064) Chen, Y., & Buck, J. (2000). Cannabinoids protect cells from oxidative cell death: A receptor-independent mechanism. Journal of Pharmacology and Experimental Therapeutics, 293(3), 807-812. https://jpet.aspetjournals.org/content/293/3/807(https://jpet.aspetjournals.org/content/293/3/807) Chu, Y. W. L., & Gershenson, S. (2018). High times: The effect of medical marijuana laws on student time use. Economics of Education Review, 66, 142-153. https://doi.org/10.1016/j.econedurev.2018.08.003(https://doi.org/10.1016/j.econedurev.2018.08.003) Colizzi, M., Tosato, S., & Ruggeri, M. (2020). Cannabis and cognition: Connecting the dots towards the understanding of the relationship. Brain Sciences, 10(3), 133. https://doi.org/10.3390/brainsci10030133(https://doi.org/10.3390/brainsci10030133) Cousijn, J., Wiers, R. W., Ridderinkhof, K. R., van den Brink, W., Veltman, D. J., & Goudriaan, A. E. (2014). Effect of baseline cannabis use and working‐memory network function on changes in cannabis use in heavy cannabis users: A prospective fMRI study. Human Brain Mapping, 35(5), 2470-2482. https://doi.org/10.1002/hbm.22342(https://doi.org/10.1002/hbm.22342) Fishbein, M., Gov, S., Assaf, F., Gafni, M., Keren, O., & Sarne, Y. (2012). Long-term behavioral and biochemical effects of an ultra-low dose of Δ 9-tetrahydrocannabinol (THC): Neuroprotection and ERK signaling. Experimental Brain Research, 221(4), 437-448. https://doi.org/10.1007/s00221-012-3186-5(https://doi.org/10.1007/s00221-012-3186-5) Harvey, M. A., Sellman, J. D., Porter, R. J., & Frampton, C. M. (2007). The relationship between non-acute adolescent cannabis use and cognition. Drug and Alcohol Review, 26(3), 309-319. https://doi.org/10.1080/09595230701247772(https://doi.org/10.1080/09595230701247772) Heath, R. G. (1973). Marijuana: Effects on deep and surface electroencephalograms of rhesus monkeys. Neuropharmacology, 12(1), 1-14. https://doi.org/10.1016/0028-3908(73)90126-3(https://doi.org/10.1016/0028-3908(73)90126-3) Jager, G., Kahn, R. S., Van Den Brink, W., Van Ree, J.,M., & Ramsey, N. F. (2006). Long-term effects of frequent cannabis use on working memory and attention: An fMRI 22 study. Psychopharmacology, 185(3), 358-368. https://doi.org/10.1007/s00213-005-0298-7(https://doi.org/10.1007/s00213-005-0298-7) Jiang, W., Zhang, Y., Xiao, L., Van Cleemput, J., Ji, S. P., Bai, G., & Zhang, X. (2005). Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic-and antidepressant-like effects. The Journal of Clinical Investigation, 115(11), 3104-3116. https://doi.org/10.1172/JCI25509(https://doi.org/10.1172/JCI25509) Kanayama, G., Rogowska, J., Pope, H. G., Gruber, S. A., & Yurgelun-Todd, D. A. (2004). Spatial working memory in heavy cannabis users: A functional magnetic resonance imaging study. Psychopharmacology, 176(3), 239-247. https://doi.org/10.1007/s00213-004-1885-8(https://doi.org/10.1007/s00213-004-1885-8) Loreto, M. (2021). Does smoking weed kill a person’s brain cells? The Growth Op. nabis-news/does-smoking-weed-kill-a-persons-brain-cells(https://www.thegrowthop.com/cannabis-news/does-smoking-weed-kill-a-persons-brain-cells) Mechoulam, R., Panikashvili, D., & Shohami, E. (2002). Cannabinoids and brain injury: Therapeutic implications. Trends in Molecular Medicine, 8(2), 58-61. https://doi.org/10.1016/s1471-4914(02)02276-1(https://doi.org/10.1016/s1471-4914(02)02276-1) Moreau, J. (2016). “I learned it by watching you!” The partnership for a drug-free america and the attack on “Responsible use” education in the 1980s. Journal of Social History, 49(3), 710-737. https://doi.org/10.1093/jsh/shv062(https://doi.org/10.1093/jsh/shv062) O’Neal, C. M., Baker, C. M., Glenn, C. A., Conner, A. K., & Sughrue, M. E. (2017). Dr. robert g. heath: A controversial figure in the history of deep brain stimulation. Neurosurgical Focus, 43(3), E12. https://doi.org/10.3171/2017.6.FOCUS17252(https://doi.org/10.3171/2017.6.FOCUS17252) Pope Jr, H. G., Gruber, A. J., Hudson, J. I., Cohane, G., Huestis, M. A., & Yurgelun-Todd, D. (2003). Early-onset cannabis use and cognitive deficits: What is the nature of the association? Drug and Alcohol Dependence, 69(3), 303-310. https://doi.org/10.1016/s0376-8716(02)00334-4(https://doi.org/10.1016/s0376-8716(02)00334-4) Schoeler, T., Kambeitz, J., Behlke, I., Murray, R., & Bhattacharyya, S. (2016). The effects of cannabis on memory function in users with and without a psychotic disorder: Findings from a combined meta-analysis. Psychological Medicine, 46(1), 177-188. https://doi.org/10.1017/S0033291715001646(https://doi.org/10.1017/S0033291715001646) Schreiner, A. M., & Dunn, M. E. (2012). Residual effects of cannabis use on neurocognitive performance after prolonged abstinence: A meta-analysis. Experimental and Clinical Psychopharmacology, 20(5), 420-429. https://doi.org/10.1037/a0029117(https://doi.org/10.1037/a0029117) The Thistle. (2000). Myths about marijuana. https://www.mit.edu/~thistle/v13/2/myths.html(https://www.mit.edu/~thistle/v13/2/myths.html) Yanes, J. A., Riedel, M. C., Ray, K. L., Kirkland, A. E., Bird, R. T., Boeving, E. R., Reid, M. A., Gonzalez, R., Robinson, J. L., Laird, A. R., & Sutherland, M. T. (2018). Neuroimaging meta-analysis of cannabis use studies reveals convergent functional alterations in brain regions supporting cognitive control and reward processing. Journal of Psychopharmacology (Oxford, England), 32(3), 283-295. https://doi.org/10.1177/0269881117744995(https://doi.org/10.1177/0269881117744995) You Can Drive Better When You’re High Asbridge, M., Hayden, J. A., & Cartwright, J. L. (2012). Acute cannabis consumption and motor vehicle collision risk: Systematic review of observational studies and meta-analysis. BMJ (Online), 344, e536. https://doi.org/10.1136/bmj.e536(https://doi.org/10.1136/bmj.e536) Asbridge, M., Mann, R., Cusimano, M. D., Trayling, C., Roerecke, M., Tallon, J. M., Whipp, A., & Rehm, J. (2014). Cannabis and traffic collision risk: Findings from a case-crossover study of injured drivers presenting to emergency departments. International Journal of Public Health, 59(2), 395-404. https://doi.org/10.1007/s00038-013-0512-z(https://doi.org/10.1007/s00038-013-0512-z) Bédard, M., Dubois, S., & Weaver, B. (2007). The impact of cannabis on driving. Canadian Journal of Public Health, 98(1), 6-11. https://doi.org/10.1007/BF03405376(https://doi.org/10.1007/BF03405376) Downey, L. A., King, R., Papafotiou, K., Swann, P., Ogden, E., Boorman, M., & Stough, C. (2013). The effects of cannabis and alcohol on simulated driving: Influences of dose and experience. Accident; analysis and prevention, 50, 879–886. https://doi.org/10.1016/j.aap.2012.07.016(https://doi.org/10.1016/j.aap.2012.07.016) Fischer, B., Russell, C., Sabioni, P., Van Den Brink, W., Le Foll, B., Hall, W., Rehm, J., & Room, R. (2017). Lower-risk cannabis use guidelines: A comprehensive update of evidence and recommendations. American Journal of Public Health, 107(8), E1-E12. https://doi.org/10.2105/AJPH.2017.303818(https://doi.org/10.2105/AJPH.2017.303818) Government of Canada. (2020). Canadian Cannabis Survey 2020: Summary. https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/research-data/canadian-cannabis-survey-2020-summary.html#a4(https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/research-data/canadian-cannabis-survey-2020-summary.html#a4) Government of Canada. (2021). Don’t drive high. https://www.canada.ca/en/campaign/don-t-drive-high.html(https://www.canada.ca/en/campaign/don-t-drive-high.html) Hartman, R. L., & Huestis, M. A. (2013). Cannabis effects on driving skills. Clinical Chemistry, 59(3), 478–492. https://doi.org/10.1373/clinchem.2012.194381(https://doi.org/10.1373/clinchem.2012.194381) Li, M. C., Brady, J. E., DiMaggio, C. J., Lusardi, A. R., Tzong, K. Y., & Li, G. (2012). Marijuana use and motor vehicle crashes. Epidemiologic Reviews, 34(1), 65-72. https://doi.org/10.1093/epirev/mxr017(https://doi.org/10.1093/epirev/mxr017) McCartney, D., Arkell, T. R., Irwin, C., & McGregor, I. S. (2021). Determining the magnitude  and duration of acute [DELTA].sup.9-tetrahydrocannabinol -induced driving and  cognitive impairment: A systematic and meta-analysis review. Neuroscience and  Biobehavioral Reviews, 126, 175. https://doi.org/10.1016/j.neubiorev.2021.01.003 (https://doi.org/10.1016/j.neubiorev.2021.01.003) Ramaekers, J. G., Robbe, H. W., & O'Hanlon, J. F. (2000). Marijuana, alcohol and actual driving performance. Human Psychopharmacology, 15(7), 551–558. https://doi.org/10.1002/1099-1077(200010)15:7<551::AID-HUP236>3.0.CO;2-P(https://doi.org/10.1002/1099-1077(200010)15:7%3C551::AID-HUP236%3E3.0.CO;2-P) Rogeberg, O., & Elvik, R. (2016). The effects of cannabis intoxication on motor vehicle collision revisited and revised. Addiction (Abingdon, England), 111(8), 1348–1359. https://doi.org/10.1111/add.13347(https://doi.org/10.1111/add.13347) Swift, W., Copeland, J., Lenton, S. (2000). Cannabis and harm reduction. Drug and Alcohol Review, 19(1), 101-112. https://doi.org/10.1080/09595230096200(https://doi.org/10.1080/09595230096200) It’s Natural So it’s Harmless American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). https://doi.org/10.1176/appi.books.9780890425596(https://doi.org/10.1176/appi.books.9780890425596) Budney, A. J., Hughes, J. R., Moore, B. A., & Vandrey, R. (2004). Review of the validity and significance of cannabis withdrawal syndrome. The American Journal of Psychiatry, 161(11), 1967-1977. https://doi.org/10.1176/appi.ajp.161.11.1967(https://doi.org/10.1176/appi.ajp.161.11.1967) Casadio, P., Fernandes, C., Murray, R. M., & Di Forti, M. (2011). Cannabis use in young people: The risk for schizophrenia. Neuroscience and Biobehavioral Reviews, 35(8), 1779-1787. https://doi.org/10.1016/j.neubiorev.2011.04.007(https://doi.org/10.1016/j.neubiorev.2011.04.007) Chang, L., Yakupov, R., Cloak, C., & Ernst, T. (2006). Marijuana use is associated with a reorganized visual-attention network and cerebellar hypoactivation. Brain: A Journal of Neurology, 129(Pt 5), 1096-1112. https://doi.org/10.1093/brain/awl064(https://doi.org/10.1093/brain/awl064) Colizzi, M., Tosato, S., & Ruggeri, M. (2020). Cannabis and cognition: Connecting the dots towards the understanding of the relationship. Brain Sciences, 10(3), 133. https://doi.org/10.3390/brainsci10030133(https://doi.org/10.3390/brainsci10030133) Joshi, M., Joshi, A., & Bartter, T. (2014). Marijuana and lung diseases. Current Opinion in Pulmonary Medicine, 20(2), 173-179. https://doi.org/10.1097/MCP.0000000000000026(https://doi.org/10.1097/MCP.0000000000000026) Moir, D., Rickert, W. S., Levasseur, G., Larose, Y., Maertens, R., White, P., & Desjardins, S. (2008). A comparison of mainstream and sidestream marijuana and tobacco cigarette smoke produced under two machine smoking conditions. Chemical Research in Toxicology, 21(2), 494-502. https://doi.org/10.1021/tx700275p(https://doi.org/10.1021/tx700275p) Moore, T. H., Zammit, S., Lingford-Hughes, A., Barnes, T. R., Jones, P. B., Burke, M., & Lewis, G. (2007). Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet (London, England), 370(9584), 319-328. https://doi.org/10.1016/S0140-6736(07)61162-3(https://doi.org/10.1016/S0140-6736(07)61162-3) Patel, J., & Marwaha, R. (2021). Cannabis use disorder. StatPearls [Internet]. https://www.ncbi.nlm.nih.gov/books/NBK538131/ (https://www.ncbi.nlm.nih.gov/books/NBK538131/) Salas-Wright, C. P., Carbone, J. T., Holzer, K. J., & Vaughn, M. G. (2019). Prevalence and correlates of cannabis poisoning diagnosis in a national emergency department sample. Drug and Alcohol Dependence, 204, 107564-107564. https://doi.org/10.1016/j.drugalcdep.2019.107564 (https://doi.org/10.1016/j.drugalcdep.2019.107564) Schoeler, T., Kambeitz, J., Behlke, I., Murray, R., & Bhattacharyya, S. (2016). The effects of cannabis on memory function in users with and without a psychotic disorder: Findings from a combined meta-analysis. Psychological Medicine, 46(1), 177-188. https://doi.org/10.1017/S0033291715001646(https://doi.org/10.1017/S0033291715001646) Schreiner, A. M., & Dunn, M. E. (2012). Residual effects of cannabis use on neurocognitive performance after prolonged abstinence: A meta-analysis. Experimental and Clinical Psychopharmacology, 20(5), 420-429. https://doi.org/10.1037/a0029117(https://doi.org/10.1037/a0029117) Yanes, J. A., Riedel, M. C., Ray, K. L., Kirkland, A. E., Bird, R. T., Boeving, E. R., Reid, M. A., Gonzalez, R., Robinson, J. L., Laird, A. R., & Sutherland, M. T. (2018). Neuroimaging meta-analysis of cannabis use studies reveals convergent functional alterations in brain regions supporting cognitive control and reward processing. Journal of Psychopharmacology (Oxford, England), 32(3), 283-295. https://doi.org/10.1177/0269881117744995(https://doi.org/10.1177/0269881117744995) If You Hold the Smoke in Longer You Get More High Azorlosa, J. L., Greenwald, M. K., & Stitzer, M. L. (1995). Marijuana smoking: Effects of varying puff volume and breathhold duration. Journal of Pharmacology and Experimental Therapeutics, 272(2), 560-569. https://pubmed.ncbi.nlm.nih.gov/7853169/(https://pubmed.ncbi.nlm.nih.gov/7853169/) Farris, S. G., & Metrik, J. (2016). Acute effects of cannabis on breath-holding duration. Experimental and Clinical Psychopharmacology, 24(4), 305–312. https://doi.org/10.1037/pha0000075(https://doi.org/10.1037/pha0000075) Fischer, B., Russell, C., Sabioni, P., Van Den Brink, W., Le Foll, B., Hall, W., Rehm, J. & Room, R. (2017). Lower-risk cannabis use guidelines: A comprehensive update of evidence and recommendations. American Journal of Public Health, 107(8), e1-e12. https://doi.org/10.2105/AJPH.2017.303818(https://doi.org/10.2105/AJPH.2017.303818) McClure, E. A., Stitzer, M. L., & Vandrey, R. (2012). Characterizing smoking topography of cannabis in heavy users. Psychopharmacology, 220(2), 309-318. https://doi.org/10.1007/s00213-011-2480-4 (https://doi.org/10.1007/s00213-011-2480-4) Zacny, J. P., & Chait, L. D. (1989). Breathhold duration and response to marijuana smoke. Pharmacology, Biochemistry, and Behavior, 33(2), 481–484. https://doi.org/10.1016/0091-3057(89)90534-0(https://doi.org/10.1016/0091-3057(89)90534-0) Zacny, J. P., & Chait, L. D. (1991). Response to marijuana as a function of potency and breathhold duration. Psychopharmacology, 103(2), 223-226. https://doi.org/10.1007/BF02244207(https://doi.org/10.1007/BF02244207) If You Eat Raw Cannabis, You Will Get High Blake, A., & Nahtigal, I. (2019). The evolving landscape of cannabis edibles. Current Opinion in Food Science, 28, 25-31. https://doi.org/10.1016/j.cofs.2019.03.009(https://doi.org/10.1016/j.cofs.2019.03.009) Hädener, M., Vieten, S., Weinmann, W., & Mahler, H. (2019). A preliminary investigation of lung availability of cannabinoids by smoking marijuana or dabbing BHO and decarboxylation rate of THC-and CBD-acids. Forensic Science International, 295, 207-212. https://doi.org/10.1016/j.forsciint.2018.12.021(https://doi.org/10.1016/j.forsciint.2018.12.021) Moreno, T., Dyer, P., & Tallon, S. (2020). Cannabinoid decarboxylation: A comparative kinetic study. Industrial & Engineering Chemistry Research, 59(46), 20307-20315. https://doi.org/10.1021/acs.iecr.0c03791(https://doi.org/10.1021/acs.iecr.0c03791) Nuapia, Y., Maraba, K., Tutu, H., Chimuka, L., & Cukrowska, E. (2021). In situ decarboxylation-pressurized hot water extraction for selective extraction of cannabinoids from cannabis sativa. Chemometric Approach. Molecules, 26(11), 3343. https://doi.org/10.3390/molecules26113343(https://doi.org/10.3390/molecules26113343) Wang, M., Wang, Y., Avula, B., Radwan, M. M., Wanas, A. S., van Antwerp, J., Parcher, J. F., ElSohly, M. A., & Khan, I. A. (2016). Decarboxylation study of acidic cannabinoids: A novel approach using ultra-high-performance supercritical fluid chromatography/photodiode array-mass spectrometry. Cannabis and Cannabinoid Research, 1(1), 262-271. https://doi.org/10.1089/can.2016.0020(https://doi.org/10.1089/can.2016.0020) Having Cannabis in Your System (ex. Blood Test) Means You are High Odell, M. S., Frei, M. Y., Gerostamoulos, D., Chu, M., & Lubman, D. I. (2015). Residual cannabis levels in blood, urine and oral fluid following heavy cannabis use. Forensic  Science International, 249, 173-180. https://doi.org/10.1016/j.forsciint.2015.01.026 (https://doi.org/10.1016/j.forsciint.2015.01.026) Cannabis and Anesthesia Imasogie, N., Rose, R. V., & Wilson, A. (2021). High quantities: Evaluating the association between cannabis use and propofol anesthesia during endoscopy. PloS One, 16(3), e0248062-e0248062. https://doi.org/10.1371/journal.pone.0248062 (https://doi.org/10.1371/journal.pone.0248062) Sadighi, T., & Londahl-Ramsey, V. (2021). Cannabis use: Change in screening for primary care preoperative clearance. Journal for Nurse Practitioners, 17(7), 819-822. https://doi.org/10.1016/j.nurpra.2021.02.021 (https://doi.org/10.1016/j.nurpra.2021.02.021) Cannabis Harms the Developing Brain Shen, H. (2020). News feature: Cannabis and the adolescent brain. PNAS, 117(1), 7-11. https://doi.org/10.1073/pnas.1920325116(https://doi.org/10.1073/pnas.1920325116) Cannabis Users are Drug Addicts Government of Canada. (2021, July 2). Addiction to cannabis. https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/healtheffects/addiction.html (https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/health-effects/addiction.html) You Can Become Addicted After One Try Behrendt, S., Wittchen, H., Höfler, M., Lieb, R., & Beesdo, K. (2008;2009;). Transitions from first substance use to substance use disorders in adolescence: Is early onset associated with a rapid escalation? Drug and Alcohol Dependence, 99(1), 68-78. https://doi.org/10.1016/j.drugalcdep.2008.06.014 (https://doi.org/10.1016/j.drugalcdep.2008.06.014)

Abrams, D. I., Vizoso, H. P., Shade, S. B., Jay, C., Kelly, M. E., & Benowitz, N. L. (2007). Vaporization as a smokeless cannabis delivery system: a pilot study. Clinical Pharmacology & Therapeutics, 82(5), 572-578. https://doi.org/10.1038/sj.clpt.6100200(https://doi.org/10.1038/sj.clpt.6100200) Adams, I. B., & Martin, B. R. (1996). Cannabis: Pharmacology and toxicology in animals and humans. Addiction (Abingdon, England), 91(11), 1585-1614. https://doi.org/10.1046/j.1360-0443.1996.911115852.x (https://doi.org/10.1046/j.1360-0443.1996.911115852.x) Alger, B. E. (2013). Getting high on the endocannabinoid system. Cerebrum : The Dana Forum on Brain Science,  2013, 14. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997295/(https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997295/) Allen, J. A., Davis, K. C., Duke, J. C., Nonnemaker, J. M., Bradfield, B. R., & Farrelly, M. C. (2017). New product trial, use of edibles, and unexpected highs among marijuana and hashish users in colorado. Drug and Alcohol Dependence, 176, 44-47. https://doi.org/10.1016/j.drugalcdep.2017.03.006 (https://doi.org/10.1016/j.drugalcdep.2017.03.006) Arboleda, M. F., Prosk, E., Cyr, C., Gamaoun, R., & Vigano, A. (2020). Medical cannabis in supportive cancer care: Lessons from Canada. Supportive Care in Cancer: Official Journal of Multinational Association of Supportive Care in Cancer, 28(7), 2999-3001. https://doi.org/10.1007/s00520-020-05403-2(https://doi.org/10.1007/s00520-020-05403-2) Aston, E. R., Scott, B., & Farris, S. G. (2019). A qualitative analysis of cannabis vaporization among medical users. Experimental and Clinical Psychopharmacology, 27(4), 301-308. https://doi.org/10.1037/pha0000279 (https://doi.org/10.1037/pha0000279) Azofeifa, A., Mattson, M. E., Schauer, G., McAfee, T., Grant, A., & Lyerla, R. (2016). National estimates of marijuana use and related indicators — national survey on drug use and health, united states, 2002–2014. Morbidity and mortality weekly report. Surveillance summaries (Washington, D.C.: 2002), 65(11), 1-28. https://doi.org/10.15585/mmwr.ss6511a1 (https://doi.org/10.15585/mmwr.ss6511a1) Baron, E. P. (2015). Comprehensive review of medicinal marijuana, cannabinoids, and therapeutic implications in medicine and headache: What a long strange trip it's been. Headache, 55(6), 885-916. https://doi.org/10.1111/head.12570 (https://doi.org/10.1111/head.12570) Barrus, D. G., Capogrossi, K. L., Cates, S. C., Gourdet, C. K., Peiper, N. C., Novak, S. P., Lefever, T. W., & Wiley, J. L. (2016). Tasty thc: Promises and challenges of cannabis edibles. Methods report (RTI Press), 2016, 10.3768/rtipress.2016.op.0035.1611. https://doi.org/10.3768/rtipress.2016.op.0035.1611 (https://doi.org/10.3768/rtipress.2016.op.0035.1611) Benjamin, D. M., & Fossler, M. J. (2016). Edible cannabis products: it is time for FDA oversight. The Journal of Clinical Pharmacology, 56(9), 1045-1047. https://doi.org/10.1002/jcph.778(https://doi.org/10.1002/jcph.778) Benzinga. (2018, March 30). Smoking is just one way to use marijuana: An introduction to vaporizers, edibles, oils, tinctures, dabs and other cannabis products. https://www.benzinga.com/general/biotech/18/03/11035855/smoking-is-just-one-way-to-use-marijuana-an-introduction-to-vaporizer(https://www.benzinga.com/general/biotech/18/03/11035855/smoking-is-just-one-way-to-use-marijuana-an-introduction-to-vaporizer) Birnbaum, A. K., Karanam, A., Marino, S. E., Barkley, C. M., Remmel, R. P., Roslawski, M., Gramling‐Aden, M., & Leppik, I. E. (2019). Food effect on pharmacokinetics of cannabidiol oral capsules in adult patients with refractory epilepsy. Epilepsia (Copenhagen), 60(8), 1586-1592. https://doi.org/10.1111/epi.16093 (https://doi.org/10.1111/epi.16093) Bjorge, P. (2020, March 4). Cannabis tinctures 101: How to make, consume, and dose them. Leafly. https://www.leafly.ca/news/cannabis-101/cannabis-tinctures-101-what-are-they-how-to-make-them-and-how-to (https://www.leafly.ca/news/cannabis-101/cannabis-tinctures-101-what-are-they-how-to-make-them-and-how-to) Blake, A., & Nahtigal, I. (2019). The evolving landscape of cannabis edibles. Current Opinion in Food Science, 28, 25-31. https://doi.org/10.1016/j.cofs.2019.03.009 (https://doi.org/10.1016/j.cofs.2019.03.009) Bloor, R. N., Wang, T. S., Spanel, P., & Smith, D. (2008). Ammonia release from heated ‘street’ cannabis leaf and its potential toxic effects on cannabis users. Addiction (Abingdon, England), 103(10), 1671-1677. https://doi.org/10.1111/j.1360-0443.2008.02281.x(https://doi.org/10.1111/j.1360-0443.2008.02281.x) Borodovsky, J. T., Crosier, B. S., Lee, D. C., Sargent, J. D., & Budney, A. J. (2016). Smoking, vaping, eating: Is legalization impacting the way people use cannabis? The International Journal of Drug Policy, 36, 141-147. https://doi.org/10.1016/j.drugpo.2016.02.022 (https://doi.org/10.1016/j.drugpo.2016.02.022) Borodovsky, J. T., Lee, D. C., Crosier, B. S., Gabrielli, J. L., Sargent, J. D., & Budney, A. J. (2017). U.S. cannabis legalization and use of vaping and edible products among youth. Drug and alcohol dependence, 177, 299-306. https://doi.org/10.1016/j.drugalcdep.2017.02.017(https://doi.org/10.1016/j.drugalcdep.2017.02.017) Bottorff, J. L., Bissell, L. J., Balneaves, L. G., Oliffe, J. L., Capler, N. R., & Buxton, J. (2013). Perceptions of cannabis as a stigmatized medicine: A qualitative descriptive study. Harm Reduction Journal, 10(1), 2. https://doi.org/10.1186/1477-7517-10-2(https://doi.org/10.1186/1477-7517-10-2) Calapai, F., Cardia, L., Sorbara, E. E., Navarra, M., Gangemi, S., Calapai, G., & Mannucci, C. (2020). Cannabinoids, blood-brain barrier, and brain disposition. Pharmaceutics, 12(3), 265. https://doi.org/10.3390/pharmaceutics12030265(https://doi.org/10.3390/pharmaceutics12030265) Canadian Centre on Substance Use and Addiction. (2019). 7 things about edible cannabis. https://www.ccsa.ca/sites/default/files/2019-06/CCSA-7-Things-About-Edible-Cannabis-2(https://www.ccsa.ca/sites/default/files/2019-06/CCSA-7-Things-About-Edible-Cannabis-2019-en.pdf)019-en.pdf (https://www.ccsa.ca/sites/default/files/2019-06/CCSA-7-Things-About-Edible-Cannabis-2019-en.pdf) Canadian Centre on Substance Use and Addiction. (2019). Edible cannabis: Always read the label. https://ccsa.ca/sites/default/files/2019-10/CCSA-Edible-Cannabis-Read-Label-Infographic-2019-en.pdf(https://ccsa.ca/sites/default/files/2019-10/CCSA-Edible-Cannabis-Read-Label-Infographic-2019-en.pdf) Cannabis Regulations (SOR/2018-144). https://laws-lois.justice.gc.ca/eng/Regulations/SOR-2018-144/index.html (https://laws-lois.justice.gc.ca/eng/Regulations/SOR-2018-144/index.html) Capano, A., Weaver, R., & Burkman, E. (2020). Evaluation of the effects of CBD hemp extract on opioid use and quality of life indicators in chronic pain patients: A prospective cohort study. Postgraduate Medicine, 132(1), 56-61. https://doi.org/10.1080/00325481.2019.1685298(https://doi.org/10.1080/00325481.2019.1685298) Carter, G. T., Weydt, P., Kyashna-Tocha, M., & Abrams, D. I. (2004). Medicinal cannabis: Rational guidelines for dosing. IDrugs: The Investigational Drugs Journal, 7(5), 464-470. https://pubmed.ncbi.nlm.nih.gov/15154108/(https://pubmed.ncbi.nlm.nih.gov/15154108/) Chait, L. D., & Zacny, J. P. (1992). Reinforcing and subjective effects of oral Δ 9-thc and smoked marijuana in humans. Psychopharmacology, 107(2), 255-262. https://doi.org/10.1007/BF02245145(https://doi.org/10.1007/BF02245145) Cone, E. J., Johnson, R. E., Paul, B. D., Mell, L. D., & Mitchell, J. (1988). Marijuana-laced brownies: Behavioral effects, physiologic effects, and urinalysis in humans following ingestion. Journal of Analytical Toxicology, 12(4), 169-175. https://doi.org/10.1093/jat/12.4.169(https://doi.org/10.1093/jat/12.4.169) Craft, S., Winstock, A., Ferris, J., Mackie, C., Lynskey, M. T., & Freeman, T. P. (2020;2019;). Characterising heterogeneity in the use of different cannabis products: Latent class analysis with 55 000 people who use cannabis and associations with severity of cannabis dependence. Psychological Medicine, 50(14), 2364-2373. https://doi.org/10.1017/S0033291719002460 (https://doi.org/10.1017/S0033291719002460) Cranford, J. A., Bohnert, K. M., Perron, B. E., Bourque, C., & Ilgen, M. (2016). Prevalence and correlates of “Vaping” as a route of cannabis administration in medical cannabis patients. Drug and Alcohol Dependence, 169, 41– 47. http://doi.org/10.1016/j.drugalcdep.2016.10.008(http://doi.org/10.1016/j.drugalcdep.2016.10.008) CSSDP. (2018). Sensible cannabis education - A toolkit for educating youth. https://cssdp.org/uploads/2018/04/Sensible-Cannabis-Education-A-Toolkit-for-Educating-(https://cssdp.org/uploads/2018/04/Sensible-Cannabis-Education-A-Toolkit-for-Educating-Youth.pdf)Youth.pdf(https://cssdp.org/uploads/2018/04/Sensible-Cannabis-Education-A-Toolkit-for-Educating-Youth.pdf) CSSDP. (2019). Cannabis harm reduction. https://cssdp.org/uploads/2019/09/Cannabis-Harm-Reduction.pdf (https://cssdp.org/uploads/2019/09/Cannabis-Harm-Reduction.pdf) Curran, V. H., Brignell, C., Fletcher, S., Middleton, P., & Henry, J. (2002). Cognitive and subjective dose-response effects of acute oral Δ 9-tetrahydrocannabinol (thc) in infrequent cannabis users. Psychopharmacology, 164(1), 61-70. https://doi.org/10.1007/s00213-002-1169-0(https://doi.org/10.1007/s00213-002-1169-0) Cuttler, C., Mischley, L. K., & Sexton, M. (2016). Sex differences in cannabis use and effects: A cross-sectional survey of cannabis users. Cannabis and Cannabinoid Research, 1(1), 166-175. https://doi.org/10.1089/can.2016.0010(https://doi.org/10.1089/can.2016.0010) Dalgarno, P., & Shewan, D. (2005). Reducing the risks of drug use: The case for set and setting. Addiction Research & Theory, 13(3), 259-265. https://doi.org/10.1080/16066350500053562 (https://doi.org/10.1080/16066350500053562) Ewusi Boisvert, E., Bae, D., Pang, R. D., Davis, J. P., Kelley-Quon, L. I., Barrington-Trimis, J. L., Kirkpatrick, M. G., Chai, S. H., & Leventhal, A. M. (2020). Subjective effects of combustible, vaporized, and edible cannabis: Results from a survey of adolescent cannabis users. Drug and Alcohol Dependence, 206, 107716. https://doi.org/10.1016/j.drugalcdep.2019.107716 (https://doi.org/10.1016/j.drugalcdep.2019.107716) Farmer, S., Slavin, M. N., Loflin, M. J. E., Luba, R., & Earleywine, M. (2019). Aversiveness and meaningfulness of uncomfortable experiences with edible cannabis. Journal of Psychoactive Drugs, 51(5), 413-420. https://doi.org/10.1080/02791072.2019.1645371 (https://doi.org/10.1080/02791072.2019.1645371) Fischer, B., Russell, C., Sabioni, P., Van Den Brink, W., Le Foll, B., Hall, W., Rehm, J., & Room, R. (2017). Lower-risk cannabis use guidelines: A comprehensive update of evidence and recommendations. American Journal of Public Health, 107(8), E1-E12. https://doi.org/10.2105/AJPH.2017.303818(https://doi.org/10.2105/AJPH.2017.303818) Fligiel, S. E., Roth, M. D., Kleerup, E. C., Barsky, S. H., Simmons, M. S., & Tashkin, D. P. (1997). Tracheobronchial histopathology in habitual smokers of cocaine, marijuana, and/or tobacco. Chest, 112(2), 319-326. https://doi.org/10.1378/chest.112.2.319(https://doi.org/10.1378/chest.112.2.319) Franciosi, A. (2017). THC patch: The ultimate guide to thc transdermal patches. Honest Marijuana. https://honestmarijuana.com/thc-patch/ (https://honestmarijuana.com/thc-patch/) Freeman, T. P., & Winstock, A. R. (2015). Examining the profile of high-potency cannabis and its association with severity of cannabis dependence. Psychological Medicine, 45(15), 3181-3189. https://doi.org/10.1017/S0033291715001178 (https://doi.org/10.1017/S0033291715001178) Geshtakovska, G., & Stefkov, G. (2016). Routes of cannabis administration: A brief review. Your hosts Macedonian Pharmaceutical Association and Faculty of Pharmacy, Ss Cyril and Methodius University in Skopje, 515. https://www.researchgate.net/profile/Marija-Vavlukis/publication/303899331_Impact_of_SLCO1B1_521TC_and_388AG_polymorphisms_on_response_to_atorvastatin_in_the_albanian_population/links/575bf9a708ae9a9c9556fa65/Impact-of-SLCO1B1-521TC-and-388AG-polymorphisms-on-response-to-atorvastatin-in-the-albanian-population.pdf#page=515(https://www.researchgate.net/profile/Marija-Vavlukis/publication/303899331_Impact_of_SLCO1B1_521TC_and_388AG_polymorphisms_on_response_to_atorvastatin_in_the_albanian_population/links/575bf9a708ae9a9c9556fa65/Impact-of-SLCO1B1-521TC-and-388AG-polymorphisms-on-response-to-atorvastatin-in-the-albanian-population.pdf#page=515) Ghosh, T. S., Van Dyke, M., Maffey, A., Whitley, E., Erpelding, D., & Wolk, L. (2015). Medical marijuana’s public health lessons—implications for retail marijuana in Colorado. The New England Journal of Medicine, 372(11), 991-993. https://doi.org/10.1056/NEJMp1500043 (https://doi.org/10.1056/NEJMp1500043) Gieringer, D. H. (2001). Cannabis “Vaporization”: A promising strategy for smoke harm reduction. Journal of Cannabis Therapeutics, 1(3-4), 153-170. https://doi.org/10.1300/J175v01n03_10 (https://doi.org/10.1300/J175v01n03_10) Giombi, K. C., Kosa, K. M., Rains, C., & Cates, S. C. (2018). Consumers' perceptions of edible marijuana products for recreational use: Likes, dislikes, and reasons for use. Substance use & Misuse, 53(4), 541-547. https://doi.org/10.1080/10826084.2017.1343353 (https://doi.org/10.1080/10826084.2017.1343353) Government of Canada. (2019, December 13). Canadian Cannabis Survey 2019-Summary. https://www.canada.ca/en/health-canada/services/publications/drugs-health-products/canadian-cannabis-survey-2019-summary.html (https://www.canada.ca/en/health-canada/services/publications/drugs-health-products/canadian-cannabis-survey-2019-summary.html) Government of Canada. (2019). Cannabis: Lower your risks. https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/resources/loW(https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/resources/lower-your-risks.html)er-your-risks.html(https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/resources/lower-your-risks.html) Government of Canada. (2019). Final regulations: Edible cannabis, cannabis extracts, cannabis topicals. https://www.canada.ca/content/dam/hc-sc/documents/services/drugs-medication/cannabis/(https://www.canada.ca/content/dam/hc-sc/documents/services/drugs-medication/cannabis/resources/final-regulations-edible-cannabis-extracts-topical-eng.pdf)resources/final-regulations-edible-cannabis-extracts-topical-eng.pdf(https://www.canada.ca/content/dam/hc-sc/documents/services/drugs-medication/cannabis/resources/final-regulations-edible-cannabis-extracts-topical-eng.pdf) Grewal, J. K., & Loh, L. C. (2020). Health considerations of the legalization of cannabis edibles. CMAJ : Canadian Medical Association Journal, 192(1), E1–E2. https://doi.org/10.1503/cmaj.191217 (https://doi.org/10.1503/cmaj.191217) Grof, C. P. L. (2018). Cannabis, from plant to pill. British Journal of Clinical Pharmacology, 84(11), 2463-2467. https://doi.org/10.1111/bcp.13618 (https://doi.org/10.1111/bcp.13618) Grotenhermen, F. (2001). Harm reduction associated with inhalation and oral administration of cannabis and thc. Journal of Cannabis Therapeutics, 1(3-4), 133-152. https://doi.org/10.1300/J175v01n03_09(https://doi.org/10.1300/J175v01n03_09) Grotenhermen, F. (2003). Clinical pharmacokinetics of cannabinoids. Journal of Cannabis Therapeutics, 3(1), 3-51. https://doi.org/10.1300/J175v03n01_02(https://doi.org/10.1300/J175v03n01_02) Grotenhermen, F. (2007). The toxicology of cannabis and cannabis prohibition. Chemistry & Biodiversity, 4(8), 1744-1769. https://doi.org/10.1002/cbdv.200790151(https://doi.org/10.1002/cbdv.200790151) Halperin, A. (2018). 'You're not going to die': How to survive an edible marijuana overdose. The Guardian. https://www.theguardian.com/society/2018/nov/18/marijuana-cannabis-edibles-overdose-t(https://www.theguardian.com/society/2018/nov/18/marijuana-cannabis-edibles-overdose-too-much)oo-much (https://www.theguardian.com/society/2018/nov/18/marijuana-cannabis-edibles-overdose-too-much) Hart, C. L., Ward, A. S., Haney, M., Comer, S. D., Foltin, R. W., & Fischman, M. W. (2002). Comparison of smoked marijuana and oral Δ9-tetrahydrocannabinol in humans. Psychopharmacology, 164(4), 407-415. https://doi.org/10.1007/s00213-002-1231-y(https://doi.org/10.1007/s00213-002-1231-y) Hartogsohn, I. (2017). Constructing drug effects: A history of set and setting. Drug Science, Policy and Law. https://doi.org/10.1177/2050324516683325 (https://doi.org/10.1177/2050324516683325) Haug, N. A., Padula, C. B., Sottile, J. E., Vandrey, R., Heinz, A. J., & Bonn-Miller, M. O. (2017). Cannabis use patterns and motives: A comparison of younger, middle-aged, and older medical cannabis dispensary patients. Addictive Behaviors, 72, 14-20. https://doi.org/10.1016/j.addbeh.2017.03.006 (https://doi.org/10.1016/j.addbeh.2017.03.006) Hazekamp, A., Ruhaak, R., Zuurman, L., van Gerven, J., & Verpoorte, R. (2006). Evaluation of a vaporizing device (Volcano) for the pulmonary administration of tetrahydrocannabinol. Journal of Pharmaceutical Sciences, 95(6), 1308 –1317. http://doi.org/10.1002/jps.20574 (http://doi.org/10.1002/jps.20574) Hillig, K. W., & Mahlberg, P. G. (2004). A chemotaxonomic analysis of cannabinoid variation in cannabis (Cannabaceae). American Journal of Botany, 91(6), 966-975. https://doi.org/10.3732/ajb.91.6.966(https://doi.org/10.3732/ajb.91.6.966) Huestis, M. A. (2007). Human cannabinoid pharmacokinetics. Chemistry & biodiversity, 4(8), 1770-1804. https://doi.org/10.1002/cbdv.200790152 (https://doi.org/10.1002/cbdv.200790152) Jett, J., Stone, E., Warren, G., & Cummings, K. M. (2018). Cannabis use, lung cancer, and related issues. Journal of Thoracic Oncology, 13(4), 480-487. https://doi.org/10.1016/j.jtho.2017.12.013 (https://doi.org/10.1016/j.jtho.2017.12.013) Jones, C. B., Hill, M. L., Pardini, D. A., & Meier, M. H. (2016). Prevalence and correlates of vaping cannabis in a sample of young adults. Psychology of Addictive Behaviors, 30(8), 915-921. https://doi.org/10.1037/adb0000217(https://doi.org/10.1037/adb0000217) Karschner, E. L., Darwin, W. D., Goodwin, R. S., Wright, S., & Huestis, M. A. (2011). Plasma cannabinoid pharmacokinetics following controlled oral Δ9-tetrahydrocannabinol and oromucosal cannabis extract administration. Clinical chemistry, 57(1), 66-75. https://doi.org/10.1373/clinchem.2010.152439(https://doi.org/10.1373/clinchem.2010.152439) Kostadinov, V., & Roche, A. (2017). Bongs and baby boomers: Trends in cannabis use among older australians. Australasian Journal on Ageing, 36(1), 56-59. https://doi.org/10.1111/ajag.12357(https://doi.org/10.1111/ajag.12357) Lamy, F. R., Daniulaityte, R., Sheth, A., Nahhas, R. W., Martins, S. S., Boyer, E. W., & Carlson, R. G. (2016). “Those edibles hit hard”: Exploration of twitter data on cannabis edibles in the U.S. Drug and Alcohol Dependence, 164, 64-70. https://doi.org/10.1016/j.drugalcdep.2016.04.029 (https://doi.org/10.1016/j.drugalcdep.2016.04.029) Lankenau, S. E., Fedorova, E. V., Reed, M., Schrager, S. M., Iverson, E., & Wong, C. F. (2017). Marijuana practices and patterns of use among young adult medical marijuana patients and non-patient marijuana users. Drug and Alcohol Dependence, 170, 181-188. https://doi.org/10.1016/j.drugalcdep.2016.10.025(https://doi.org/10.1016/j.drugalcdep.2016.10.025) Lau, N., Sales, P., Averill, S., Murphy, F., Sato, S., & Murphy, S. (2015). A safer alternative: Cannabis substitution as harm reduction. Drug and Alcohol Review, 34(6), 654-659. https://doi.org/10.1111/dar.12275 (https://doi.org/10.1111/dar.12275) Lau, N., Sales, P., Averill, S., Murphy, F., Sato, S., & Murphy, S. (2015). Responsible and controlled use: Older cannabis users and harm reduction. The International Journal on Drug Policy, 26(8), 709–718. https://doi.org/10.1016/j.drugpo.2015.03.008 (https://doi.org/10.1016/j.drugpo.2015.03.008) Lemberger, L., Martz, R., Rodda, B., Forney, R., & Rowe, H. (1973). Comparative pharmacology of Δ9-tetrahydrocannabinol and its metabolite, 11-OH-Δ9-tetrahydrocannabinol. The Journal of Clinical Investigation, 52(10), 2411-2417. https://doi.org/10.1172/JCI107431 (https://doi.org/10.1172/JCI107431) Levinsohn, E. A., & Hill, K. P. (2020). Clinical uses of cannabis and cannabinoids in the unitedstates. Journal of the Neurological Sciences, 411, 116717. https://doi.org/10.1016/j.jns.2020.116717(https://doi.org/10.1016/j.jns.2020.116717) Loflin, M., & Earleywine, M. (2014). A new method of cannabis ingestion: The dangers of dabs? Addictive Behaviors, 39(10), 1430-1433. https://doi.org/10.1016/j.addbeh.2014.05.013 (https://weedoutmisinformation.ca/resources/%20https:/doi.org/10.1016/j.addbeh.2014.05.013) Loflin, M., & Earleywine, M. (2015). No smoke, no fire: What the initial literature suggests regarding vapourized cannabis and respiratory risk. Canadian Journal of Respiratory Therapy: CJRT, 51(1), 7-9. https://pubmed.ncbi.nlm.nih.gov/26078621/(https://pubmed.ncbi.nlm.nih.gov/26078621/) MacCallum, C. A., & Russo, E. B. (2018). Practical considerations in medical cannabis administration and dosing. European Journal of Internal Medicine, 49, 12-19. https://doi.org/10.1016/j.ejim.2018.01.004(https://doi.org/10.1016/j.ejim.2018.01.004) MacCoun, R. J., & Mello, M. M. (2015). Half-baked—the retail promotion of marijuana edibles. The New England Journal of Medicine, 372(11), 989-991. https://doi.org/10.1056/NEJMp1416014(https://doi.org/10.1056/NEJMp1416014) Marangoni, I. P., & Marangoni, A. G. (2019). Cannabis edibles: Dosing, encapsulation, and stability considerations. Current Opinion in Food Science, 28, 1-6. https://doi.org/10.1016/j.cofs.2019.01.005 (https://doi.org/10.1016/j.cofs.2019.01.005) Mariani, J. J., Brooks, D., Haney, M., & Levin, F. R. (2011). Quantification and comparison of marijuana smoking practices: Blunts, joints, and pipes. Drug and Alcohol Dependence, 113(2-3), 249-251. https://doi.org/10.1016/j.drugalcdep.2010.08.008(https://doi.org/10.1016/j.drugalcdep.2010.08.008) Marsot, A., Audebert, C., Attolini, L., Lacarelle, B., Micallef, J., & Blin, O. (2017). Population pharmacokinetics model of thc used by pulmonary route in occasional cannabis smokers. Journal of Pharmacological and Toxicological Methods, 85, 49-54. https://doi.org/10.1016/j.vascn.2017.02.003 (https://doi.org/10.1016/j.vascn.2017.02.003) Moore, T. R. (2002). A primer of drug action: A concise nontechnical guide to the actions, uses, and side effects of psychoactive drugs, ninth edition. American Journal of Health-System Pharmacy, 59(11), 1130-1131. https://doi.org/10.1093/ajhp/59.11.1130a (https://doi.org/10.1093/ajhp/59.11.1130a) National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice; Committee on the Health Effects of Marijuana: An Evidence Review and Research Agenda. (2017). The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. Washington (DC): National Academies Press (US); 2017 Jan 12. https://doi.org/10.17226/24625(https://doi.org/10.17226/24625) OCS. (n.d.). Intro to cannabis beverages. Retrieved October 20, 2021, from https://ocs.ca/blogs/cannabis-basics/intro-to-cannabis-beverages (https://ocs.ca/blogs/cannabis-basics/intro-to-cannabis-beverages) Ohlsson, A., Lindgren, J. E., Wahlen, A., Agurell, S., Hollister, L. E., & Gillespie, H. K. (1980). Plasma delta‐9‐tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking. Clinical Pharmacology & Therapeutics, 28(3), 409-416. https://doi.org/10.1038/clpt.1980.181(https://doi.org/10.1038/clpt.1980.181) Pacula, R. L., Jacobson, M., & Maksabedian, E. J. (2016). In the weeds: a baseline view of cannabis use among legalizing states and their neighbours. Addiction (Abingdon, England), 111(6), 973-980. https://doi.org/10.1111/add.13282(https://doi.org/10.1111/add.13282) Papaseit, E., Pérez-Mañá, C., Pérez-Acevedo, A. P., Hladun, O., Torres-Moreno, M. C., Muga, R., Torrens, M., & Farré, M. (2018). Cannabinoids: from pot to lab. International Journal of Medical Sciences, 15(12), 1286–1295. https://doi.org/10.7150/ijms.27087 (https://doi.org/10.7150/ijms.27087) Perkins, D. (2021, August 5). Understanding milligram doses in cannabis drinks. Sorse Technology. https://sorsetech.com/understanding-milligram-doses-in-cannabis-drinks/ (https://sorsetech.com/understanding-milligram-doses-in-cannabis-drinks/) Ribeiro, L. I., & Ind, P. W. (2016). Effect of cannabis smoking on lung function and respiratory symptoms: A structured literature review. NPJ Primary Care Respiratory Medicine, 26(1), 16071. https://doi.org/10.1038/npjpcrm.2016.71(https://doi.org/10.1038/npjpcrm.2016.71) Rotermann, M. (2021). Looking back from 2020, how cannabis use and related behaviours changed in canada. Health Reports, 32(4), 3-14. https://doi.org/10.25318/82-003-x202100400001-eng(https://doi.org/10.25318/82-003-x202100400001-eng) Russell, C., Rueda, S., Room, R., Tyndall, M., & Fischer, B. (2018). Routes of administration for cannabis use – basic prevalence and related health outcomes: A scoping review and synthesis. The International Journal of Drug Policy, 52, 87-96. https://doi.org/10.1016/j.drugpo.2017.11.008(https://doi.org/10.1016/j.drugpo.2017.11.008) Russo E. B. (2011). Taming thc: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. British Journal of Pharmacology, 163(7), 1344–1364. https://doi.org/10.1111/j.1476-5381.2011.01238.x (https://doi.org/10.1111/j.1476-5381.2011.01238.x) Sadhir, M. (2016). Pharmacology of cannabis. Journal of Pain Management, 9(4), 375-379. https://uknowledge.uky.edu/pediatrics_facpub/265/(https://uknowledge.uky.edu/pediatrics_facpub/265/) Schauer, G. L., King, B. A., Bunnell, R. E., Promoff, G., & McAfee, T. A. (2016). Toking, vaping, and eating for health or fun: Marijuana use patterns in adults, U.S., 2014. American Journal of Preventive Medicine, 50(1), 1-8. https://doi.org/10.1016/j.amepre.2015.05.027(https://doi.org/10.1016/j.amepre.2015.05.027) Schlienz, N. J., Spindle, T. R., Cone, E. J., Herrmann, E. S., Bigelow, G. E., Mitchell, J. M., Flegel, R., LoDico, C., & Vandrey, R. (2020). Pharmacodynamic dose effects of oral cannabis ingestion in healthy adults who infrequently use cannabis. Drug and Alcohol Dependence, 211, 107969. https://doi.org/10.1016/j.drugalcdep.2020.107969(https://doi.org/10.1016/j.drugalcdep.2020.107969) Schmidt, E. (2020, February 6). Water-soluble cannabinoids: A challenge and solution for the cannabis beverage market. ACS Laboratory. https://acslabcannabis.com/blog/cannabinoids/water-soluble-cannabinoids-a-challenge-and-solution-for-the-cannabis-beverage-market/ (https://acslabcannabis.com/blog/cannabinoids/water-soluble-cannabinoids-a-challenge-and-solution-for-the-cannabis-beverage-market/) Shakya, P., Madhav, N. V. S., Shakya, A. K., & Singh, K. (2011). Palatal mucosa as a route for systemic drug delivery: A review. Journal of Controlled Release, 151(1), 2-9. https://doi.org/10.1016/j.jconrel.2010.11.003 (https://doi.org/10.1016/j.jconrel.2010.11.003) Shiplo, S., Asbridge, M., Leatherdale, S. T., & Hammond, D. (2016). Medical cannabis use in Canada: Vapourization and modes of delivery. Harm Reduction Journal, 13(1), 30. https://doi.org/10.1186/s12954-016-0119-9(https://doi.org/10.1186/s12954-016-0119-9) Simpson, K. A., Cho, J., & Barrington-Trimis, J. L. (2021). The association of type of cannabis product used and frequency of use with problematic cannabis use in a sample of young adult cannabis user. Drug and Alcohol Dependence, 226, 108865-108865. https://doi.org/10.1016/j.drugalcdep.2021.108865 (https://doi.org/10.1016/j.drugalcdep.2021.108865) Sith, D., Bloor, R., George, C., Pysanenko, A., & Španěl, P. (2015). Release of toxic ammonia and volatile organic compounds by heated cannabis and their relation to tetrahydrocannabinol content. Analytical Methods, 7(10), 4104-4110. https://doi.org/10.1039/C5AY00593K (https://doi.org/10.1039/C5AY00593K) Subritzky, T., Pettigrew, S., & Lenton, S. (2016). Issues in the implementation and evolution of the commercial recreational cannabis market in Colorado. International Journal of Drug Policy, 27, 1-12. https://doi.org/10.1016/j.drugpo.2015.12.001(https://doi.org/10.1016/j.drugpo.2015.12.001) Swan, C., Ferro, M. A., & Thompson, K. (2021). Does how you use matter? The link between mode of use and cannabis-related risk. Addictive Behaviors, 112, 106620-106620. https://doi.org/10.1016/j.addbeh.2020.106620 (https://doi.org/10.1016/j.addbeh.2020.106620) Tetrault, J. M., Crothers, K., Moore, B. A., Mehra, R., Concato, J., & Fiellin, D. A. (2007). Effects of marijuana smoking on pulmonary function and respiratory complications: A systematic review. Archives of Internal Medicine, 167(3), 221–228. https://doi.org/10.1001/archinte.167.3.221(https://doi.org/10.1001/archinte.167.3.221) The Canadian Press. (2019, October 18). Edibles, vapes and oils: What you need to know about cannabis 2.0. CTV News. https://www.ctvnews.ca/canada/edibles-vapes-and-oils-what-you-need-to-know-about-can(https://www.ctvnews.ca/canada/edibles-vapes-and-oils-what-you-need-to-know-about-cannabis-2-0-1.4644511)nabis-2-0-1.4644511 (https://www.ctvnews.ca/canada/edibles-vapes-and-oils-what-you-need-to-know-about-cannabis-2-0-1.4644511) Timberlake, D. S. (2009). A comparison of drug use and dependence between blunt smokers and other cannabis users. Substance use & Misuse, 44(3), 401-415. https://doi.org/10.1080/10826080802347651 (https://weedoutmisinformation.ca/resources/%20https:/doi.org/10.1080/10826080802347651) United Nations Office on Drugs and Crime. (2009). World drug report. https://www.unodc.org/documents/wdr/WDR_2009/WDR2009_eng_web.pdf(https://www.unodc.org/documents/wdr/WDR_2009/WDR2009_eng_web.pdf) Urits, I., Gress, K., Charipova, K., Habib, K., Lee, D., Lee, C., Jung, J. W., Kassem, H., Cornett, E., Paladini, A., Varrassi, G., Kaye, A., D., Viswanath, O. (2020). Use of cannabidiol (CBD) for the treatment of chronic pain. Best Practice & Research. Clinical Anaesthesiology, 34(3), 463-477. https://doi.org/10.1016/j.bpa.2020.06.004(https://doi.org/10.1016/j.bpa.2020.06.004) van der Pol, P., Liebregts, N., Brunt, T., van Amsterdam, J., de Graaf, R., Korf, D. J., van den Brink, W., & van Laar, M. (2014). Cross-sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: An ecological study. Addiction (Abingdon, England), 109(7), 1101-1109. https://doi.org/10.1111/add.12508 (https://doi.org/10.1111/add.12508) Varlet, V., Concha-Lozano, N., Berthet, A., Plateel, G., Favrat, B., De Cesare, M., Lauer, E., Augsburger, M., Thomas, A. and Giroud, C. (2016). Drug vaping applied to cannabis: Is “Cannavaping” a therapeutic alternative to marijuana? Scientific reports, 6(1), 25599. https://doi.org/10.1038/srep25599(https://doi.org/10.1038/srep25599) Wang, M., Wang, Y., Avula, B., Radwan, M. M., Wanas, A. S., van Antwerp, J., Parcher, J. F., ElSohly, M. A., & Khan, I. A. (2016). Decarboxylation study of acidic cannabinoids: A novel approach using ultra-high-performance supercritical fluid chromatography/photodiode array-mass spectrometry. Cannabis and Cannabinoid Research, 1(1), 262-271. https://doi.org/10.1089/can.2016.0020 (https://doi.org/10.1089/can.2016.0020) Watanabe, K., Yamaori, S., Funahashi, T., Kimura, T., & Yamamoto, I. (2007). Cytochrome p450 enzymes involved in the metabolism of tetrahydrocannabinols and cannabinol by human hepatic microsomes. Life Sciences, 80(15), 1415-1419. https://doi.org/10.1016/j.lfs.2006.12.032 (https://doi.org/10.1016/j.lfs.2006.12.032) Watkins, A. (2020, March 4). Understanding edible and beverage onset times. Cannabis Retailer. https://cannabisretailer.ca/2020/understanding-edible-and-beverage-onset-times/ (https://cannabisretailer.ca/2020/understanding-edible-and-beverage-onset-times/) White, A. E., Van Tubbergen, C., Raymes, B., Contreras, A. E., & Scallan Walter, E. J. (2020). Cannabis-infused edible products in colorado: Food safety and public health implications. American Journal of Public Health, 110(6), 790-795. https://doi.org/10.2105/AJPH.2020.305601(https://doi.org/10.2105/AJPH.2020.305601) Zinberg, N. E. (1984). Drug, set, and setting: The basis for controlled intoxicant use. Yale University Press.

Abizaid, A., Merali, Z., & Anisman, H. (2019). Cannabis: A potential efficacious intervention for ptsd or simply snake oil? Journal of Psychiatry & Neuroscience: JPN, 44(2), 75-78. https://doi.org/10.1503/jpn.190021(https://doi.org/10.1503/jpn.190021) Abrams, D. I. (2018). The therapeutic effects of cannabis and cannabinoids: An update from the national academies of sciences, engineering and medicine report. European Journal of Internal Medicine, 49, 7-11. https://doi.org/10.1016/j.ejim.2018.01.003(https://doi.org/10.1016/j.ejim.2018.01.003) Addison, S. (2017). How can cannabis help in the treatment of depression. Cannabis Digest. https://cannabisdigest.ca/cannabis-treatment-depression/(https://cannabisdigest.ca/cannabis-treatment-depression/) A guide to microdosing cannabis. (n.d.). Green Sativa. https://greensativa.com/guide-to-microdosing-cannabis/(https://greensativa.com/guide-to-microdosing-cannabis/) Alkadhi, K., Zagaar, M., Alhaider, I., Salim, S., & Aleisa, A. (2013). Neurobiological consequences of sleep deprivation. Current Neuropharmacology, 11(3), 231-249. https://doi.org/10.2174/1570159X11311030001(https://doi.org/10.2174/1570159X11311030001) Anderson, D. M., Rees, D. I., & Sabia, J. J. (2012). High on life? Medical marijuana laws and suicide. American Journal of Public Health (1971), 104(12), 2369-2376. https://doi.org/10.2105/AJPH.2013.301612(https://doi.org/10.2105/AJPH.2013.301612) Anxiety. (2021). American Psychological Association. https://www.apa.org/topics/anxiety/(https://www.apa.org/topics/anxiety/) Arendt, M., Rosenberg, R., Foldager, L., Perto, G., & Munk-Jørgensen, P. (2005). Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: Follow-up study of 535 incident cases. British Journal of Psychiatry, 187(6), 510-515. https://doi.org/10.1192/bjp.187.6.510(https://doi.org/10.1192/bjp.187.6.510) Arkowitz, H., & Lilienfeld, S. (2021, March 1). Experts tell the truth about pot. Scientific American. https://www.scientificamerican.com/article/the-truth-about-pot/(https://www.scientificamerican.com/article/the-truth-about-pot/) Aronin, T. (2018). In michigan will cannabis-infused drinks elbow beer off the shelves? 517 Mag. https://517mag.com/business/in-michigan-will-cannabis-infused-drinks-elbow-beer-off-t(https://517mag.com/business/in-michigan-will-cannabis-infused-drinks-elbow-beer-off-)he(https://517mag.com/business/in-michigan-will-cannabis-infused-drinks-elbow-beer-off-the-shelves/)-shelves/(https://517mag.com/business/in-michigan-will-cannabis-infused-drinks-elbow-beer-off-the-shelves/) Bally, N., Zullino, D., & Aubry, J. (2014). Cannabis use and first manic episode. Journal of Affective Disorders, 165, 103-108. https://doi.org/10.1016/j.jad.2014.04.038(https://doi.org/10.1016/j.jad.2014.04.038) Bhattacharyya, S., Egerton, A., Kim, E., Rosso, L., Riano Barros, D., Hammers, A., Brammer, M., Turkheimer, F. E., Howes, O. D., & McGuire, P. (2017). Acute induction of anxiety in humans by delta-9-tetrahydrocannabinol related to amygdalar cannabinoid-1 (cb1) receptors. Scientific Reports, 7(1), 15025-15. https://doi.org/10.1038/s41598-017-14203-4(https://doi.org/10.1038/s41598-017-14203-4) Bipolar disorder. (n.d.). Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/bipolar-disorder/symptoms-causes/syc-20(https://www.mayoclinic.org/diseases-conditions/bipolar-disorder/symptoms-causes/syc-20355955)355955(https://www.mayoclinic.org/diseases-conditions/bipolar-disorder/symptoms-causes/syc-20355955) Blessing, E. M., Steenkamp, M. M., Manzanares, J., & Marmar, C. R. (2015). Cannabidiol as a potential treatment for anxiety disorders. Neurotherapeutics, 12(4), 825-836. https://doi.org/10.1007/s13311-015-0387-1(https://doi.org/10.1007/s13311-015-0387-1) Boden, M. T., Babson, K. A., Vujanovic, A. A., Short, N. A., & Bonn‐Miller, M. O. (2013). Posttraumatic stress disorder and cannabis use characteristics among military veterans with cannabis dependence. The American Journal on Addictions, 22(3), 277-284. https://doi.org/10.1111/j.1521-0391.2012.12018.x(https://doi.org/10.1111/j.1521-0391.2012.12018.x) Bolla, K. I., Lesage, S. R., Gamaldo, C. E., Neubauer, D. N., Funderburk, F. R., Lud Cadet, J., David, P. M., Verdejo-Garcia, A., & Benbrook, A. R. (2008). Sleep disturbance in heavy marijuana users. Sleep, 31(6), 901-908. https://doi.org/10.1093/sleep/31.6.901(https://doi.org/10.1093/sleep/31.6.901) Bonn-Miller, M. O., Babson, K. A., & Vandrey, R. (2013;2014;). Using cannabis to help you sleep: Heightened frequency of medical cannabis use among those with ptsd. Drug and Alcohol Dependence, 136, 162-165. https://doi.org/10.1016/j.drugalcdep.2013.12.008(https://doi.org/10.1016/j.drugalcdep.2013.12.008) Bonn‐Miller, M. O., Vujanovic, A. A., Feldner, M. T., Bernstein, A., & Zvolensky, M. J. (2007). Posttraumatic stress symptom severity predicts marijuana use coping motives among traumatic event‐exposed marijuana users. Journal of Traumatic Stress, 20(4), 577-586. https://doi.org/10.1002/jts.20243(https://doi.org/10.1002/jts.20243) Bonn-Miller, M. O., & Zvolensky, M. J. (2009). An evaluation of the nature of marijuana use and its motives among young adult active users. American Journal on Addictions, 18(5), 409-416. https://pubmed.ncbi.nlm.nih.gov/19874161/(https://pubmed.ncbi.nlm.nih.gov/19874161/) Boys, A., Marsden, J., Griffiths, P., Fountain, J., Stillwell, G., & Strang, J. (1999). Substance use among young people: The relationship between perceived functions and intentions. Addiction (Abingdon, England), 94(7), 1043-1050. https://doi.org/10.1046/j.1360-0443.1999.94710439.x(https://doi.org/10.1046/j.1360-0443.1999.94710439.x) Braida, D., Limonta, V., Malabarba, L., Zani, A., & Sala, M. (2007). 5-ht1a receptors are involved in the anxiolytic effect of Δ9-tetrahydrocannabinol and am 404, the anandamide transport inhibitor, in sprague–dawley rats. European Journal of Pharmacology, 555(2-3), 156-163. https://doi.org/10.1016/j.ejphar.2006.10.038(https://doi.org/10.1016/j.ejphar.2006.10.038) Braga, R. J., Burdick, K. E., DeRosse, P., Malhotra, A. K. (2012). Cognitive and clinical outcomes associated with cannabis use in patients with bipolar I disorder. Psychiatry Research, 200(2-3), 242-245. https://doi.org/10.1016/j.psychres.2012.05.025(https://doi.org/10.1016/j.psychres.2012.05.025) Brown, A. S. (2011). The environment and susceptibility to schizophrenia. Progress in Neurobiology, 93(1), 23-58. https://doi.org/10.1016/j.pneurobio.2010.09.003(https://doi.org/10.1016/j.pneurobio.2010.09.003) Buckner, J. D., Crosby, R. D., Wonderlich, S. A., & Schmidt, N. B. (2011;2012;). Social anxiety and cannabis use: An analysis from ecological momentary assessment. Journal of Anxiety Disorders, 26(2), 297-304. https://doi.org/10.1016/j.janxdis.2011.12.006 (https://doi.org/10.1016/j.janxdis.2011.12.006) CAMH. (n.d.). Psychosis. https://www.camh.ca/en/health-info/mental-illness-and-addiction-index/psychosis(https://www.camh.ca/en/health-info/mental-illness-and-addiction-index/psychosis) Campos A, Guimarães F. S. (2008). Involvement of 5ht1a receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats. Psychopharmacology 199(2): 223–230. https://doi.org/10.1007/s00213-008-1168-x(https://doi.org/10.1007/s00213-008-1168-x) Carney, R., Cotter, J., Firth, J., Bradshaw, T., & Yung, A. R. (2017). Cannabis use and symptom severity in individuals at ultra high risk for psychosis: A meta‐analysis. Acta Psychiatrica Scandinavica, 136(1), 5-15. https://doi.org/10.1111/acps.12699(https://doi.org/10.1111/acps.12699) Casadio, P., Fernandes, C., Murray, R. M., & Di Forti, M. (2011). Cannabis use in young people: The risk for schizophrenia. Neuroscience and Biobehavioral Reviews, 35(8), 1779-1787. https://doi.org/10.1016/j.neubiorev.2011.04.007 (https://doi.org/10.1016/j.neubiorev.2011.04.007) Chandra, S., Radwan, M. M., Majumdar, C. G., Church, J. C., Freeman, T. P., & ElSohly, M. A. (2019). New trends in cannabis potency in usa and europe during the last decade (2008–2017). European Archives of Psychiatry and Clinical Neuroscience, 269(1), 5-15. https://doi.org/10.1007/s00406-019-00983-5(https://doi.org/10.1007/s00406-019-00983-5) Chan, G. C., Hall, W., Freeman, T. P., Ferris, J., Kelly, A. B., & Winstock, A. (2017). User characteristics and effect profile of butane hash oil: An extremely high-potency cannabis concentrate. Drug and Alcohol Dependence, 178, 32-38. https://doi.org/10.1016/j.drugalcdep.2017.04.014(https://doi.org/10.1016/j.drugalcdep.2017.04.014) Chen, M. (2009). Does cannabis cause or treat anxiety? Medical News Today. https://www.medicalnewstoday.com/articles/marijuana-and-anxiety(https://www.medicalnewstoday.com/articles/marijuana-and-anxiety) Choi, N. G., DiNitto, D. M., & Phillips, K. T. (2021). Mental health treatment use among cannabis users aged 50+: Associations with cannabis use characteristics. Drug and Alcohol Dependence, 223, 108705. https://doi.org/10.1016/j.drugalcdep.2021.108705(https://doi.org/10.1016/j.drugalcdep.2021.108705) Clausen, L., Hjorthoj, C. R., Thorup, A., Jeppesen, P., Petersen, L., Bertelsen, M., & Nordentoft, M. (2014). Change in cannabis use, clinical symptoms and social functioning among patients with first-episode psychosis: A 5-year follow-up study of patients in the opus trial. Psychological Medicine, 44(1), 117-126. https://doi.org/10.1017/S0033291713000433(https://doi.org/10.1017/S0033291713000433) Clough, A. R., D’Abbs P., Cairney, S., Gray, D., Maruff, P., Parker, R., & O’reilly, B. (2005). Adverse mental health effects of cannabis use in two indigenous communities in arnhem land, northern territory, australia: Exploratory study. Australian and New Zealand Journal of Psychiatry, 39(7), 612–620. https://doi.org/10.1080/j.1440-1614.2005.01634.x(https://doi.org/10.1080/j.1440-1614.2005.01634.x) Compton III, W. M., Cottler, L. B., Ben Abdallah, A., Phelps, D. L., Spitznagel, E. L., & Horton, J. C. (2000). Substance dependence and other psychiatric disorders among drug dependent subjects: Race and gender correlates. The American Journal on Addictions, 9(2), 113-125. https://doi.org/10.1080/10550490050173181(https://doi.org/10.1080/10550490050173181) Conger, J. J. (1956). II. Reinforcement theory and the dynamics of alcoholism. Quarterly Journal of Studies on Alcohol, 17(2), 296-305. https://doi.org/10.15288/qjsa.1956.17.296(https://doi.org/10.15288/qjsa.1956.17.296) Cousens, K., & DiMascio, A. (1973). (−)δ9THC as an hypnotic. Psychopharmacologia, 33, 355–364 (1973). https://doi.org/10.1007/BF00437513(https://doi.org/10.1007/BF00437513) Crippa, J. A., Derenusson, G. N., Ferrari, T. B., Wichert-Ana, L., Duran, F. L., Martin-Santos, R., Simoes, M. V., Bhattacharyya, S., Fusar-Poli, P., Atakan, Z., Santos Filho, A., Freitas-Ferrari, M. C., McGuire, P. K., Zuardi, A. W., Busatto, G. F., & Hallak, J. E. C. (2011). Neural basis of anxiolytic effects of cannabidiol (cbd) in generalized social anxiety disorder: a preliminary report. Journal of Psychopharmacology (Oxford, England), 25(1), 121-130. https://doi.org/10.1177/0269881110379283(https://doi.org/10.1177/0269881110379283) Crippa, J. A., Zuardi, A. W., Garrido, G. E., Wichert-Ana, L., Guarnieri, R., Ferrari, L., Azevedo-Marques, P. M., Hallak, J. E., McGuire, P. K., & Filho Busatto, G. (2004). Effects of cannabidiol (cbd) on regional cerebral blood flow. Neuropsychopharmacology, 29(2), 417–426. https://doi.org/10.1038/sj.npp.1300340(https://doi.org/10.1038/sj.npp.1300340) Crippa, J. A., Zuardi, A. W., Martín-Santos, R., Bhattacharyya, S., Atakan, Z., McGuire, P., & Fusar-Poli, P. (2009). Cannabis and anxiety: A critical review of the evidence. Human Psychopharmacology, 24(7), 515-523. https://doi.org/10.1002/hup.1048(https://doi.org/10.1002/hup.1048) Crocker, C. E., Carter, A. J. E., Emsley, J. G., Magee, K., Atkinson, P., & Tibbo, P. G. (2021). When cannabis use goes wrong: Mental health side effects of cannabis use that present to emergency services. Frontiers in Psychiatry, 12, 640222. https://doi.org/10.3389/fpsyt.2021.640222(https://doi.org/10.3389/fpsyt.2021.640222) Cuttler, C., Spradlin, A., & McLaughlin, R. J. (2018). A naturalistic examination of the perceived effects of cannabis on negative affect. Journal of Affective Disorders, 235, 198-205. https://doi.org/10.1016/j.jad.2018.04.054(https://doi.org/10.1016/j.jad.2018.04.054) Dannon, P. N., Lowengrub, K., Amiaz, R., Grunhaus, L., & Kotler, M. (2004). Comorbid cannabis use and panic disorder: Short term and long term follow‐up study. Human Psychopharmacology: Clinical and Experimental, 19(2), 97-101. https://doi.org/10.1002/hup.560(https://doi.org/10.1002/hup.560) Deas, D., Gerding, L., & Hazy, J. (2000). Marijuana and panic disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 39(12), 1467. https://doi.org/10.1097/00004583-200012000-00006(https://doi.org/10.1097/00004583-200012000-00006) Degenhardt, L., Hall, W., & Lynskey, M. (2003). Exploring the association between cannabis use and depression. Addiction (Abingdon, England), 98(11), 1493-1504. https://doi.org/10.1046/j.1360-0443.2003.00437.x(https://doi.org/10.1046/j.1360-0443.2003.00437.x) DeVylder, J. E., & Lukens, E. P. (2013). Family history of schizophrenia as a risk factor for axis I psychiatric conditions. Journal of Psychiatric Research, 47(2), 181–187. https://doi.org/10.1016/j.jpsychires.2012.09.023(https://doi.org/10.1016/j.jpsychires.2012.09.023) Dorard, G., Berthoz, S., Phan, O., Corcos, M., & Bungener, C. (2008). Affect dysregulation in cannabis abusers: A study in adolescents and young adults. European Child & Adolescent Psychiatry, 17(5), 274–282. https://doi.org/10.1007/s00787-007-0663-7(https://doi.org/10.1007/s00787-007-0663-7) Dreher, M. (2002). Crack heads and roots daughters: The therapeutic use of cannabis in jamaica. Journal of Cannabis Therapeutics, 2(3-4), 121-133. https://doi.org/10.1300/J175v02n03_08(https://doi.org/10.1300/J175v02n03_08) D'Souza, D. C., Perry, E., MacDougall, L., Ammerman, Y., Cooper, T., Braley, G., Gueorguieva, R., & Krystal, J. H. (2004). The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis. Neuropsychopharmacology, 29(8), 1558-1572. https://doi.org/10.1038/sj.npp.1300496(https://doi.org/10.1038/sj.npp.1300496) Earlenbaugh, E. (2020). New research reveals why cannabis helps ptsd sufferers. Forbes. https://www.forbes.com/sites/emilyearlenbaugh/2020/09/17/new-research-reveals-why-cannabis-helps-ptsd-sufferers/?sh=26183289179a(https://www.forbes.com/sites/emilyearlenbaugh/2020/09/17/new-research-reveals-why-cannabis-helps-ptsd-sufferers/?sh=26183289179a) Farris, M. S., Shakeel, M. K., & Addington, J. (2020). Cannabis use in individuals at clinical high-risk for psychosis: A comprehensive review. Social Psychiatry and Psychiatric Epidemiology, 55(5), 527-537. https://doi.org/10.1007/s00127-019-01810-x(https://doi.org/10.1007/s00127-019-01810-x) Feingold, D., & Weinstein, A. (2021). Cannabis and Depression. Advances in Experimental Medicine and Biology, 1264, 67-80. https://doi.org/10.1007/978-3-030-57369-0_5(https://doi.org/10.1007/978-3-030-57369-0_5) Fischer, B., Jeffries, V., Hall, W., Room, R., Goldner, E., & Rehm, J. (2011). Lower risk cannabis use guidelines for canada (lrcug): A narrative review of evidence and recommendations. Canadian Journal of Public Health, 102(5), 324-327. https://doi.org/10.1007/BF03404169(https://doi.org/10.1007/BF03404169) Fischer, B., Russell, C., Sabioni, P., van den Brink, W., Le Foll, B., Hall, W., Rehm, J., & Room, R. (2017). Lower-risk cannabis use guidelines: A comprehensive update of evidence and recommendations. American Journal of Public Health (1971), 107(8), E1-E12. https://doi.org/10.2105/AJPH.2017.303818 (https://doi.org/10.2105/AJPH.2017.303818) Freeman, T. P., & Winstock, A. R. (2015). Examining the profile of high-potency cannabis and its association with severity of cannabis dependence. Psychological Medicine, 45(15), 3181-3189. https://doi.org/10.1017/S0033291715001178(https://doi.org/10.1017/S0033291715001178) Garrison, E., Gilligan, C., Ladd, B. O., & Anderson, K. G. (2021). Social anxiety, cannabis use motives, and social context’s impact on willingness to use cannabis. International Journal of Environmental Research and Public Health, 18(9), 4882. https://doi.org/10.3390/ijerph18094882(https://doi.org/10.3390/ijerph18094882) Gibbs, M., Winsper, C., Marwaha, S., Gilbert, E., Broome, M., & Singh, S. P. (2015). Cannabis use and mania symptoms: A systematic review and meta-analysis. Journal of Affective Disorders, 171, 39-47. https://doi.org/10.1016/j.jad.2014.09.016(https://doi.org/10.1016/j.jad.2014.09.016) Gillette, H. (2021). Does cannabis use affect bipolar disorder symptoms. Psychcentral. https://psychcentral.com/bipolar/cannabis-bipolar-disorder-symptoms(https://psychcentral.com/bipolar/cannabis-bipolar-disorder-symptoms) Giordano, G.N., Ohlsson, H., Sundquist, K., Sundquist, J., & Kendler, K. (2015). The association between cannabis abuse and subsequent schizophrenia: A swedish national co-relative control study. Psychological Medicine, 45(2), 407–414. https://doi.org/10.1017/S0033291714001524(https://doi.org/10.1017/S0033291714001524) Gregg, J. M., Small, E. W., Moore, R., Raft, D., & Toomey, T. C. (1976). Emotional response to intravenous delta9tetrahydrocannabinol during oral surgery. Journal of Oral Surgery (American Dental Association: 1965), 34(4), 301-313. https://pubmed.ncbi.nlm.nih.gov/1062533/(https://pubmed.ncbi.nlm.nih.gov/1062533/) Grewal, J. K., & Loh, L. C. (2020). Health considerations of the legalization of cannabis edibles. Canadian Medical Association Journal (CMAJ), 192(1), E1-E2. https://doi.org/10.1503/cmaj.191217 (https://doi.org/10.1503/cmaj.191217) Grewal. S., & George. T. (2017). Cannabis-induced psychosis: A review. Psychiatric Times, 34(7). https://www.psychiatrictimes.com/view/cannabis-induced-psychosis-review(https://www.psychiatrictimes.com/view/cannabis-induced-psychosis-review) Grunberg, V. A., Cordova, K. A., Bidwell, L. C., & Ito, T. A. (2015). Can marijuana make it better? Prospective effects of marijuana and temperament on risk for anxiety and depression. Psychology of Addictive Behaviors, 29(3), 590-602. https://doi.org/10.1037/adb0000109(https://doi.org/10.1037/adb0000109) Guimarães, F. S., Chiaretti, T. M., Graeff, F. G., and Zuardi, A. W. (1990). Antianxiety effect of cannabidiol in the elevated plus-maze. Psychopharmacology, 100(4), 558–559. https://doi.org/10.1007/BF02244012(https://doi.org/10.1007/BF02244012) Guzman, F. ( 2019). 5-ht1a receptors in psychopharmacology. Psychopharmacology Institute. https://psychopharmacologyinstitute.com/publication/5-ht1a-receptors-in-psychopharmaco(https://psychopharmacologyinstitute.com/publication/5-ht1a-receptors-in-psychopharmacology-2123)logy-2123(https://psychopharmacologyinstitute.com/publication/5-ht1a-receptors-in-psychopharmacology-2123) Hall, W. (2015). What has research over the past two decades revealed about the adverse health effects of recreational cannabis use? Addiction (Abingdon, Endlang), 110(1), 19-35. https://doi.org/10.1111/add.12703(https://doi.org/10.1111/add.12703) Hall, W., Hoch, E., & Lorenzetti, V. (2019). Cannabis use and mental health: Risks and benefits. European Archives of Psychiatry and Clinical Neuroscience, 269(1), 1-3. https://doi.org/10.1007/s00406-019-00986-2(https://doi.org/10.1007/s00406-019-00986-2) Hall, W., & Solowij, N. (1998). Adverse effects of cannabis. Lancet (London, England), 352(9140), 1611-1616. https://doi.org/10.1016/S0140-6736(98)05021-1(https://doi.org/10.1016/S0140-6736(98)05021-1) Hartogsohn, I. (2017). Constructing drug effects: A history of set and setting. Drug Science, Policy and Law. https://doi.org/10.1177/2050324516683325(https://doi.org/10.1177/2050324516683325) Hasin, D. S., Saha, T. D., Kerridge, B. T., Goldstein, R. B., Chou, S. P., Zhang, H., Jung, J., Pickering, R. P., Ruan, W. J., Smith, S. M., Huang, B., & Grant, B. F. (2015). Prevalence of marijuana use disorders in the united states between 2001-2002 and 2012-2013. JAMA Psychiatry, 72(12), 1235-1242. https://doi.org/10.1001/jamapsychiatry.2015.1858(https://doi.org/10.1001/jamapsychiatry.2015.1858) Hathaway, A. D. (2003). Cannabis effects and dependency concerns in long-term frequent users: A missing piece of the public health puzzle. Addiction Research & Theory, 11(6), 441-458. https://doi.org/10.1080/1606635021000041807(https://doi.org/10.1080/1606635021000041807) Henquet, C., Di Forti, M., Morrison, P., Kuepper, R., & Murray, R. M. (2008). Gene-environment interplay between cannabis and psychosis. Schizophrenia Bulletin, 34(6), 1111-1121. https://doi.org/10.1093/schbul/sbn108(https://doi.org/10.1093/schbul/sbn108) Henquet, C., Krabbendam, L., de Graaf, R., ten Have, M., & van Os, J. (2006). Cannabis use and expression of mania in the general population. Journal of Affective Disorders, 95(1–3), 103–110. https://doi.org/10.1016/j.jad.2006.05.002(https://doi.org/10.1016/j.jad.2006.05.002) Hodgson, K., Coleman, J. R. I., Hagenaars, S. P., Purves, K. L., Glanville, K., Choi, S. W., O'Reilly, P., Breen, G., Lewis, C. M., & Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium. (2020). Cannabis use, depression and self‐harm: Phenotypic and genetic relationships. Addiction (Abingdon, England), 115(3), 482-492. https://doi.org/10.1111/add.14845 (https://doi.org/10.1111/add.14845) Hollister, L. E. (1986). Health aspects of cannabis. Pharmacological Reviews, 38(1), 1-20. https://pubmed.ncbi.nlm.nih.gov/3520605/(https://pubmed.ncbi.nlm.nih.gov/3520605/) Huizink, A. C. (2013). Commentary on degenhardt et al. (2013): Specific effect of adolescent cannabis use on anxiety – Tentative explanations. Addiction (Abingdon, England), 108(1), 134-135. https://doi.org/10.1111/add.12046(https://doi.org/10.1111/add.12046) Iliades, C. (2012). Depression’s effect on your appetite. Everyday Health. https://www.everydayhealth.com/hs/major-depression/depressions-effect-on-appetite/(https://www.everydayhealth.com/hs/major-depression/depressions-effect-on-appetite) Innamorati, M., Pompili, M., Ferrari, V., Girardi, P., Tatarelli, R., Tamburello, A., & Lester, D. (2008). Cannabis use and the risk behavior syndrome in italian university students: Are they related to suicide risk? Psychological Reports, 102(2), 577-594. https://doi.org/10.2466/pr0.102.2.577-594(https://doi.org/10.2466/pr0.102.2.577-594) Kamal, B. S., Kamal, F., & Lantela, D. E. (2018). Cannabis and the anxiety of fragmentation-A systems approach for finding an anxiolytic cannabis chemotype. Frontiers in Neuroscience, 12, 730. https://doi.org/10.3389/fnins.2018.00730(https://doi.org/10.3389/fnins.2018.00730) Kaplan, H. B., Martin, S. S., Johnson, R. J., & Robbins, C. A. (1986). Escalation of marijuana use: Application of a general theory of deviant behavior. Journal of Health and Social Behavior, 27(1), 44-61. https://doi.org/10.2307/2136502(https://doi.org/10.2307/2136502) Kedzior, K. K., & Laeber, L. T. (2014). A positive association between anxiety disorders and cannabis use or cannabis use disorders in the general population--a meta-analysis of 31 studies. BMC Psychiatry, 14(1), 136-136. https://doi.org/10.1186/1471-244X-14-136 (https://doi.org/10.1186/1471-244X-14-136) Kim, S. W., Dodd, S., Berk, L., Kulkarni, J., de Castella, A., Fitzgerald, P. B., Kim, J. M., Yoon, J. S., & Berk, M. (2015). Impact of cannabis use on long-term remission in bipolar I and schizoaffective disorder. Psychiatry Investigation, 12(3), 349-355. https://doi.org/10.4306/pi.2015.12.3.349(https://doi.org/10.4306/pi.2015.12.3.349) Konefal, S., Gabrys, R., & Porath, A. (2019). Clearing the smoke on cannabis. Canadian Centre on Substance Use and Addiction. https://www.ccsa.ca/clearing-smoke-cannabis-regular-use-and-mental-health(https://www.ccsa.ca/clearing-smoke-cannabis-regular-use-and-mental-health) Korem, N., Zer-Aviv, T. M., Ganon-Elazar, E., Abush, H., & Akirav, I. (2016). Targeting the endocannabinoid system to treat anxiety-related disorders. Journal of Basic and Clinical Physiology and Pharmacology, 27(3), 193-202. https://doi.org/10.1515/jbcpp-2015-0058(https://doi.org/10.1515/jbcpp-2015-0058) Kraan, T., Velthorst, E., Koenders, L., Zwaart, K., Ising, H. K., van den Berg, D., de Haan, L., & van der Gaag, M. (2016). Cannabis use and transition to psychosis in individuals at ultra-high risk: Review and meta-analysis. Psychological Medicine, 46(4), 673-681. https://doi.org/10.1017/S0033291715002329(https://doi.org/10.1017/S0033291715002329) Ksir, C., & Hart, C. L. (2016). Cannabis and psychosis: A critical overview of the relationship. Current Psychiatry Reports, 18(2), 1-11. https://doi.org/10.1007/s11920-015-0657-y(https://doi.org/10.1007/s11920-015-0657-y) Lake, S., Kerr, T., Buxton, J., Walsh, Z., Marshall, B. D., Wood, E., & Milloy, M. (2020). Does cannabis use modify the effect of post-traumatic stress disorder on severe depression and suicidal ideation? Evidence from a population-based cross-sectional study of canadians. Journal of Psychopharmacology (Oxford, England), 34(2), 181-188. https://doi.org/10.1177/0269881119882806(https://doi.org/10.1177/0269881119882806) Lake, S., Kerr, T., Werb, D., Haines‐Saah, R., Fischer, B., Thomas, G., Walsh, Z., Ware, M. A., Wood, E., & Milloy, M. (2019). Guidelines for public health and safety metrics to evaluate the potential harms and benefits of cannabis regulation in canada. Drug and Alcohol Review, 38(6), 606-621. https://doi.org/10.1111/dar.12971 (https://doi.org/10.1111/dar.12971) Langs, G., Fabisch, H., Fabisch, K., & Zapotoczky, H. G. (1997). Can cannabis trigger recurrent panic attacks in susceptible patients? European Psychiatry, 12(8), 415-419. https://doi.org/10.1016/S0924-9338(97)83568-7(https://doi.org/10.1016/S0924-9338(97)83568-7) Lau, N., Sales, P., Averill, S., Murphy, F., Sato, S., & Murphy, S. (2015). A safer alternative: Cannabis substitution as harm reduction. Drug and Alcohol Review, 34(6), 654-659. https://doi.org/10.1111/dar.12275 (https://doi.org/10.1111/dar.12275) Lesch, K. P., Wiesmann, M., Hoh, A., Muller, T., Disselkamp-Tietze, J., Osterheider, M., & Schulte, H. M. (1992). 5-ht1a receptor-effector system responsivity in panic disorder. Psychopharmacology, 106(1), 111-7. https://doi.org/10.1007/BF02253597(https://doi.org/10.1007/BF02253597) Lev-Ran, S., Le Foll, B., McKenzie, K., George, T. P., & Rehm, J. (2013). Cannabis use and cannabis use disorders among individuals with mental illness. Comprehensive Psychiatry, 54(6), 589-598. https://doi.org/10.1016/j.comppsych.2012.12.021(https://doi.org/10.1016/j.comppsych.2012.12.021) Leweke, F. M., Piomelli, D., Pahlisch, F., Muhl, D., Gerth, C. W., Hoyer, C., Klosterkötter, J., Hellmich, M., & Koethe, D. (2012). Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia. Translational Psychiatry, 2(3), e94-e94. https://doi.org/10.1038/tp.2012.15(https://doi.org/10.1038/tp.2012.15) Linscott, R. J., & van Os, J. (2013). An updated and conservative systematic review and meta-analysis of epidemiological evidence on psychotic experiences in children and adults: On the pathway from proneness to persistence to dimensional expression across mental disorders. Psychological Medicine, 43(6), 1133-1149. https://doi.org/10.1017/S0033291712001626(https://doi.org/10.1017/S0033291712001626) Lowe, D. J. E., Sasiadek, J. D., Coles, A. S., & George, T. P. (2019). Cannabis and mental illness: A review. European Archives of Psychiatry and Clinical Neuroscience, 269(1), 107-120. https://doi.org/10.1007/s00406-018-0970-7(https://doi.org/10.1007/s00406-018-0970-7) Lucas, P. (2012). Cannabis as an adjunct to or substitute for opiates in the treatment of chronic pain. Journal of Psychoactive Drugs, 44(2), 125–33. https://doi.org/10.1080/02791072.2012.684624(https://doi.org/10.1080/02791072.2012.684624) Lucas, P., Reiman, A., Earleywine, M., McGowan, S. K., Oleson, M., Coward, M. P., & Thomas, B. (2013). Cannabis as a substitute for alcohol and other drugs: A dispensary-based survey of substitution effect in canadian medical cannabis patients. Addiction Research & Theory, 21(5), 435–442. https://doi.org/10.3109/16066359.2012.733465(https://doi.org/10.3109/16066359.2012.733465) Lynskey, M. T., Heath, A. C., Nelson, E. C., Bucholz, K. K., Madden, P. A. F., Slutske, W. S., Statham, D. J., & Martin, N. G. (2002). Genetic and environmental contributions to cannabis dependence in a national young adult twin sample. Psychological Medicine, 32(2), 195-207. https://doi.org/10.1017/s0033291701005062(https://doi.org/10.1017/s0033291701005062) Manzanares, J., Urigüen, L., Rubio, G., & Palomo, T. (2004). Role of endocannabinoid system in mental diseases. Neurotoxicity Research, 6(3), 213-224. https://doi.org/10.1007/BF03033223(https://doi.org/10.1007/BF03033223) Marconi, A., Di Forti, M., Lewis, C. M., Murray, R. M., & Vassos, E. (2016). Meta-analysis of the association between the level of cannabis use and risk of psychosis. Schizophrenia Bulletin, 42(5), 1262-1269. https://doi.org/10.1093/schbul/sbw003(https://doi.org/10.1093/schbul/sbw003) McGee, R., Williams, S., Poulton, R., & Moffitt, T. (2000). A longitudinal study of cannabis use and mental health from adolescence to early adulthood. Addiction (Abingdon, England), 95(4), 491-503. https://doi.org/10.1046/j.1360-0443.2000.9544912.x(https://doi.org/10.1046/j.1360-0443.2000.9544912.x) McGill University. (2007). Cannabis: Potent anti-depressant in low doses, worsens depression at high doses. https://www.sciencedaily.com/releases/2007/10/071023183937.htm(https://www.sciencedaily.com/releases/2007/10/071023183937.htm) McGuire, P., Robson, P., Cubala, W. J., Vasile, D., Morrison, P. D., Barron, R., Taylor, A., & Wright, S. (2018). Cannabidiol (CBD) as an adjunctive therapy in schizophrenia: A multicenter randomized controlled trial. The American Journal of Psychiatry, 175(3), 225-231. https://doi.org/10.1176/appi.ajp.2017.17030325(https://doi.org/10.1176/appi.ajp.2017.17030325) Medical cannabis for anxiety. (n.d.). Cannabis clinics. https://www.cannabisclinics.ca/medical-cannabis/anxiety/(https://www.cannabisclinics.ca/medical-cannabis/anxiety/) Mental Health Commission of Canada. (2019). Cannabis and mental health: Priorities for research in canada. https://www.mentalhealthcommission.ca/wp-content/uploads/drupal/2019-07/Cannabis_m(https://www.mentalhealthcommission.ca/wp-content/uploads/drupal/2019-07/Cannabis_mental_Health_Summary_july_2019_eng.pdf)ental_Health_Summary_july_2019_eng.pdf(https://www.mentalhealthcommission.ca/wp-content/uploads/drupal/2019-07/Cannabis_mental_Health_Summary_july_2019_eng.pdf) Metzner, R., & Leary, T. (1967). On programming psychedelic experiences. Psychedelic Review, 9, 5-19. https://maps.org/research-archive/psychedelicreview/n09/n09005met.pdf(https://maps.org/research-archive/psychedelicreview/n09/n09005met.pdf) Mikuriya, T., & Mandel, J. (2001). Cannabis substitution: Harm reduction treatment for alcoholism and drug dependence. https://www.mikuriya.com/cw_cansub.html(https://www.mikuriya.com/cw_cansub.html) Mikuriya, T. H. (2004). Cannabis as a substitute for alcohol: A harm-reduction approach. Journal of Cannabis Therapeutics, 4(1), 79-93. https://doi.org/10.1300/J175v04n01_04(https://doi.org/10.1300/J175v04n01_04) Miller, B. (2021). Does cannabis cause psychosis? Psychiatric Times, 38(3). https://www.psychiatrictimes.com/view/cannabis-cause-psychosis(https://www.psychiatrictimes.com/view/cannabis-cause-psychosis) Misiak, B., Stramecki, F., Gawęda, Ł., Prochwicz, K., Sąsiadek, M.M., Moustafa, A.A., & Frydecka, D. (2018). Interactions between variation in candidate genes and environmental factors in the etiology of schizophrenia and bipolar disorder: A systematic review. Molecular Neurobiology, 55(6), 5075–5100. https://doi.org/10.1007/s12035-017-0708-y(https://doi.org/10.1007/s12035-017-0708-y) Moran, C. (1986). Depersonalization and agoraphobia associated with marijuana use. British Journal of Medical Psychology, 59(2), 187-196. https://doi.org/10.1111/j.2044-8341.1986.tb02684.x(https://doi.org/10.1111/j.2044-8341.1986.tb02684.x) Mueser, K. T., Drake, R. E., & Wallach, M. A. (1998). Dual diagnosis: A review of etiological theories. Addictive Behaviors, 23(6), 717-734. https://doi.org/10.1016/S0306-4603(98)00073-2(https://doi.org/10.1016/S0306-4603(98)00073-2) Mundell, E., J. (2020). One joint may cause psychotic symptoms: Study. A Family Pharmacy Apple Valley. https://www.afamilypharmacy.com/patient-resources/article/755848/one-joint-may-cause-(https://www.afamilypharmacy.com/patient-resources/article/755848/one-joint-may-cause-psychotic-symptoms-study)psychotic-symptoms-study(https://www.afamilypharmacy.com/patient-resources/article/755848/one-joint-may-cause-psychotic-symptoms-study) Muntoni, A. L., Pillolla, G., Melis, M., Perra, S., Gessa, G. L., & Pistis, M. (2006). Cannabinoids modulate spontaneous neuronal activity and evoked inhibition of locus coeruleus noradrenergic neurons. European Journal of Neuroscience, 23(9), 2385-2394. https://doi.org/10.1111/j.1460-9568.2006.04759.x(https://doi.org/10.1111/j.1460-9568.2006.04759.x) Naliboff, B. D., Rickles, W. H., Cohen, M. J., & Naimark, R. S. (1976). Interactions of marijuana and induced stress: Forearm blood flow, heart rate, and skin conductance. Psychophysiology, 13(6), 517-522. https://doi.org/10.1111/j.1469-8986.1976.tb00871.x(https://doi.org/10.1111/j.1469-8986.1976.tb00871.x) Ogborne, A. C., Smart, R. G., Weber, T., & Birchmore-Timney, C. (2000). Who is using cannabis as a medicine and why: An exploratory study. Journal of Psychoactive Drugs, 32(4), 435-443. https://doi.org/10.1080/02791072.2000.10400245(https://doi.org/10.1080/02791072.2000.10400245) O'Shea, M., McGregor, I. S., & Mallet, P. E. (2006). Repeated cannabinoid exposure during perinatal, adolescent or early adult ages produces similar long lasting deficits in object recognition and reduced social interaction in rats. Journal of Psychopharmacology (Oxford), 20(5), 611-621. https://doi.org/10.1177/0269881106065188(https://doi.org/10.1177/0269881106065188) O'Shea, M., Singh, M. E., McGregor, I. S., & Mallet, P. E. (2004). Chronic cannabinoid exposure produces lasting memory impairment and increased anxiety in adolescent but not adult rats. Journal of Psychopharmacology (Oxford), 18(4), 502-508. https://doi.org/10.1177/0269881104047277(https://doi.org/10.1177/0269881104047277) Ortiz-Medina, M. B., Perea, M., Torales, J., Ventriglio, A., Vitrani, G., Aguilar, L., & Roncero, C. (2018). Cannabis consumption and psychosis or schizophrenia development. The International Journal of Social Psychiatry, 64(7), 690-703. https://doi.org/10.1177/0020764018801690(https://doi.org/10.1177/0020764018801690) Passie, T., Emrich, H. M., Karst, M., Brandt, S. D., & Halpern, J. H. (2012). Mitigation of post‐traumatic stress symptoms by cannabis resin: A review of the clinical and neurobiological evidence. Drug Testing and Analysis, 4(7-8), 649-659. https://doi.org/10.1002/dta.1377(https://doi.org/10.1002/dta.1377) Patel, S., & Hillard, C. J. (2006). Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: Further evidence for an anxiolytic role for endogenous cannabinoid signaling. The Journal of Pharmacology and Experimental Therapeutics, 318(1), 304–311. https://doi.org/10.1124/jpet.106.101287(https://doi.org/10.1124/jpet.106.101287) Patel, S., Hill, M. N., Cheer, J. F., Wotjak, C. T., and Holmes, A. (2017). The endocannabinoid system as a target for novel anxiolytic drugs. Neuroscience and Biobehavioral Reviews, 76(Pt A), 56–66. https://doi.org/10.1016/j.neubiorev.2016.12.033(https://doi.org/10.1016/j.neubiorev.2016.12.033) Pertwee, R. G. (2008). The diverse cb1 and cb2 receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarin. British Journal of Pharmacology, 153(2), 199-215. https://doi.org/10.1038/sj.bjp.0707442(https://doi.org/10.1038/sj.bjp.0707442) Pierre, J. M. (2010). Psychosis associated with medical marijuana: Risk vs. benefits of medicinal cannabis use. The American Journal of Psychiatry, 167(5), 598-599. https://doi.org/10.1176/appi.ajp.2010.09121762(https://doi.org/10.1176/appi.ajp.2010.09121762) Price, C., Tomas, H., Lewis, G., Zammit, S., & Allebeck, P. (2009). Cannabis and suicide: Longitudinal study. The British Journal of Psychiatry, 195(6), 492-497. https://doi.org/10.1192/bjp.bp.109.065227(https://doi.org/10.1192/bjp.bp.109.065227) Proal, A. C., Fleming, J., Galvez-Buccollini, J. A., & DeLisi, L. E. (2014). A controlled family study of cannabis users with and without psychosis. Schizophrenia Research, 152(1), 283–288; https://doi.org/10.1016/j.schres.2013.11.014(https://doi.org/10.1016/j.schres.2013.11.014) Rabinak, C. A., Blanchette, A., Zabik, N. L., Peters, C., Marusak, H. A., Iadipaolo, A., & Elrahal, F. (2020). Cannabinoid modulation of corticolimbic activation to threat in trauma-exposed adults: A preliminary study. Psychopharmacology, 237(6), 1813-1826. https://doi.org/10.1007/s00213-020-05499-8(https://doi.org/10.1007/s00213-020-05499-8) Radhakrishnan, R., Wilkinson, S. T., D'Souza, D. C. (2014). Gone to pot—A review of the association between cannabis and psychosis. Frontiers in Psychiatry, 5, 54. https://doi.org/10.3389/fpsyt.2014.00054(https://doi.org/10.3389/fpsyt.2014.00054) Raymundi, A. M., da Silva, T. R., Sohn, J. M. B., Bertoglio, L. J., & Stern, C. A. (2020). Effects of ∆ 9 -tetrahydrocannabinol on aversive memories and anxiety: A review from human studies. BMC Psychiatry, 20(1), 420-17. https://doi.org/10.1186/s12888-020-02813-8(https://doi.org/10.1186/s12888-020-02813-8) Reilly, D., Didcott, P., Swift, W., & Hall, W. (1998). Long‐term cannabis use: Characteristics of users in an australian rural area. Addiction (Abingdon, England), 93(6), 837-846. https://doi.org/10.1046/j.1360-0443.1998.9368375.x(https://doi.org/10.1046/j.1360-0443.1998.9368375.x)

Ashton, C. H. (2001). Pharmacology and effects of cannabis: A brief review. The British Journal of Psychiatry, 178(2), 101-106. https://doi.org/10.1192/bjp.178.2.101(https://doi.org/10.1192/bjp.178.2.101) Aurora. (n.d.). What to do if you green out. https://www.auroramedical.com/blogs/news/what-to-do-if-you-green-out(https://www.auroramedical.com/blogs/news/what-to-do-if-you-green-out) Brust, J. C. (1993). Other agents. Phencyclidine, marijuana, hallucinogens, inhalants, and anticholinergics. Neurologic Clinics, 11(3), 555-561. https://pubmed.ncbi.nlm.nih.gov/8377742/(https://pubmed.ncbi.nlm.nih.gov/8377742/) Canadian Nurses Association. (2017). Harm reduction for non-medical cannabis use. https://hl-prod-ca-oc-download.s3-ca-central-1.amazonaws.com/CNA/2f975e7e-4a40-45c(https://hl-prod-ca-oc-download.s3-ca-central-1.amazonaws.com/CNA/2f975e7e-4a40-45ca-863c-5ebf0a138d5e/UploadedImages/documents/Harm_Reduction_for_Non_Medical_Cannabis_Use.pdf)a-863c-5ebf0a138d5e/UploadedImages/documents/Harm_Reduction_for_Non_Medical_(https://hl-prod-ca-oc-download.s3-ca-central-1.amazonaws.com/CNA/2f975e7e-4a40-45ca-863c-5ebf0a138d5e/UploadedImages/documents/Harm_Reduction_for_Non_Medical_Cannabis_Use.pdf)Cannabis_Use.pdf(https://hl-prod-ca-oc-download.s3-ca-central-1.amazonaws.com/CNA/2f975e7e-4a40-45ca-863c-5ebf0a138d5e/UploadedImages/documents/Harm_Reduction_for_Non_Medical_Cannabis_Use.pdf) Cao, D., Srisuma, S., Bronstein, A. C., & Hoyte, C. O. (2016). Characterization of edible marijuana product exposures reported to united states poison centers. Clinical Toxicology, 54(9), 840-846. https://doi.org/10.1080/15563650.2016.1209761(https://doi.org/10.1080/15563650.2016.1209761) Centers for Disease Control and Prevention. (2009). Inadvertent ingestion of marijuana-los angeles, california, 2009. MMWR: Morbidity and Mortality Weekly Report, 58(34), 947-950. https://pubmed.ncbi.nlm.nih.gov/19730407/(https://pubmed.ncbi.nlm.nih.gov/19730407/) Crippa, J. A., Derenusson, G. N., Chagas, M. H., Atakan, Z., Martín-Santos, R., Zuardi, A. W., & Hallak, J. E. (2012). Pharmacological interventions in the treatment of the acute effects of cannabis: A systematic review of literature. Harm reduction journal, 9(1), 7. https://doi.org/10.1186/1477-7517-9-7(https://doi.org/10.1186/1477-7517-9-7) Crippa, J. A., Zuardi, A. W., Martín‐Santos, R., Bhattacharyya, S., Atakan, Z., McGuire, P., & Fusar‐Poli, P. (2009). Cannabis and anxiety: A critical review of the evidence. Human Psychopharmacology: Clinical and Experimental, 24(7), 515-523. https://doi.org/10.1002/hup.1048(https://doi.org/10.1002/hup.1048) CSSDP. (2018). Sensible cannabis education - A toolkit for educating youth. https://cssdp.org/uploads/2018/04/Sensible-Cannabis-Education-A-Toolkit-for-Educating-(https://cssdp.org/uploads/2018/04/Sensible-Cannabis-Education-A-Toolkit-for-Educating-Youth.pdf)Youth.pdf(https://cssdp.org/uploads/2018/04/Sensible-Cannabis-Education-A-Toolkit-for-Educating-Youth.pdf) Dalgarno, P., & Shewan, D. (2005). Reducing the risks of drug use: The case for set and setting. Addiction Research & Theory, 13(3), 259-265. https://doi.org/10.1080/16066350500053562(https://doi.org/10.1080/16066350500053562) Egan, K. L., Cox, M. J., Suerken, C. K., Reboussin, B. A., Song, E. Y., Wagoner, K. G., & Wolfson, M. (2019). More drugs, more problems? Simultaneous use of alcohol and marijuana at parties among youth and young adults. Drug and Alcohol Dependence, 202, 69-75. https://doi.org/10.1016/j.drugalcdep.2019.07.003(https://doi.org/10.1016/j.drugalcdep.2019.07.003) Government of Canada. (2019). Cannabis: Lower your risks. https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/resources/loW(https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/resources/lower-your-risks.html)er-your-risks.html(https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/resources/lower-your-risks.html) Grotenhermen, F. (2003). Pharmacokinetics and pharmacodynamics of cannabinoids. Clinical Pharmacokinetics, 42(4), 327-360. https://doi.org/10.2165/00003088-200342040-00003(https://doi.org/10.2165/00003088-200342040-00003) Grotenhermen, F. (2007). The toxicology of cannabis and cannabis prohibition. Chemistry & Biodiversity, 4(8), 1744-1769. https://doi.org/10.1002/cbdv.200790151(https://doi.org/10.1002/cbdv.200790151) Guidet, C., Gregoire, M., Le Dreau, A., Vrignaud, B., Deslandes, G., & Monteil-Ganière, C. (2020). Cannabis intoxication after accidental ingestion in infants: Urine and plasma concentrations of Δ-9-tetrahydrocannabinol (thc), thc-cooh and 11-oh-thc in 10 patients. Clinical Toxicology (Philadelphia, Pa.), 58(5), 421-423. https://doi.org/10.1080/15563650.2019.1655569(https://doi.org/10.1080/15563650.2019.1655569) Hammond, D. (2019). Communicating thc levels and ‘dose’ to consumers: implications for product labelling and packaging of cannabis products in regulated markets. International Journal of Drug Policy, 91, 102509. https://doi.org/10.1016/j.drugpo.2019.07.004(https://doi.org/10.1016/j.drugpo.2019.07.004) Hand, A., Blake, A., Kerrigan, P., Samuel, P., & Friedberg, J. (2016). History of medical cannabis. Journal of Pain Management, 9(4), 387-394. https://www.researchgate.net/publication/316545890_History_of_medical_cannabis(https://www.researchgate.net/publication/316545890_History_of_medical_cannabis) Hartogsohn, I. (2017). Constructing drug effects: A history of set and setting. Drug Science, Policy and Law, 3. https://doi.org/10.1177/2050324516683325(https://doi.org/10.1177/2050324516683325) Hendrickson, R. G., McKeown, N. J., Kusin, S. G., & Lopez, A. M. (2020). Acute cannabis toxicity in older adults. Toxicology Communications, 4(1), 67-70. https://doi.org/10.1080/24734306.2020.1852821(https://doi.org/10.1080/24734306.2020.1852821) Hudak, M., Severn, D., & Nordstrom, K. (2015). Edible cannabis–induced psychosis: Intoxication and beyond. American Journal of Psychiatry, 172(9), 911-912. https://doi.org/10.1176/appi.ajp.2015.15030358(https://doi.org/10.1176/appi.ajp.2015.15030358) Huestis, M. A. (2007). Human cannabinoid pharmacokinetics. Chemistry & Biodiversity, 4(8), 1770–1804. https://doi.org/10.1002/cbdv.200790152(https://doi.org/10.1002/cbdv.200790152) Levene, R. J., Pollak-Christian, E., & Wolfram, S. (2019). A 21st century problem: Cannabis toxicity in a 13-month-old child. The Journal of Emergency Medicine, 56(1), 94-96. https://doi.org/10.1016/j.jemermed.2018.09.040(https://doi.org/10.1016/j.jemermed.2018.09.040) Levinsohn, E. A., & Hill, K. P. (2020). Clinical uses of cannabis and cannabinoids in the united states. Journal of the Neurological Sciences, 411, 116717. https://doi.org/10.1016/j.jns.2020.116717(https://doi.org/10.1016/j.jns.2020.116717) MacCallum, C. A., & Russo, E. B. (2018). Practical considerations in medical cannabis administration and dosing. European Journal of Internal Medicine, 49, 12-19. https://doi.org/10.1016/j.ejim.2018.01.004(https://doi.org/10.1016/j.ejim.2018.01.004) Molly, C., Mory, O., Basset, T., & Patural, H. (2012). Acute cannabis poisoning in a 10-month-old infant. Archives de pediatrie: Organe Officiel de la Societe Francaise de Pediatrie, 19(7), 729-732. https://doi.org/10.1016/j.arcped.2012.04.018(https://doi.org/10.1016/j.arcped.2012.04.018) Murphy, K. (2017). “Greening out” Treating cannabis-related problems in the ed. Nursing Made Incredibly Easy!, 15(6), 47-50. https://doi.org/10.1097/01.NME.0000521808.84893.e7(https://doi.org/10.1097/01.NME.0000521808.84893.e7) Nickel J. C. (2018). Medical marijuana for urologic chronic pelvic pain. Canadian Urological Association Journal, 12(6 Suppl 3), S181–S183. https://doi.org/10.5489/cuaj.5331(https://doi.org/10.5489/cuaj.5331) Noble, M. J., Hedberg, K., & Hendrickson, R. G. (2019). Acute cannabis toxicity. Clinical Toxicology (Philadelphia, Pa.), 57(8), 735-742. https://doi.org/10.1080/15563650.2018.1548708(https://doi.org/10.1080/15563650.2018.1548708) Richards, J. R., Smith, N. E., & Moulin, A. K. (2017). Unintentional cannabis ingestion in children: A systematic review. The Journal of Pediatrics, 190, 142-152. https://doi.org/10.1016/j.jpeds.2017.07.005(https://doi.org/10.1016/j.jpeds.2017.07.005) Rock, E. M., Bolognini, D., Limebeer, C. L., Cascio, M. G., Anavi-Goffer, S., Fletcher, P. J., Mechoulam, R., Pertwee, R. G., & Parker, L. A. (2013). Cannabidiol, a non-intoxicating component of cannabis, suppresses nausea and vomiting in rats and shrews. University of Guelph, Institute for Community Engaged Scholarship. https://atrium.lib.uoguelph.ca/xmlui/bitstream/handle/10214/5491/Parker%20-%20Cannib(https://atrium.lib.uoguelph.ca/xmlui/bitstream/handle/10214/5491/Parker%20-%20Cannibidiol%20a%20non-psychotropic%20component.pdf?sequence=3)idiol%20a%20non-psychotropic%20component.pdf?sequence=3(https://atrium.lib.uoguelph.ca/xmlui/bitstream/handle/10214/5491/Parker%20-%20Cannibidiol%20a%20non-psychotropic%20component.pdf?sequence=3) Rough, L. (2020). 8 ways to sober up from being high. Leafly. https://www.leafly.ca/news/cannabis-101/8-ways-to-counteract-a-too-intense-cannabis-hig(https://www.leafly.ca/news/cannabis-101/8-ways-to-counteract-a-too-intense-cannabis-high)h(https://www.leafly.ca/news/cannabis-101/8-ways-to-counteract-a-too-intense-cannabis-high) Sachs, J., McGlade, E., & Yurgelun-Todd, D. (2015). Safety and toxicology of cannabinoids. Neurotherapeutics : The Journal of the American Society for Experimental NeuroTherapeutics, 12(4), 735–746. https://doi.org/10.1007/s13311-015-0380-8(https://doi.org/10.1007/s13311-015-0380-8) Saez, A. (n.d.). How much weed is too much? 7 signs you’re greening out and how to handle it. The Bluntness. https://www.thebluntness.com/posts/signs-you-re-greening-out-and-how-to-handle-it(https://www.thebluntness.com/posts/signs-you-re-greening-out-and-how-to-handle-it) Schlag, A. K., Hindocha, C., Zafar, R., Nutt, D. J., & Curran, H. V. (2021). Cannabis based medicines and cannabis dependence: A critical review of issues and evidence. Journal of Psychopharmacology (Oxford, England), 35(7), 773-785. https://doi.org/10.1177/0269881120986393(https://doi.org/10.1177/0269881120986393) Schmid, Y., Scholz, I., Mueller, L., Exadaktylos, A. K., Ceschi, A., Liechti, M. E., & Liakoni, E. (2020). Emergency department presentations related to acute toxicity following recreational use of cannabis products in switzerland. Drug and Alcohol Dependence, 206, 107726. https://doi.org/10.1016/j.drugalcdep.2019.107726(https://doi.org/10.1016/j.drugalcdep.2019.107726) Sharpe, L., Sinclair, J., Kramer, A., de Manincor, M., & Sarris, J. (2020). Cannabis, a cause for anxiety? A critical appraisal of the anxiogenic and anxiolytic properties. Journal of Translational Medicine, 18(1), 374. https://doi.org/10.1186/s12967-020-02518-2(https://doi.org/10.1186/s12967-020-02518-2) Shen, L. (2021). Greening out explained–and what to do when you do go green. Cannabis Life Network. https://cannabislifenetwork.com/greening-out-explained-and-what-to-do-when-you-do-go-(https://cannabislifenetwork.com/greening-out-explained-and-what-to-do-when-you-do-go-green/)green/(https://cannabislifenetwork.com/greening-out-explained-and-what-to-do-when-you-do-go-green/) Shewan, D., Dalgarno, P., & Reith, G. (2000). Perceived risk and risk reduction among ecstasy users: The role of drug, set, and setting. International Journal of Drug Policy, 10(6), 431-453. https://doi.org/10.1016/S0955-3959(99)00038-9(https://doi.org/10.1016/S0955-3959(99)00038-9) Venkatesan,T., Levinthal, D. J., Li, B. U., Tarbell, S. E., Adams, K. A., Issenman, R. M., Sarosiek, I., Jaradeh, S. S., Sharaf, R. N., Sultan, S., Stave, C. D., Monte, A. A., & Hasler, W. L. (2019). Role of chronic cannabis use: Cyclic vomiting syndrome vs cannabinoid hyperemesis syndrome. Neurogastroenterology and Motility, 31(S2). https://doi.org/10.1111/nmo.13606(https://doi.org/10.1111/nmo.13606) Vo, K. T., Horng, H., Li, K., Ho, R. Y., Wu, A. H., Lynch, K. L., & Smollin, C. G. (2018). Cannabis intoxication case series: The dangers of edibles containing tetrahydrocannabinol. Annals of Emergency Medicine, 71(3), 306-313. https://doi.org/10.1016/j.annemergmed.2017.09.008(https://doi.org/10.1016/j.annemergmed.2017.09.008) Voser, S. (2020). What is greening out and how to avoid it. Canna Connection. https://www.cannaconnection.com/blog/18321-what-greening-out-how-prevent-solve-it(https://www.cannaconnection.com/blog/18321-what-greening-out-how-prevent-solve-it) Wang, G. S., Banerji, S., Contreras, A. E., & Hall, K. E. (2020). Marijuana exposures in colorado, reported to regional poison centre, 2000–2018. Injury Prevention, 26(2), 184-186. https://doi.org/10.1136/injuryprev-2019-043360(https://doi.org/10.1136/injuryprev-2019-043360) Wang, T., Collet, J. P., Shapiro, S., & Ware, M. A. (2008). Adverse effects of medical cannabinoids: A systematic review. CMAJ : Canadian Medical Association Journal, 178(13), 1669–1678. https://doi.org/10.1503/cmaj.071178(https://doi.org/10.1503/cmaj.071178) Weinstein, L. C., & Worster, B. (2019). Medical Cannabis: A guide to the clinical and legal landscapes. The Journal of Family Practice, 68(7), 390-399. https://pubmed.ncbi.nlm.nih.gov/31532813/(https://pubmed.ncbi.nlm.nih.gov/31532813/) Zinberg, N. E. (1984). Drug, set and setting: The basis for controlled intoxicant use. JAMA (1985), 253(10), 1467. https://doi.org/10.1001/jama.1985.03350340121039(https://doi.org/10.1001/jama.1985.03350340121039)

Acion, L., Ramirez, M. R., Jorge, R. E., & Arndt, S. (2013). Increased risk of alcohol and drug use among children from deployed military families. Addiction, 108(8), 1418–1425. https://doi.org/10.1111/add.12161(https://doi.org/10.1111/add.12161) Ahmadi, H., & Green, S. L. (2011). Screening, brief intervention, and referral to treatment for military spouses experiencing alcohol and substance use disorders: A literature review. Journal of Clinical Psychology in Medical Settings, 18(2), 129-136. https://doi.org/10.1007/s10880-011-9234-7(https://doi.org/10.1007/s10880-011-9234-7) Arkes, J. (2007). Does the economy affect teenage substance use? Health Economics, 16(1), 19–36. https://doi.org/10.1002/hec.1132(https://doi.org/10.1002/hec.1132) Arkes, J. (2011). Recessions and the participation of youth in the selling and use of illicit drugs. International Journal of Drug Policy, 22(5), 335–340. https://doi.org/10.1016/j.drugpo.2011.03.001(https://doi.org/10.1016/j.drugpo.2011.03.001) Attar, B. K., Guerra, N. G., & Tolan, P. H. (1994). Neighborhood disadvantage, stressful life events and adjustments in urban elementary-school children. Journal of Clinical Child Psychology, 23(4), 391–400. https://doi.org/10.1207/s15374424jccp2304_5(https://doi.org/10.1207/s15374424jccp2304_5) Ayer, L. A., Harder, V. S., Rose, G. L., & Helzer, J. E. (2011). Drinking and stress: An examination of sex and stressor differences using ivr-based daily data. Drug and Alcohol Dependence, 115(3), 205–212. https://doi.org/10.1016/j.drugalcdep.2010.10.022(https://doi.org/10.1016/j.drugalcdep.2010.10.022) Bachman, J. G., Freedman-Doan, P., O’Malley, P. M., Johnston, L. D., & Segal, D. R. (1999). Changing patterns of drug use among us military recruits before and after enlistment. American Journal of Public Health (1971), 89(5), 672–677. https://doi.org/10.2105/AJPH.89.5.672(https://doi.org/10.2105/AJPH.89.5.672) Baker, C. K., Hishinuma, E. S., Chang, J. Y., & Nixon, D. C. (2010). The relationship among exposure to stressful life events, drug use, and violence perpetration in a sample of native hawaiian, samoan, and filipino adolescents. Journal of Interpersonal Violence, 25(3), 379–399. https://doi.org/10.1177/0886260509334397(https://doi.org/10.1177/0886260509334397) Boardman, J. D., Finch, B. K., Ellison, C. G., Williams, D. R., & Jackson, J. S. (2001). Neighborhood disadvantage, stress, and drug use among adults. Journal of Health and Social Behavior, 42(2), 151–165. https://doi.org/10.2307/3090175(https://doi.org/10.2307/3090175) Boden, J. M., Fergusson, D. M., & Horwood, L. J. (2014). Associations between exposure to stressful life events and alcohol use disorder in a longitudinal birth cohort studied to age 30. Drug and Alcohol Dependence, 142, 154–160. https://doi.org/10.1016/j.drugalcdep.2014.06.010(https://doi.org/10.1016/j.drugalcdep.2014.06.010) Bolton, J. M., Robinson, J., & Sareen, J. (2009). Self-medication of mood disorders with alcohol and drugs in the national epidemiologic survey on alcohol and related conditions. Journal of Affective Disorders, 115(3), 367–375. https://doi.org/10.1016/j.jad.2008.10.003(https://doi.org/10.1016/j.jad.2008.10.003) Bonin, M. F., McCreary, D. R., & Sadava, S. W. (2000). Problem drinking behavior in two community-based samples of adults: Influence of gender, coping, loneliness, and depression. Psychology of Addictive Behaviors, 14(2), 151-161. https://doi.org/10.1037/0893-164X.14.2.151(https://doi.org/10.1037/0893-164X.14.2.151) Booth, B., Segal, M. W., Bell, D. B., Martin, J. A., Ender, M. G., & Rohall, D. (2007). What we know about army families. Fairfax, VA: Caliber. Bor, J., Basu, S., Coutts, A., McKee, M., & Stuckler, D. (2013). Alcohol use during the great recession of 2008–2009. Alcohol and Alcoholism (Oxford), 48(3), 343–348. https://doi.org/10.1093/alcalc/agt002(https://doi.org/10.1093/alcalc/agt002) Boscarino, J. A., Adams, R. E., & Galea, S. (2006). Alcohol use in new york after the terrorist attacks: a study of the effects of psychological trauma on drinking behavior. Addictive Behaviors, 31(4), 606–621. https://doi.org/10.1016/j.addbeh.2005.05.035(https://doi.org/10.1016/j.addbeh.2005.05.035) Bretteville-Jensen, A. L. (2011). Illegal drug use and the economic recession—What can we learn from the existing research? International Journal of Drug Policy, 22(5), 353–359. https://doi.org/10.1016/j.drugpo.2011.03.009(https://doi.org/10.1016/j.drugpo.2011.03.009) Brown, P. J., & Wolfe, J. (1994). Substance abuse and post-traumatic stress disorder comorbidity. Drug and Alcohol Dependence, 35(1), 51–59. https://doi.org/10.1016/0376-8716(94)90110-4(https://doi.org/10.1016/0376-8716(94)90110-4) Bruguera, P., Reynolds, J., Gilvarry, E., Braddick, F., Marath-Veettil, A. L., Anderson, P., Mielecka-Kubien, Z., Kaner, E., & Gual, A. (2018). How does economic recession affect substance use? A reality check with clients of drug treatment centres. The Journal of Mental Health Policy and Economics, 21(1), 11–16. https://pubmed.ncbi.nlm.nih.gov/29643264/(https://pubmed.ncbi.nlm.nih.gov/29643264/) Cappell, H., & Greeley, J. (1987). Alcohol and tension reduction: An update on research and theory. In H. T. Blane & K. E. Leonard (Eds.), Psychological theories of drinking and alcoholism New York: The Guilford Press. Carliner, H., Keyes, K. M., McLaughlin, K. A., Meyers, J. L., Dunn, E. C., & Martins, S. S. (2016). Childhood trauma and illicit drug use in adolescence: A population-based national comorbidity survey replication–adolescent supplement study. Journal of the American Academy of Child & Adolescent Psychiatry, 55(8), 701–708. https://doi.org/10.1016/j.jaac.2016.05.010(https://doi.org/10.1016/j.jaac.2016.05.010) Catalano, R., Goldman-Mellor, S., Saxton, K., Margerison-Zilko, C., Subbaraman, M., LeWinn, K., & Anderson, E. (2011). The health effects of economic decline. Annual Review of Public Health, 32, 431–450. https://doi.org/10.1146/annurev-publhealth-031210-101146(https://doi.org/10.1146/annurev-publhealth-031210-101146) Chatterjee, D. (2020). The mellow high and the psychedelic war: The rise of marijuana, the (counter)-culture of dissidence, and the fall of the american army in the vietnam war. eSharp, 25(1). https://www.researchgate.net/publication/340454299_The_Mellow_High_and_the_Psyche(https://www.researchgate.net/publication/340454299_The_Mellow_High_and_the_Psychedelic_War)delic_War(https://www.researchgate.net/publication/340454299_The_Mellow_High_and_the_Psychedelic_War) Colder, C. R. (2001). Life stress, physiological and subjective indexes of negative emotionality, and coping reasons for drinking: Is there evidence for a self-medication model of alcohol use? Psychology of Addictive Behaviors, 15(3), 237-245. https://doi.org/10.1037/0893-164X.15.3.237(https://doi.org/10.1037/0893-164X.15.3.237) Colell, E., Sánchez‐Niubò, A., Delclos, G. L., Benavides, F. G., & Domingo‐Salvany, A. (2015). Economic crisis and changes in drug use in the spanish economically active population. Addiction (Abingdon, England), 110(7), 1129–1137. https://doi.org/10.1111/add.12923(https://doi.org/10.1111/add.12923) Compton, W. M., Gfroerer, J., Conway, K. P., & Finger, M. S. (2014). Unemployment and substance outcomes in the united states 2002–2010. Drug and Alcohol Dependence, 142, 350–353. https://doi.org/10.1016/j.drugalcdep.2014.06.012(https://doi.org/10.1016/j.drugalcdep.2014.06.012) Darke, S. (2013). Pathways to heroin dependence: Time to re‐appraise self‐medication. Addiction (Abingdon, England), 108(4), 659–667. https://doi.org/10.1111/j.1360-0443.2012.04001.x(https://doi.org/10.1111/j.1360-0443.2012.04001.x) Darke, S., Williamson, A., Ross, J., & Teesson, M. (2005). Attempted suicide among heroin users: 12-month outcomes from the australian treatment outcome study (atos). Drug and Alcohol Dependence, 78(2), 177–186. https://doi.org/10.1016/j.drugalcdep.2004.10.009(https://doi.org/10.1016/j.drugalcdep.2004.10.009) Dávalos, M. E., Fang, H., & French, M. T. (2012). Easing the pain of an economic downturn: Macroeconomic conditions and excessive alcohol consumption. Health Economics, 21(11), 1318–1335. https://doi.org/10.1002/hec.1788(https://doi.org/10.1002/hec.1788) Dawson, D. A., Grant, B. F., & Ruan, W. J. (2005). The association between stress and drinking: Modifying effects of gender and vulnerability. Alcohol and Alcoholism (Oxford, Oxfordshire), 40(5), 453–460. https://doi.org/10.1093/alcalc/agh176(https://doi.org/10.1093/alcalc/agh176) Dee, T. S. (2001). Alcohol abuse and economic conditions: Evidence from repeated cross‐sections of individual‐level data. Health Economics, 10(3), 257–270. https://doi.org/10.1002/hec.588(https://doi.org/10.1002/hec.588) de Goeij, M. C. M., Suhrcke, M., Toffolutti, V., van de Mheen, D., Schoenmakers, T. M., & Kunst, A. E. (2015). How economic crises affect alcohol consumption and alcohol-related health problems: A realist systematic review. Social Science & Medicine (1982), 131, 131–146. https://doi.org/10.1016/j.socscimed.2015.02.025(https://doi.org/10.1016/j.socscimed.2015.02.025) Deutsch, H. (1967). Selected problems of adolescence. International Universities Press, New York. Dom, G., Samochowiec, J., Evans-Lacko, S., Wahlbeck, K., Van Hal, G., & McDaid, D. (2016). The impact of the 2008 economic crisis on substance use patterns in the countries of the European Union. International Journal of Environmental Research and Public Health, 13(1), 122. https://doi.org/10.3390/ijerph13010122(https://doi.org/10.3390/ijerph13010122) Dore, G., Mills, K., Murray, R., Teesson, M., & Farrugia, P. (2012). Post‐traumatic stress disorder, depression and suicidality in inpatients with substance use disorders. Drug and Alcohol Review, 31(3), 294–302. https://doi.org/10.1111/j.1465-3362.2011.00314.x(https://doi.org/10.1111/j.1465-3362.2011.00314.x) Dube, S. R., Miller, J. W., Brown, D. W., Giles, W. H., Felitti, V. J., Dong, M., & Anda, R. F. (2006). Adverse childhood experiences and the association with ever using alcohol and initiating alcohol use during adolescence. Journal of Adolescent Health, 38(4), 444.e1-444.e10. https://doi.org/10.1016/j.jadohealth.2005.06.006(https://doi.org/10.1016/j.jadohealth.2005.06.006) DuBois, D. L., Felner, R. D., Meares, H., & Krier, M. (1994). Prospective investigation of the effects of socioeconomic disadvantage, life stress, and social support on early adolescent adjustment. Journal of Abnormal Psychology, 103(3), 511-522. https://doi.org/10.1037/0021-843X.103.3.511(https://doi.org/10.1037/0021-843X.103.3.511) Ehring, T., & Quack, D. (2010). Emotion regulation difficulties in trauma survivors: The role of trauma type and ptsd symptom severity. Behavior Therapy, 41(4), 587–598. https://doi.org/10.1016/j.beth.2010.04.004(https://doi.org/10.1016/j.beth.2010.04.004) Enoch, M. A. (2011). The role of early life stress as a predictor for alcohol and drug dependence. Psychopharmacology, 214(1), 17–31. https://doi.org/10.1007/s00213-010-1916-6(https://doi.org/10.1007/s00213-010-1916-6) Ettner, S. L. (1997). Measuring the human cost of a weak economy: Does unemployment lead to alcohol abuse? Social Science & Medicine (1982), 44(2), 251–260. https://doi.org/10.1016/S0277-9536(96)00160-8(https://doi.org/10.1016/S0277-9536(96)00160-8) Falba, T., Teng, H., Sindelar, J. L., & Gallo, W. T. (2005). The effect of involuntary job loss on smoking intensity and relapse. Addiction (Abingdon, England), 100(9), 1330–1339. https://doi.org/10.1111/j.1360-0443.2005.01150.x(https://doi.org/10.1111/j.1360-0443.2005.01150.x) Farris, C. A., & Fenaughty, A. M. (2002). Social isolation and domestic violence among female drug users. The American Journal of Drug and Alcohol Abuse, 28(2), 339–351. https://doi.org/10.1081/ADA-120002977(https://doi.org/10.1081/ADA-120002977) Flett, R. A., Kazantzis, N., Long, N. R., MacDonald, C., & Millar, M. (2002). Traumatic events and physical health in a new zealand community sample. Journal of Traumatic Stress, 15(4), 303–312. https://doi.org/10.1023/A:1016251828407(https://doi.org/10.1023/A:1016251828407) Fosnocht, A. Q., Lucerne, K. E., Ellis, A. S., Olimpo, N. A., & Briand, L. A. (2019). Adolescent social isolation increases cocaine seeking in male and female mice. Behavioural Brain Research, 359, 589–596. https://doi.org/10.1016/j.bbr.2018.10.007(https://doi.org/10.1016/j.bbr.2018.10.007) Fu, S. S., McFall, M., Saxon, A. J., Beckham, J. C., Carmody, T. P., Baker, D. G., & Joseph, A. M. (2007). Post-traumatic stress disorder and smoking: A systematic review. Nicotine & Tobacco Research, 9(11), 1071–1084. https://doi.org/10.1080/14622200701488418(https://doi.org/10.1080/14622200701488418) Goodwin, D. W., Davis, D. H., & Robins, L. N. (1975). Drinking amid abundant illicit drugs: The Vietnam case. Archives of General Psychiatry, 32(2), 230–233. https://doi.org/10.1001/archpsyc.1975.01760200094009(https://doi.org/10.1001/archpsyc.1975.01760200094009) Hall, W., & Weier, M. (2017). Lee robins’ studies of heroin use among us vietnam veterans. Addiction (Abingdon, England), 112(1), 176–180. https://doi.org/10.1111/add.13584(https://doi.org/10.1111/add.13584) Hamilton, S. B., van Mouwerik, S., Oetting, E. R., Beauvais, F., & Keilin, W. G. (1988). Nuclear war as a source of adolescent worry: Relationships with age, gender, traitemotionality, and drug use. The Journal of Social Psychology, 128(6), 745–763. https://doi.org/10.1080/00224545.1988.9924554(https://doi.org/10.1080/00224545.1988.9924554) Hammarström, A., Janlert, U., & Theorell, T. (1988). Youth unemployment and ill health: Results from a 2-year follow-up study. Social Science & Medicine (1982), 26(10), 1025–1033. https://doi.org/10.1016/0277-9536(88)90220-1(https://doi.org/10.1016/0277-9536(88)90220-1) Hammer, T. (1992). Unemployment and use of drug and alcohol among young people: A longitudinal study in the general population. British Journal of Addiction, 87(11), 1571–1581. https://doi.org/10.1111/j.1360-0443.1992.tb02665.x(https://doi.org/10.1111/j.1360-0443.1992.tb02665.x) Harrell, A. (1992). Drugs, crime, and social isolation: Barriers to urban opportunity. The Urban Institute. Henkel, D. (2011). Unemployment and substance use: A review of the literature (1990-2010). Current Drug Abuse Reviews, 4(1), 4–27. https://doi.org/10.2174/1874473711104010004(https://doi.org/10.2174/1874473711104010004) Hoffmann, J. P., & Su, S. S. (1997). The conditional effects of stress on delinquency and drug use: A strain theory assessment of sex differences. Journal of Research in Crime and Delinquency, 34(1), 46–78. https://doi.org/10.1177/0022427897034001004(https://doi.org/10.1177/0022427897034001004) House, J. S., Landis, K. R., & Umberson, D. (1988). Social relationships and health. Science (New York, N.Y.), 241(4865), 540–545. https://doi.org/10.1126/science.3399889(https://doi.org/10.1126/science.3399889) Johnson, B. R., Pagano, M. E., Lee, M. T., & Post, S. G. (2018). Alone on the inside: The impact of social isolation and helping others on aod use and criminal activity. Youth & Society, 50(4), 529–550. https://doi.org/10.1177/0044118X15617400(https://doi.org/10.1177/0044118X15617400) Kalousova, L., & Burgard, S. A. (2014). Unemployment, measured and perceived decline of economic resources: Contrasting three measures of recessionary hardships and their implications for adopting negative health behaviors. Social Science & Medicine, 106, 28–34. https://doi.org/10.1016/j.socscimed.2014.01.007(https://doi.org/10.1016/j.socscimed.2014.01.007) Kelsall, H. L., Wijesinghe, M. S. D., Creamer, M. C., McKenzie, D. P., Forbes, A. B., Page, M. J., & Sim, M. R. (2015). Alcohol use and substance use disorders in gulf war, afghanistan, and iraq war veterans compared with nondeployed military personnel. Epidemiologic Reviews, 37(1), 38–54. https://doi.org/10.1093/epirev/mxu014(https://doi.org/10.1093/epirev/mxu014) Keyes, K. M., Hatzenbuehler, M. L., & Hasin, D. S. (2011). Stressful life experiences, alcohol consumption, and alcohol use disorders: The epidemiologic evidence for four main types of stressors. Psychopharmacology, 218(1), 1–17. https://doi.org/10.1007/s00213-011-2236-1(https://doi.org/10.1007/s00213-011-2236-1) Khan, S., Murray, R. P., & Barnes, G. E. (2002). A structural equation model of the effect of poverty and unemployment on alcohol abuse. Addictive Behaviors, 27(3), 405–423. https://doi.org/10.1016/s0306-4603(01)00181-2(https://doi.org/10.1016/s0306-4603(01)00181-2) Khantzian, E. J. (2013). Addiction as a self‐regulation disorder and the role of self‐medication. Addiction (Abingdon, England), 108(4), 668–669. https://doi.org/10.1111/add.12004(https://doi.org/10.1111/add.12004) Kilpatrick, D. G., Acierno, R., Resnick, H. S., Saunders, B. E., & Best, C. L. (1997). A 2-year longitudinal analysis of the relationships between violent assault and substance use in women. Journal of Consulting and Clinical Psychology, 65(5), 834-837. https://doi.org/10.1037/0022-006X.65.5.834(https://doi.org/10.1037/0022-006X.65.5.834) King, A. C., Bernardy, N. C., & Hauner, K. (2003). Stressful events, personality, and mood disturbance:: Gender differences in alcoholics and problem drinkers. Addictive Behaviors, 28(1), 171–187. https://doi.org/10.1016/S0306-4603(01)00264-7(https://doi.org/10.1016/S0306-4603(01)00264-7) Lee, J. O., Hill, K. G., Hartigan, L. A., Boden, J. M., Guttmannova, K., Kosterman, R., Bailey, J. A., & Catalano, R. F. (2015). Unemployment and substance use problems among young adults: Does childhood low socioeconomic status exacerbate the effect? Social Science & Medicine (1982), 143, 36–44. https://doi.org/10.1016/j.socscimed.2015.08.016(https://doi.org/10.1016/j.socscimed.2015.08.016) Lemke, S., Schutte, K. K., Brennan, P. L., & Moos, R. H. (2008). Gender differences in social influences and stressors linked to increased drinking. Journal of Studies on Alcohol and Drugs, 69(5), 695–702. https://doi.org/10.15288/jsad.2008.69.695(https://doi.org/10.15288/jsad.2008.69.695) Lijffijt, M., Hu, K., & Swann, A. C. (2014). Stress modulates illness-course of substance use disorders: A translational review. Frontiers in Psychiatry, 5, 83. https://doi.org/10.3389/fpsyt.2014.00083(https://doi.org/10.3389/fpsyt.2014.00083) McAloney, K., McCrystal, P., Percy, A., & McCartan, C. (2009). Damaged youth: Prevalence of community violence exposure and implications for adolescent well‐being in post‐conflict Northern Ireland. Journal of Community Psychology, 37(5), 635–648. https://doi.org/10.1002/jcop.20322(https://doi.org/10.1002/jcop.20322) Miller, N. S., Mahler, J. C., & Gold, M. S. (1991). Suicide risk associated with drug and alcohol dependence. Journal of Addictive Diseases, 10(3), 49–61. https://doi.org/10.1300/J069v10n03_06(https://doi.org/10.1300/J069v10n03_06) Mulia, N., Ye, Y., Zemore, S. E., & Greenfield, T. K. (2008). Social disadvantage, stress, and alcohol use among black, hispanic, and white americans: Findings from the 2005 us national alcohol survey. Journal of Studies on Alcohol and Drugs, 69(6), 824–833. https://doi.org/10.15288/jsad.2008.69.824(https://doi.org/10.15288/jsad.2008.69.824) Myers, B., McLaughlin, K. A., Wang, S., Blanco, C., & Stein, D. J. (2014). Associations between childhood adversity, adult stressful life events, and past-year drug use disorders in the national epidemiological study of alcohol and related conditions (nesarc). Psychology of Addictive Behaviors, 28(4), 1117-1126. https://doi.org/10.1037/a0037459(https://doi.org/10.1037/a0037459) Nagelhout, G. E., Hummel, K., de Goeij, M. C. M., de Vries, H., Kaner, E., & Lemmens, P. (2017). How economic recessions and unemployment affect illegal drug use: A systematic realist literature review. International Journal of Drug Policy, 44, 69–83. https://doi.org/10.1016/j.drugpo.2017.03.013(https://doi.org/10.1016/j.drugpo.2017.03.013) Nandi, A., Charters, T. J., Strumpf, E. C., Heymann, J., & Harper, S. (2013). Economic conditions and health behaviours during the ‘great recession.’. Journal of Epidemiology and Community Health (1979), 67(12), 1038–1046. https://doi.org/10.1136/jech-2012-202260(https://doi.org/10.1136/jech-2012-202260) Ngo, H. M., & Le, T. N. (2007). Stressful life events, culture, and violence. Journal of Immigrant and Minority Health, 9(2), 75–84. https://doi.org/10.1007/s10903-006-9018-6(https://doi.org/10.1007/s10903-006-9018-6) Ornish, D. (1998). Love & survival: The scientific basis for the healing power of intimacy and love. Rocco Publishing Company. Pelissier, B. M. M., & O’Neil, J. A. (2000). Antisocial personality and depression among incarcerated drug treatment participants. Journal of Substance Abuse, 11(4), 379–393. https://doi.org/10.1016/S0899-3289(00)00034-1(https://doi.org/10.1016/S0899-3289(00)00034-1) Pilowsky, D. J., Keyes, K. M., & Hasin, D. S. (2009). Adverse childhood events and lifetime alcohol dependence. American Journal of Public Health (1971), 99(2), 258–263. https://doi.org/10.2105/AJPH.2008.139006(https://doi.org/10.2105/AJPH.2008.139006) Rardin, D. R., Lawson, T. R., & Rush Jr, J. A. (1973). Drug use by american soldiers in europe. Social Work (New York), 18(1), 34–41. https://doi.org/10.1093/sw/18.1.34(https://doi.org/10.1093/sw/18.1.34) Raz, S., & Berger, B. D. (2010). Social isolation increases morphine intake: Behavioral and psychopharmacological aspects. Behavioural Pharmacology, 21(1), 39–46. https://doi.org/10.1097/FBP.0b013e32833470bd(https://doi.org/10.1097/FBP.0b013e32833470bd) Reed, S. C., Bell, J. F., & Edwards, T. C. (2011). Adolescent well-being in washington state military families. American Journal of Public Health (1971), 101(9), 1676–1682. https://doi.org/10.2105/AJPH.2011.300165(https://doi.org/10.2105/AJPH.2011.300165) Ritter, A., & Chalmers, J. (2011). The relationship between economic conditions and substance use and harm. Drug and Alcohol Review, 30(1), 1–3. https://doi.org/10.1111/j.1465-3362.2010.00282.x(https://doi.org/10.1111/j.1465-3362.2010.00282.x) Robins, L. N. (1974). The Vietnam drug user returns: Final report, September 1973. US Government Printing Office. Robins, L. N., Davis, D. H., & Nurco, D. N. (1974). How permanent was vietnam drug addiction? American Journal of Public Health (1971), 64 Suppl 12(12_Suppl), 38–43. https://doi.org/10.2105/AJPH.64.12_Suppl.38(https://doi.org/10.2105/AJPH.64.12_Suppl.38) Rokach, A. (2000). Loneliness and the life cycle. Psychological Reports, 86(2), 629–642. https://doi.org/10.2466/PR0.86.2.629-642(https://doi.org/10.2466/PR0.86.2.629-642) Rokach, A., & Orzeck, T. (2003). Coping with loneliness and drug use in young adults. Social Indicators Research, 61(3), 259–283. https://doi.org/10.1023/A:1021977731756(https://doi.org/10.1023/A:1021977731756) Rospenda, K. M., Fujishiro, K., Shannon, C. A., & Richman, J. A. (2008). Workplace harassment, stress, and drinking behavior over time: Gender differences in a national sample. Addictive Behaviors, 33(7), 964–967. https://doi.org/10.1016/j.addbeh.2008.02.009(https://doi.org/10.1016/j.addbeh.2008.02.009) Rossi, D., Singh, D. Z., Pawlowicz, M. P., Touzé, G., Bolyard, M., Mateu-Gelabert, P., Sandoval, M., & Friedman, S. R. (2011). Changes in time-use and drug use by youngadults in poor neighbourhoods of greater buenos aires, argentina, after the political transitions of 2001-2002: Results of a survey. Harm Reduction Journal, 8(1), 2. https://doi.org/10.1186/1477-7517-8-2(https://doi.org/10.1186/1477-7517-8-2) Schiff, M. (2006). Living in the shadow of terrorism: Psychological distress and alcohol use among religious and non-religious adolescents in jerusalem. Social Science & Medicine (1982), 62(9), 2301–2312. https://doi.org/10.1016/j.socscimed.2005.10.016(https://doi.org/10.1016/j.socscimed.2005.10.016) Schiff, M., Benbenishty, R., McKay, M., DeVoe, E., Liu, X., & Hasin, D. (2006). Exposure to terrorism and israeli youths’ psychological distress and alcohol use: An exploratory study. American Journal on Addictions, 15(3), 220–226. https://doi.org/10.1080/10550490600626200(https://doi.org/10.1080/10550490600626200) Schiff, M., Pat-Horenczyk, R., Benbenishty, R., Brom, D., Baum, N., & Astor, R. A. (2012). High school students’ posttraumatic symptoms, substance abuse and involvement in violence in the aftermath of war. Social Science & Medicine (1982), 75(7), 1321–1328. https://doi.org/10.1016/j.socscimed.2012.05.010(https://doi.org/10.1016/j.socscimed.2012.05.010) Schiff, M., Zweig, H. H., Benbenishty, R., & Hasin, D. S. (2007). Exposure to terrorism and israeli youths’ cigarette, alcohol, and cannabis use. American Journal of Public Health (1971), 97(10), 1852–1858. https://doi.org/10.2105/AJPH.2006.090514(https://doi.org/10.2105/AJPH.2006.090514) Shedler, J., & Block, J. (1990). Adolescent drug use and psychological health: A longitudinal inquiry. American Psychologist, 45(5), 612-630. https://doi.org/10.1037/0003-066X.45.5.612(https://doi.org/10.1037/0003-066X.45.5.612) Sinha, R. (2001). How does stress increase risk of drug abuse and relapse? Psychopharmacology, 158(4), 343–359. https://doi.org/10.1007/s002130100917(https://doi.org/10.1007/s002130100917) Sinha, R. (2008). Chronic stress, drug use, and vulnerability to addiction. Annals of the New York Academy of Sciences, 1141(1), 105-130. https://doi.org/10.1196/annals.1441.030(https://doi.org/10.1196/annals.1441.030) Skaff, M. M., Finney, J. W., & Moos, R. H. (1999). Gender differences in problem drinking and depression: Different “vulnerabilities?” American Journal of Community Psychology, 27(1), 25–54. https://doi.org/10.1023/A:1022813727823(https://doi.org/10.1023/A:1022813727823) Slopen, N., Williams, D. R., Fitzmaurice, G. M., & Gilman, S. E. (2011). Sex, stressful life events, and adult onset depression and alcohol dependence: Are men and women equally vulnerable? Social Science & Medicine (1982), 73(4), 615–622. https://doi.org/10.1016/j.socscimed.2011.06.022(https://doi.org/10.1016/j.socscimed.2011.06.022) Stanton, M. D. (1976). Drugs, vietnam, and the vietnam veteran: an overview. The American Journal of Drug and Alcohol Abuse, 3(4), 557–570. https://doi.org/10.3109/00952997609014295(https://doi.org/10.3109/00952997609014295) Steckler, T., Kalin, N. H., & Reul, J. M. H. M. (2005). Handbook of stress and the brain part 2: Stress: Integrative and clinical aspects. Elsevier. Stewart, S. H. (1996). Alcohol abuse in individuals exposed to trauma: A critical review. Psychological Bulletin, 120(1), 83-112. https://doi.org/10.1037/0033-2909.120.1.83(https://doi.org/10.1037/0033-2909.120.1.83) Stewart, S. H., & Israeli, A. L. (2002). Substance abuse and co-occurring psychiatric disorders in victims of intimate violence. In C. Wekerle & A. -M. Walls (Eds.), The violence and addiction equation: Theoretical and clinical issues in substance abuse and relationship violence (pp. 98-122). Brunner-Routledge. Ullman, S. E., Relyea, M., Peter-Hagene, L., & Vasquez, A. L. (2013). Trauma histories, substance use coping, ptsd, and problem substance use among sexual assault victims. Addictive Behaviors, 38(6), 2219–2223. https://doi.org/10.1016/j.addbeh.2013.01.027(https://doi.org/10.1016/j.addbeh.2013.01.027) Veenstra, M. Y., Lemmens, P. H. H. M., Friesema, I. H. M., Tan, F. E. S., Garretsen, H. F. L., Knottnerus, J. A., & Zwietering, P. J. (2007). Coping style mediates impact of stress on alcohol use: A prospective population‐based study. Addiction (Abingdon, England), 102(12), 1890–1898. https://doi.org/10.1111/j.1360-0443.2007.02026.x(https://doi.org/10.1111/j.1360-0443.2007.02026.x) Whitaker, L. R., Degoulet, M., & Morikawa, H. (2013). Social deprivation enhances vta synaptic plasticity and drug-induced contextual learning. Neuron, 77(2), 335–345. https://doi.org/10.1016/j.neuron.2012.11.022(https://doi.org/10.1016/j.neuron.2012.11.022) Winton, M., Heather, N., & Robertson, I. (1986). Effects of unemployment on drinking behavior: A review of the relevant evidence. International Journal of the Addictions,21(12), 1261–1283. https://doi.org/10.3109/10826088609074854(https://doi.org/10.3109/10826088609074854) Wish, E. D., Robins, L. N., Hesselbrock, M., & Helzer, J. E. (1979). The course of alcohol problems in vietnam veterans. Currents in Alcoholism, 6, 239-256. https://pubmed.ncbi.nlm.nih.gov/520054/(https://pubmed.ncbi.nlm.nih.gov/520054/) Youngstrom, E., Weist, M. D., & Albus, K. E. (2003). Exploring violence exposure, stress, protective factors and behavioral problems among inner‐city youth. American Journal of Community Psychology, 32(1–2), 115–129. https://doi.org/10.1023/A:1025607226122(https://doi.org/10.1023/A:1025607226122)

Government of Canada. (2020). What you need to know about cannabis. https://www.canada.ca/en/services/health/campaigns/cannabis/canadians.html(https://www.canada.ca/en/services/health/campaigns/cannabis/canadians.html) Government of Canada. (2021). Authorized cannabis retailers in the provinces and territories. https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/laws-regulati(https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/laws-regulations/provinces-territories.html)ons/provinces-territories.html(https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/laws-regulations/provinces-territories.html) Hahn, R. A., Middleton, J. C., Elder, R., Brewer, R., Fielding, J., Naimi, T. S., Toomey, T. L., Chattopadhyay, S., Lawrence, B., Campbell, C. A., & Community Preventive Services Task Force. (2012). Effects of alcohol retail privatization on excessive alcohol consumption and related harms: A community guide systematic review. American Journal of Preventive Medicine, 42(4), 418-427. https://doi.org/10.1016/j.amepre.2012.01.002(https://doi.org/10.1016/j.amepre.2012.01.002) How to read a label. (2020). Tweed. https://www.tweed.com/en/vault/articles/how-to-read-a-cannabis-label(https://www.tweed.com/en/vault/articles/how-to-read-a-cannabis-label) Legal vs. Illegal: Inside canada’s marketplace. (2020). Responsible Cannabis Use. https://thercu.org/blogs/blog/legal-vs-illegal-inside-canada-s-cannabis-marketplace(https://thercu.org/blogs/blog/legal-vs-illegal-inside-canada-s-cannabis-marketplace) Macdonald, A. (2018). Cannabis is now legal in canada! What is still illegal? (Part II). Right Legal https://www.rightlegal.ca/canada-cannabis-illegal-part2/(https://www.rightlegal.ca/canada-cannabis-illegal-part2/) Myran, D. T., Chen, J. T., Giesbrecht, N., Rees, V. W. (2019). The association between alcohol access and alcohol-attributable emergency department visits in ontario, canada. Addiction (Abingdon, England), 114(7), 1183–1191. https://doi.org/10.1111/add.14597(https://doi.org/10.1111/add.14597) Myran, D. T., Staykov, E., Cantor, N., Taljaard, M., Quach, B. I., Hawken, S., & Tanuseputro, P. (2021). How has access to legal cannabis changed over time? an analysis of the cannabis retail market in canada 2 years following the legalisation of recreational cannabis. Drug and Alcohol Review, 41(2), 377-385. https://doi.org/10.1111/dar.13351(https://doi.org/10.1111/dar.13351) Nunavut - Department of Finance. (2021). Cannabis. https://gov.nu.ca/finance/information/cannabis(https://gov.nu.ca/finance/information/cannabis) Ontario. (2019). Buying recreational cannabis. https://www.ontario.ca/page/buying-recreational-cannabis(https://www.ontario.ca/page/buying-recreational-cannabis) Ontario Cannabis Store. (2020). A Year in review-2019-2020: Ontario's first full year of legal cannabis operations. https://regulatorwatch.com/wp-content/uploads/2020/07/Cannabis-OCS-InsightsReport_20(https://regulatorwatch.com/wp-content/uploads/2020/07/Cannabis-OCS-InsightsReport_2019-2020.pdf)19-2020.pdf(https://regulatorwatch.com/wp-content/uploads/2020/07/Cannabis-OCS-InsightsReport_2019-2020.pdf) Ontario Cannabis Store. (n.d.). Reading a cannabis label. https://ocs.ca/blogs/choosing-cannabis-products/reading-a-cannabis-product-label(https://ocs.ca/blogs/choosing-cannabis-products/reading-a-cannabis-product-label) Prince Edward Island. (2018). Cannabis policy, legislation and regulation. https://www.princeedwardisland.ca/en/information/cannabis-policy-legislation-and-regulA(https://www.princeedwardisland.ca/en/information/cannabis-policy-legislation-and-regulation)tion(https://www.princeedwardisland.ca/en/information/cannabis-policy-legislation-and-regulation) Rotermann, M. (2019). National cannabis survey 2nd quarter. Statistics Canada. https://www150.statcan.gc.ca/n1/en/catalogue/11-627-M2019057(https://www150.statcan.gc.ca/n1/en/catalogue/11-627-M2019057) Rotermann, M. (2021). Looking back from 2020, how cannabis use and related behaviours changed in canada. Health Reports, 32(4), 3-14. https://doi.org/10.25318/82-003-x202100400001-eng(https://doi.org/10.25318/82-003-x202100400001-eng) Statistics Canada. (2019). The retail cannabis market in canada: A portrait of the first year. https://www150.statcan.gc.ca/n1/pub/11-621-m/11-621-m2019005-eng.htm(https://www150.statcan.gc.ca/n1/pub/11-621-m/11-621-m2019005-eng.htm) Wadsworth, E., Driezen, P., & Hammond, D. (2021). Retail availability and legal purchases of dried flower in canada post-legalization. Drug and Alcohol Dependence, 225, 108794. https://doi.org/10.1016/j.drugalcdep.2021.108794(https://doi.org/10.1016/j.drugalcdep.2021.108794) Where can I buy recreational cannabis in canada? (2019). BudHubCanada. https://budhubcanada.ca/where-can-i-buy-legal-recreational-cannabis-in-canada/(https://budhubcanada.ca/where-can-i-buy-legal-recreational-cannabis-in-canada/) Where to buy legal cannabis online in canada. (2020). Namaste. https://www.namaste.ca/blog/buy-marijuana-online-canada/(https://www.namaste.ca/blog/buy-marijuana-online-canada/)

Alberta Health Services. (2020). Tobacco reduction program. https://myhealth.alberta.ca/Alberta/Pages/Using-cannabis-and-tobacco-together.aspx(https://myhealth.alberta.ca/Alberta/Pages/Using-cannabis-and-tobacco-together.aspx) Alston, E. (2020). What happens when you mix xanax and marijuana. The Recovery Village. https://www.therecoveryvillage.com/xanax-addiction/xanax-and-weed/(https://www.therecoveryvillage.com/xanax-addiction/xanax-and-weed/) Alston, L. (2021). Cbd and xanax: Can you take them together? CFAH. https://cfah.org/cbd-and-xanax/(https://cfah.org/cbd-and-xanax/) Carter, A. (2019). What really happens when you mix alcohol and weed? Healthline. https://www.healthline.com/health/alcohol-and-weed(https://www.healthline.com/health/alcohol-and-weed) Christiansen, T. (2020). Can you mix weed and cocaine? The Recovery Village. https://www.therecoveryvillage.com/cocaine-addiction/cocaine-and-weed/(https://www.therecoveryvillage.com/cocaine-addiction/cocaine-and-weed/) Dangers of combining marijuana and lsd. (2018). Skywood Recovery. https://skywoodrecovery.com/marijuana/dangers-of-combining-marijuana-and-lsd/(https://skywoodrecovery.com/marijuana/dangers-of-combining-marijuana-and-lsd/) DeVito, L. (2017). Cb1 and cb2: Different cannabinoid receptors in the brain. LabRoots. https://www.labroots.com/trending/health-and-medicine/7420/cb1-cb2-cannabinoid-recept(https://www.labroots.com/trending/health-and-medicine/7420/cb1-cb2-cannabinoid-receptors-brain)ors-brain(https://www.labroots.com/trending/health-and-medicine/7420/cb1-cb2-cannabinoid-receptors-brain) Goodwin, R. D., Pacek, L. R., Copeland, J., Moeller, S. J., Dierker, L., Weinberger, A., Gbedemah, M., Zvolensky, M. J., Wall, M. M., & Hasin, D. S. (2018). Trends in daily cannabis use among cigarette smokers: United states, 2002–2014. American Journal of Public Health, 108(1), 137-142. https://doi.org/10.2105/AJPH.2017.304050(https://doi.org/10.2105/AJPH.2017.304050) Haney, M., Bedi, G., Cooper, Z. D., Glass, A., Vosburg, S. K., Comer, S. D., & Foltin, R. W. (2013). Predictors of marijuana relapse in the human laboratory: Robust impact of tobacco cigarette smoking status. Biological Psychiatry (1969), 73(3), 242-248. https://doi.org/10.1016/j.biopsych.2012.07.028(https://doi.org/10.1016/j.biopsych.2012.07.028) Henry, J. A., Oldfield, W. L. G., & Kon, O. M. (2003). Comparing cannabis with tobacco: Smoking cannabis, like smoking tobacco, can be a major public health hazard. BMJ: British Medical Journal, 326(7396), 942-943. https://doi.org/10.1136/bmj.326.7396.942(https://doi.org/10.1136/bmj.326.7396.942) Hindocha, C., Brose, L. S., Walsh, H., & Cheeseman, H. (2021). Cannabis use and co‐use in tobacco smokers and non‐smokers: Prevalence and associations with mental health in a cross‐sectional, nationally representative sample of adults in great britain, 2020. Addiction (Abingdon, England), 116(8), 2209-2219. https://doi.org/10.1111/add.15381(https://doi.org/10.1111/add.15381) How do you look after someone who is ‘greening out’ on cannabis? ( 2014). Drug and Alcohol Research and Training Australia. https://darta.net.au/wordpress-content/uploads/2015/01/YPID-GREENING-OUT.pdf(https://darta.net.au/wordpress-content/uploads/2015/01/YPID-GREENING-OUT.pdf) Hutchison, S. (2021). The effects of mixing marijuana and ecstasy. River Oaks Treatment. https://riveroakstreatment.com/marijuana-abuse/mixing-with-ecstasy/(https://riveroakstreatment.com/marijuana-abuse/mixing-with-ecstasy/) Isbell, H., & Jasinski, D. R. (1969). A comparison of lsd-25 with (-)-Δ9-trans-tetrahydrocannabinol (thc) and attempted cross tolerance between lsd and thc. Psychopharmacologia, 14(2), 115-123. https://doi.org/10.1007/BF00403684(https://doi.org/10.1007/BF00403684) Iversen, L. (2003). Cannabis and the brain. Brain (London, England : 1878), 126(6), 1252-1270. https://doi.org/10.1093/brain/awg143(https://doi.org/10.1093/brain/awg143) Kossen, J. (2017). How does cannabis interact with other drugs? Leafly. https://www.leafly.ca/news/health/cannabis-cannabinoids-drug-interactions(https://www.leafly.ca/news/health/cannabis-cannabinoids-drug-interactions) LaNeve, N. (2021). Is it safe to mix alcohol & marijuana? The Recovery Village. https://www.therecoveryvillage.com/alcohol-abuse/alcohol-and-marijuana/(https://www.therecoveryvillage.com/alcohol-abuse/alcohol-and-marijuana/) Martin, P., & Consroe, P. (1981). A preliminary study of thc-lsd interactions on rabbit eeg and behavior. Physiological Psychology, 9(2), 219-222. https://doi.org/10.3758/BF03332927(https://doi.org/10.3758/BF03332927) McClure, E. A., Rabin, R. A., Lee, D. C., & Hindocha, C. (2020). Treatment implications associated with cannabis and tobacco co-use. Current Addiction Reports, 7(4), 533-544. https://doi.org/10.1007/s40429-020-00334-8(https://doi.org/10.1007/s40429-020-00334-8) McDaniel, B. (2020). Why mixing opioids and marijuana to treat chronic pain is dangerous? Asheville Recovery Center. https://www.ashevillerecoverycenter.com/why-mixing-opioids-and-marijuana-to-treat-chronic-pain-is-dangerous/(https://www.ashevillerecoverycenter.com/why-mixing-opioids-and-marijuana-to-treat-chronic-pain-is-dangerous/) Melamede, R. (2005). Cannabis and tobacco smoke are not equally carcinogenic. Harm Reduction Journal, 2(1), 21. https://doi.org/10.1186/1477-7517-2-21(https://doi.org/10.1186/1477-7517-2-21) Meier, E., & Hatsukami, D. K. (2016). A review of the additive health risk of cannabis and tobacco co-use. Drug and Alcohol Dependence, 166, 6-12. https://doi.org/10.1016/j.drugalcdep.2016.07.013(https://doi.org/10.1016/j.drugalcdep.2016.07.013) Mixing marijuana with other drugs. (2020). Aspenridge Recovery. https://www.aspenridgerecoverycenters.com/mixing-marijuana-with-other-drugs/(https://www.aspenridgerecoverycenters.com/mixing-marijuana-with-other-drugs/) Moke: What it is and why it is unhealthy for teens? ( 2018). Newport Academy. https://www.newportacademy.com/resources/substance-abuse/moke-drug-definition-and-r(https://www.newportacademy.com/resources/substance-abuse/moke-drug-definition-and-risks/)isks/(https://www.newportacademy.com/resources/substance-abuse/moke-drug-definition-and-risks/) National Institute on Drug Abuse. (2021). Cocaine drug facts. What is cocaine? https://www.drugabuse.gov/publications/drugfacts/cocaine(https://www.drugabuse.gov/publications/drugfacts/cocaine) Pacek, L. R., Copeland, J., Dierker, L., Cunningham, C. O., Martins, S. S., & Goodwin, R. D. (2018). Among whom is cigarette smoking declining in the united states? The impact of cannabis use status, 2002–2015. Drug and Alcohol Dependence, 191, 355-360. https://doi.org/10.1016/j.drugalcdep.2018.01.040(https://doi.org/10.1016/j.drugalcdep.2018.01.040) Parrott, A. C., Milani, R. M., Gouzoulis-Mayfrank, E., & Daumann, J. (2007). Cannabis and ecstasy/mdma (3,4-methylenedioxymethamphetamine): An analysis of their neuropsychobiological interactions in recreational users. Journal of Neural Transmission, 114(8), 959-968. https://doi.org/10.1007/s00702-007-0715-7(https://doi.org/10.1007/s00702-007-0715-7) Peters, E. N., Budney, A. J., & Carroll, K. M. (2012). Clinical correlates of co‐occurring cannabis and tobacco use: A systematic review. Addiction (Abingdon, England), 107(8), 1404-1417. https://doi.org/10.1111/j.1360-0443.2012.03843.x(https://doi.org/10.1111/j.1360-0443.2012.03843.x) Peters, E. N., Schwartz, R. P., Wang, S., O’Grady, K. E., & Blanco, C. (2014). Psychiatric, psychosocial, and physical health correlates of co-occurring cannabis use disorders and nicotine dependence. Drug and Alcohol Dependence, 134, 228-234. https://doi.org/10.1016/j.drugalcdep.2013.10.003(https://doi.org/10.1016/j.drugalcdep.2013.10.003) Rahn, B. (2015). Why does cannabis cause paranoia in some but helps anxiety in others? Leafly. https://www.leafly.ca/news/cannabis-101/why-does-cannabis-cause-paranoia-and-anxiety(https://www.leafly.ca/news/cannabis-101/why-does-cannabis-cause-paranoia-and-anxiety) Ramo, D. E., Liu, H., & Prochaska, J. J. (2012). Tobacco and marijuana use among adolescents and young adults: A systematic review of their co-use. Clinical Psychology Review, 32(2), 105-121. https://doi.org/10.1016/j.cpr.2011.12.002(https://doi.org/10.1016/j.cpr.2011.12.002) Rettner, R. (2016). Mixing the pot? 7 ways marijuana interacts with medicines. LiveScience. https://www.livescience.com/56439-how-marijuana-interacts-with-medicines.html(https://www.livescience.com/56439-how-marijuana-interacts-with-medicines.html) Schauer, G. L., Berg, C. J., Kegler, M. C., Donovan, D. M., & Windle, M. (2015). Differences in tobacco product use among past month adult marijuana users and nonusers: Findings from the 2003–2012 national survey on drug use and Health. Nicotine & Tobacco Research, 18(3), 281-288. https://doi.org/10.1093/ntr/ntv093(https://doi.org/10.1093/ntr/ntv093) Sidney, S., Beck, J. E., Tekawa, I. S., Quesenberry, C. P., & Friedman, G. D. (1997). Marijuana use and mortality. American Journal of Public Health, 87(4), 585-590. https://doi.org/10.2105/ajph.87.4.585(https://doi.org/10.2105/ajph.87.4.585) Singh, T., Kennedy, S. M., Sharapova, S. S., Schauer, G. L., & Rolle, I. V. (2016). Modes of ever marijuana use among adult tobacco users and non-tobacco users—styles 2014. Journal of Substance Use, 21(6), 631-635. https://doi.org/10.3109/14659891.2015.1122100(https://doi.org/10.3109/14659891.2015.1122100) Statistics Canada. (2017). Canadian tobacco, alcohol and drugs survey. https://www.canada.ca/en/health-canada/services/canadian-alcohol-drugs-survey/2017-suM(https://www.canada.ca/en/health-canada/services/canadian-alcohol-drugs-survey/2017-summary.html)mary.html(https://www.canada.ca/en/health-canada/services/canadian-alcohol-drugs-survey/2017-summary.html) Stephens, C. (2017). What should you know about hyperthermia? Medical News Today. https://www.medicalnewstoday.com/articles/320226(https://www.medicalnewstoday.com/articles/320226) Tashkin, D. P., Baldwin, G. C., Sarafian, T., Dubinett, S., Roth, M. D. (2002). Respiratory and immunologic consequences of marijuana smoking. Journal of Clinical Pharmacology, 42(S1), 71S-81S. https://doi.org/10.1002/j.1552-4604.2002.tb06006.x(https://doi.org/10.1002/j.1552-4604.2002.tb06006.x) The dangers of mixing marijuana and cocaine. (2021). Vertava Health. https://vertavahealth.com/polysubstances/marijuana-and-cocaine/(https://vertavahealth.com/polysubstances/marijuana-and-cocaine/) Tucker, J. S., Pedersen, E. R., Seelam, R., Dunbar, M.S., Shih, R. A., & D'Amico, E. J. (2019). Types of cannabis and tobacco/nicotine co-use and associated outcomes in young adulthood. Psychology of Addictive Behaviors, 33(4), 401-411. https://doi.org/10.1037/adb0000464(https://doi.org/10.1037/adb0000464) United Nations Office on Drugs and Crime. (2019). World drug report 2019. https://wdr.unodc.org/wdr2019/(https://wdr.unodc.org/wdr2019/) Wilcox, A. (2019). What happens to your body when you mix weed and tobacco? Herb. https://herb.co/learn/smoke-weed-and-tobacco/(https://herb.co/learn/smoke-weed-and-tobacco/) Wilson, D., R. (2019). Is weed a depressant, stimulant, or hallucinogen? Healthline. https://www.healthline.com/health/is-weed-a-depressant(https://www.healthline.com/health/is-weed-a-depressant) World Health Organization. (2020). Tobacco. https://www.who.int/news-room/fact-sheets/detail/tobacco(https://www.who.int/news-room/fact-sheets/detail/tobacco) Van der Kooy, F., Pomahacova, B., & Verpoorte, R. (2009). Cannabis smoke condensate II: Influence of tobacco on tetrahydrocannabinol levels. Inhalation Toxicology, 21(2), 87-90. https://doi.org/10.1080/08958370802187296(https://doi.org/10.1080/08958370802187296)

Abdallah, S. J., Smith, B. M., Ware, M. A., Moore, M., Li, P. Z., Bourbeau, J., & Jensen, D. (2018). Effect of vaporized cannabis on exertional breathlessness and exercise endurance in advanced chronic obstructive pulmonary disease: A randomized controlled trial. Annals of the American Thoracic Society, 15(10), 1146-1158. https://doi.org/10.1513/AnnalsATS.201803-198OC(https://doi.org/10.1513/AnnalsATS.201803-198OC) Aldington, S., Williams, M., Nowitz, M., Weatherall, M., Pritchard, A., McNaughton, A., Robinson, G., & Beasley, R. (2007). Effects of cannabis on pulmonary structure,function and symptoms. Thorax, 62(12), 1058-1063. https://doi.org/10.1136/thx.2006.077081(https://doi.org/10.1136/thx.2006.077081) Baczynsky, W. O., & Zimmerman, A. M. (1983a). Effects of Δ9-tetrahydrocannabinol, cannabinol and cannabidiol on the immune system in mice. I. In vivo investigation of the primary and secondary immune response. Pharmacology, 26(1), 12-19. https://doi.org/10.1159/000137763(https://doi.org/10.1159/000137763) Baczynsky, W. O., & Zimmerman, A. M. (1983b). Effects of Δ9-tetrahydrocannabinol, cannabinol and cannabidiol on the immune system in mice: II. In vitro investigation using cultured mouse splenocytes. Pharmacology, 26(1), 12-19. https://doi.org/10.1159/000137764(https://doi.org/10.1159/000137764) BC Lung Foundation. (2019). Cannabis and Lung Health. https://bclung.ca/how-we-can-help/cannabis-and-lung-health(https://bclung.ca/how-we-can-help/cannabis-and-lung-health) Biles, M. (2019). Cannabis & the immune system: A complex balancing act. Project CBD. https://www.projectcbd.org/science/cannabis-and-immune-system(https://www.projectcbd.org/science/cannabis-and-immune-system) CDC. (2018). Marijuana and public health: Immune function. Centers for Disease Control and Prevention. https://www.cdc.gov/marijuana/nas/immune-function.html(https://www.cdc.gov/marijuana/nas/immune-function.html) Coggans, N., Dalgarno, P., Johnson, L., & Shewan, D. (2020). Long-term heavy cannabis use: Implications for health education. Drugs: Education Prevention and Policy, 11(4), 299-313. https://doi.org/10.108009687630410001687860(https://doi.org/10.108009687630410001687860) Croxford, J. L., & Yamamura, T. (2005). Cannabinoids and the immune system: potential for the treatment of inflammatory diseases? Journal of Neuroimmunology, 166(1-2), 3–18. https://doi.org/10.1016/j.jneuroim.2005.04.023(https://doi.org/10.1016/j.jneuroim.2005.04.023) Dax, E.M., Pilotte, N.S., Adler, W.H., Nagel, J.E., & Lange, W. R. (1989). The effects of 9-ene-tetrahydrocannabinol on hormone release and immune function. Journal of Steroid Biochemistry, 34(1-6), 263-270. https://doi.org/10.1016/0022-4731(89)90090-3(https://doi.org/10.1016/0022-4731(89)90090-3) Earleywine, M., & Barnwell, S. S. (2007). Decreased respiratory symptoms in cannabis users who vaporize. Harm Reduction Journal, 4(11). https://doi.org/10.1186/1477-7517-4-11(https://doi.org/10.1186/1477-7517-4-11) Gates, P., Jaffe, A., & Copeland, J. (2014). Cannabis smoking and respiratory health: Consideration of the literature. Respirology, 19(5), 655-662. https://doi.org/10.1111/resp.12298(https://doi.org/10.1111/resp.12298) Hancox, R. J., Poulton, R., Ely, M., Welch, D., Taylor, D. R., McLachlan, C. R., Greene, J. M., Moffitt, T. E., Caspi, A., & Sears, M. R. (2010). Effects of cannabis on lung function: A population-based cohort study. The European Respiratory Journal, 35(1), 42–47. https://doi.org/10.1183/09031936.00065009(https://doi.org/10.1183/09031936.00065009) He, T., Oks, M., Esposito, M., Steinberg, H., & Makaryus, M. (2017). “Tree-in-bloom”: Severe acute lung injury induced by vaping cannabis oil. Annals of the American Thoracic Society, 14(3). https://doi.org/10.1513/AnnalsATS.201612-974LE(https://doi.org/10.1513/AnnalsATS.201612-974LE) Hui-ChihWu, J. (2014). Evidence brief: Communicable disease impacts of sharing electronic-cigarettes with drip tips. Public Health Ontario. https://www.publichealthontario.ca/-/media/documents/eb-ecig-communicable-driptip.pdf(https://www.publichealthontario.ca/-/media/documents/eb-ecig-communicable-driptip.pdf?la=en)?la=en(https://www.publichealthontario.ca/-/media/documents/eb-ecig-communicable-driptip.pdf?la=en) Joshi, M., Joshi, A., & Bartter, T. (2014). Marijuana and lung diseases. Current Opinion in Pulmonary Medicine, 20(2), 173-179. https://doi.org/10.1097/MCP.0000000000000026(https://doi.org/10.1097/MCP.0000000000000026) Keen, L., 2nd, Abbate, A., Blanden, G., Priddie, C., Moeller, F. G., & Rathore, M. (2017). Confirmed marijuana use and lymphocyte count in black people living with hiv. Drug and Alcohol Dependence, 180, 22–25. https://doi.org/10.1016/j.drugalcdep.2017.07.026 (https://doi.org/10.1016/j.drugalcdep.2017.07.026)(Retraction published Drug Alcohol Depend. 2019 May 1;198:199) Klein, T. W., & Friedman, H. (1990). Modulation of murine immune cell function by marijuana components. In R. R. Watson (Ed.), Drugs of Abuse and Immune Function, (pp. 87-112). CRC Press. https://books.google.ca/books?hl=en&lr=&id=5ePEDE1-r5YC&oi=fnd&pg=PA87&dq=K(https://books.google.ca/books?hl=en&lr=&id=5ePEDE1-r5YC&oi=fnd&pg=PA87&dq=Klein+and+Friedman,+1990+immune&ots=_Jh7HBFTTJ&sig=hFM-xogPK0HMXqIPGhHtw5M0-hg#v=onepage&q=Klein%20and%20Friedman%2C%201990%20immune&f=false)lein+and+Friedman,+1990+immune&ots=_Jh7HBFTTJ&sig=hFM-xogPK0HMXqIPGh(https://books.google.ca/books?hl=en&lr=&id=5ePEDE1-r5YC&oi=fnd&pg=PA87&dq=Klein+and+Friedman,+1990+immune&ots=_Jh7HBFTTJ&sig=hFM-xogPK0HMXqIPGhHtw5M0-hg#v=onepage&q=Klein%20and%20Friedman%2C%201990%20immune&f=false)Htw5M0-hg#v=onepage&q=Klein%20and%20Friedman%2C%201990%20immune&f=f(https://books.google.ca/books?hl=en&lr=&id=5ePEDE1-r5YC&oi=fnd&pg=PA87&dq=Klein+and+Friedman,+1990+immune&ots=_Jh7HBFTTJ&sig=hFM-xogPK0HMXqIPGhHtw5M0-hg#v=onepage&q=Klein%20and%20Friedman%2C%201990%20immune&f=false)alse(https://books.google.ca/books?hl=en&lr=&id=5ePEDE1-r5YC&oi=fnd&pg=PA87&dq=Klein+and+Friedman,+1990+immune&ots=_Jh7HBFTTJ&sig=hFM-xogPK0HMXqIPGhHtw5M0-hg#v=onepage&q=Klein%20and%20Friedman%2C%201990%20immune&f=false) Klein, T. W., Friedman, H., Specter, S. (1998, March 15). Marijuana, immunity, and infection. The Journal of Neuroimmunology, 83(1-2), 102-115. https://doi.org/10.1016/S0165-5728(97)00226-9(https://doi.org/10.1016/S0165-5728(97)00226-9) Klein, T. W., Newton, C., & Friedman, H. (1986). Inhibition of natural killer cell function by marijuana components. Journal of Toxicology and Environmental Health, 20(4), 321- 332. https://doi.org/10.1080/15287398709530986(https://doi.org/10.1080/15287398709530986) Lee, M. H. S., & Hancox, R. J. (2011). Effects of smoking cannabis on lung function. Expert Review of Respiratory Medicine, 5(4), 537-547. https://doi.org/10.1586/ers.11.40(https://doi.org/10.1586/ers.11.40) Marcellin, F., Lions, C., Rosenthal, E., Roux, P., Sogni, P., Wittkop, L., Protopopescu, C., Spire, B., Salmon-Ceron, D., Dabis, F., Carrieri, M. P., & HEPAVIH ANRS CO13 StudyGroup (2017). No significant effect of cannabis use on the count and percentage of circulating cd4 t-cells in hiv-hcv co-infected patients (anrs co13-hepavih french cohort). Drug and Alcohol Review, 36(2), 227–238. https://doi.org/10.1111/dar.12398(https://doi.org/10.1111/dar.12398) Martin, R., Safaee, S. D., Somsamouth, K., Mounivong, B., Sinclair, R., Bansal, S., & Singh,P. N. (2013). Mixed methods pilot study of sharing behaviors among waterpipe smokers of rural lao pdr: Implications for infectious disease transmission. International Journal of Environmental Research and Public Health, 10(6), 2120-2132. https://doi.org/10.3390/ijerph10062120(https://doi.org/10.3390/ijerph10062120) McInnis, O. A., & Plecas, D. (2016). Clearing the smoke on cannabis: Respiratory effects of cannabis smoking: An update. Canadian Centre on Substance Abuse. https://www.ccsa.ca/sites/default/files/2019-04/CCSA-Cannabis-Use-Respiratory-Effects-(https://www.ccsa.ca/sites/default/files/2019-04/CCSA-Cannabis-Use-Respiratory-Effects-Report-2016-en.pdf)Report-2016-en.pdf(https://www.ccsa.ca/sites/default/files/2019-04/CCSA-Cannabis-Use-Respiratory-Effects-Report-2016-en.pdf) Michael G. DeGroote Centre for Medicinal Cannabis Research. (2018).What effects does smoking cannabis have on the respiratory system? McMaster University MDCMCR. https://cannabisresearch.mcmaster.ca/news/2018/04/27/cannabis-smoking-and-effects-on-the-respiratory-system(https://cannabisresearch.mcmaster.ca/news/2018/04/27/cannabis-smoking-and-effects-on-the-respiratory-system) Molina, P. E., Amedee, A. M., LeCaptaine, N. J., Zabaleta, J., Mohan, M., Winsauer, J., Vande Stouwe, C., McGoey, R. R., Auten, M. W., LaMotte, L., Chandra, L. C., & Birke, L. L. (2014). Modulation of gut-specific mechanisms by chronic Δ9-tetrahydrocannabinol administration in male rhesus macaques infected with simian immunodeficiency virus: A systems biology analysis. AIDS Research and Human Retroviruses, 30(6), 567-578. https://doi.org/10.1089/aid.2013.0182(https://doi.org/10.1089/aid.2013.0182) Molina, P. E., Winsauer, P., Zhang, P., Walker, E., Birke, L., Amedee, A., Stouwe, C. V., Troxclair, D., McGoey, R., Varner, K., Byerley, L., & LaMotte, L. (2011). Cannabinoid administration attenuates the progression of simian immunodeficiency virus. AIDS Research and Human Retroviruses, 27(6), 585–592. https://doi.org/10.1089/aid.2010.0218(https://doi.org/10.1089/aid.2010.0218) Munckhof, W. J., Konstantinos, A., Wamsley, M., Mortlock, M., & Gilpin, C. (2003). A cluster of tuberculosis associated with use of a marijuana water pipe. The International Journal of Tuberculosis and Lung Disease, 7(9), 860–865. https://pubmed.ncbi.nlm.nih.gov/12971670/(https://pubmed.ncbi.nlm.nih.gov/12971670/) National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice; Committee on the Health Effects of Marijuana: An Evidence Review and Research Agenda. (2017). The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. Washington (DC): National Academies Press (US); 2017 Jan 12. https://doi.org/10.17226/24625(https://doi.org/10.17226/24625) National Institute on Drug Abuse. (2019). What are marijuana's effects on lung health? https://nida.nih.gov/publications/research-reports/marijuana/what-are-marijuanas-effects-lung-health(https://nida.nih.gov/publications/research-reports/marijuana/what-are-marijuanas-effects-lung-health) Papatheodorou, S. I., Buettner, H., Rice, M. B., & Mittleman, M. A. (2016). Recent marijuana use and associations with exhaled nitric oxide and pulmonary function in adults in the united states. Chest, 149(6), 1428-1435. https://doi.org/10.1016/j.chest.2015.12.033(https://doi.org/10.1016/j.chest.2015.12.033) Patel, V., Borysenko, M., Kumar, M. S. A., & Millard, W.J. (1985). Effects of acute and subchronic Δ9-tetrahydrocannabinol administration on the plasma catecholamine, β-endorphin, and corticosterone levels and splenic natural killer cell activity in rats. Proceedings of the Society for Experimental Biology and Medicine, 180(2), 400–404. https://doi.org/10.3181/00379727-180-42195(https://doi.org/10.3181/00379727-180-42195) Pletcher, M. J., Vittinghoff, E., Kalhan, R., Richman, J., Safford, M., Sidney, S., Lin, F., & Kertesz, S. (2012). Association between marijuana exposure and pulmonary function over 20 years. JAMA, 307(2), 173–181. https://doi.org/10.1001/jama.2011.1961(https://doi.org/10.1001/jama.2011.1961) Ribeiro, L., & Ind, P. (2016). S127 effect of cannabis smoking on the development of bullous lung disease: A structured literature review. Thorax, 71, A74-A76. https://dx.doi.org/10.1136/thoraxjnl-2016-209333.133(https://dx.doi.org/10.1136/thoraxjnl-2016-209333.133) Statistics Canada. (2018). Canadian tobacco, alcohol and drugs (ctads) survey: 2017 detailed tables. https://www.canada.ca/en/health-canada/services/canadian-tobacco-alcohol-drugs-survey/2(https://www.canada.ca/en/health-canada/services/canadian-tobacco-alcohol-drugs-survey/2017-summary/2017-detailed-tables.html#t16)017-summary/2017-detailed-tables.html#t16(https://www.canada.ca/en/health-canada/services/canadian-tobacco-alcohol-drugs-survey/2017-summary/2017-detailed-tables.html#t16) Tan, W.C., Lo, C., Jong, A., Xing, L., FitzGerald, M.J., Vollmer, W.M., Buist, S.A., & Sin, D.D. (2009). Marijuana and chronic obstructive lung disease: A population-based study. CMAJ : Canadian Medical Association Journal, 180(8), 814-820. https://doi.org/10.1503/cmaj.081040(https://doi.org/10.1503/cmaj.081040) Tashkin, D.P. & Roth, M.D. (2019). Pulmonary effects of inhaled cannabis smoke. The American Journal of Drug and Alcohol Abuse, 45(6), 596-609. https://doi.org/10.1080/00952990.2019.1627366(https://doi.org/10.1080/00952990.2019.1627366) Taylor, D. R., Fergusson, D. M., Milne, B. J., Horwood, L. J., Moffitt, T. E., Sears, M. R., & Poulton, R. (2002). A longitudinal study of the effects of tobacco and cannabis exposure on lung function in young adults. Addiction (Abingdon, England), 97(8), 1055–1061. https://doi.org/10.1046/j.1360-0443.2002.00169.x(https://doi.org/10.1046/j.1360-0443.2002.00169.x) Tetrault, J.M., Crothers, K., Moore, B.A., Mehra, R., Concato, & J., Fiellin, D.A. (2007). Effects of marijuana smoking on pulmonary function and respiratory complications: A systematic review. Archives of Internal Medicine, 167(3), 221–228. https://doi.org/10.1001/archinte.167.3.221(https://doi.org/10.1001/archinte.167.3.221) Thu, K., Hayes, M., Miles, S., Tierney, L., & Foy, A. (2013). Marijuana 'bong' smoking and tuberculosis. Internal Medicine Journal, 43(4), 456–458. https://doi.org/10.1111/imj.12089(https://doi.org/10.1111/imj.12089) Van Dam, N. T., & Earleywine, M. (2010). Pulmonary function in cannabis users: Support for a clinical trial of the vaporizer. International Journal on Drug Policy, 21(6), 511–513. https://doi.org/10.1016/j.drugpo.2010.04.001(https://doi.org/10.1016/j.drugpo.2010.04.001) Wu, T. C., Tashkin, D. P., Djahed, B., & Rose, J. E. (1988). Pulmonary hazards of smoking marijuana as compared with tobacco. The New England Journal of Medicine, 318(6), 347–351. https://doi.org/10.1056/NEJM198802113180603(https://doi.org/10.1056/NEJM198802113180603)

Asbridge, M., Hayden, J. A., & Cartwright, J. L. (2012). Acute cannabis consumption and motor vehicle collision risk: Systematic review of observational studies and meta-analysis. BMJ (Online), 344, e536. https://doi.org/10.1136/bmj.e536 (https://doi.org/10.1136/bmj.e536) Downey, L. A., King, R., Papafotiou, K., Swann, P., Ogden, E., Boorman, M., & Stough, C. (2013). The effects of cannabis and alcohol on simulated driving: Influences of dose and experience. Accident Analysis and Prevention, 50, 879-886. https://doi.org/10.1016/j.aap.2012.07.016 (https://doi.org/10.1016/j.aap.2012.07.016) Fischer, B., Jeffries, V., Hall, W., Room, R., Goldner, E., & Rehm, J. (2011). Lower risk cannabis use guidelines for canada (lrcug): A narrative review of evidence and recommendations. Canadian Journal of Public Health, 102(5), 324-327. https://doi.org/10.1007/BF03404169(https://doi.org/10.1007/BF03404169) Fischer, B., Russell, C., Sabioni, P., van den Brink, W., Le Foll, B., Hall, W., Rehm, J., & Room, R. (2017). Lower-risk cannabis use guidelines: A comprehensive update ofevidence and recommendations. American Journal of Public Health (1971), 107(8), E1-E12. https://doi.org/10.2105/AJPH.2017.303818 (https://doi.org/10.2105/AJPH.2017.303818) Hall, W. (2018). How should we respond to cannabis‐impaired driving? Drug and Alcohol Review, 37(1), 3-5. https://doi.org/10.1111/dar.12651 (https://doi.org/10.1111/dar.12651) Hall, W., & Homel, R. (2007). [commentary] Reducing cannabis‐impaired driving: Is there sufficient evidence for drug testing of drivers? Addiction (Abingdon, England), 102(12), 1918-1919. https://doi.org/10.1111/j.1360-0443.2007.02042.x (https://doi.org/10.1111/j.1360-0443.2007.02042.x) Jones, C. B., Meier, M. H., & Pardini, D. A. (2018). Comparison of the locations where young adults smoke, vape, and eat/drink cannabis: Implications for harm reduction. Addictive Behaviors Reports, 8, 140-146. https://doi.org/10.1016/j.abrep.2018.09.002(https://doi.org/10.1016/j.abrep.2018.09.002) Lake, S., Kerr, T., Werb, D., Haines‐Saah, R., Fischer, B., Thomas, G., Walsh, Z., Ware, M. A., Wood, E., & Milloy, M. (2019). Guidelines for public health and safety metrics to evaluate the potential harms and benefits of cannabis regulation in canada. Drug and Alcohol Review, 38(6), 606-621. https://doi.org/10.1111/dar.12971 (https://doi.org/10.1111/dar.12971) Laumon, B., Gadegbeku, B., Martin, J., Biecheler, M., & SAM Group. (2005). Cannabis intoxication and fatal road crashes in france: Population based case-control study. BMJ, 331(7529), 1371-1374. https://doi.org/10.1136/bmj.38648.617986.1F (https://doi.org/10.1136/bmj.38648.617986.1F) Richer, I., & Bergeron, J. (2009). Driving under the influence of cannabis: Links with dangerous driving, psychological predictors, and accident involvement. Accident Analysis and Prevention, 41(2), 299-307. https://doi.org/10.1016/j.aap.2008.12.004 (https://doi.org/10.1016/j.aap.2008.12.004) Shiplo, S., Asbridge, M., Leatherdale, S. T., & Hammond, D. (2016). Medical cannabis use in canada: Vapourization and modes of delivery. Harm Reduction Journal, 13(1), 30-30. https://doi.org/10.1186/s12954-016-0119-9(https://doi.org/10.1186/s12954-016-0119-9) Wettlaufer, A., Florica, R. O., Asbridge, M., Beirness, D., Brubacher, J., Callaghan, R., Fischer, B., Gmel, G., Imtiaz, S., Mann, R. E., McKiernan, A., & Rehm, J. (2017). Estimating the harms and costs of cannabis-attributable collisions in the canadian provinces. Drug and Alcohol Dependence, 173, 185-190. https://doi.org/10.1016/j.drugalcdep.2016.12.024(https://doi.org/10.1016/j.drugalcdep.2016.12.024)

American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). https://doi.org/10.1176/appi.books.9780890425596(https://doi.org/10.1176/appi.books.9780890425596) Anthony, J. C, & Helzer, J. E. (1991). Syndromes of drug abuse and dependence. In Robins, L. N, & Regier, D. A. (eds). Psychiatric disorders in america. (pp. 116-154). New York. Free Press. McMillan. Arendt, M., Rosenberg, R., Foldager, L., Perto, G., & Munk-Jørgensen, P. (2005). Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: Follow-up study of 535 incident cases. British Journal of Psychiatry, 187(6), 510-515. https://doi.org/10.1192/bjp.187.6.510(https://doi.org/10.1192/bjp.187.6.510) Arkowitz, H., & Lilienfeld, S. (2021, March 1). Experts tell the truth about pot. Scientific American. https://www.scientificamerican.com/article/the-truth-about-pot/(https://www.scientificamerican.com/article/the-truth-about-pot/) Barnwell, S. S., Earleywine, M., & Wilcox, R. (2006). Cannabis, motivation, and life satisfaction in an internet sample. Substance Abuse Treatment, Prevention and Policy, 1(1), 2-2. https://doi.org/10.1186/1747-597X-1-2(https://doi.org/10.1186/1747-597X-1-2) Bloomfield, M. A. P., Morgan, C. J. A., Kapur, S., Curran, H. V., & Howes, O. D. (2014). The link between dopamine function and apathy in cannabis users: An [18f]-Dopa pet imaging study. Psychopharmacology, 231(11), 2251-2259. https://doi.org/10.1007/s00213-014-3523-4(https://doi.org/10.1007/s00213-014-3523-4) Birchard, K. (2001). Cannabis weakens immune system, may cause mental illness: Cannabis today much more potent than in past. The Medical Post, 37(7), 59. https://www.proquest.com/trade-journals/cannabis-weakens-immune-system-may-cause-m(https://www.proquest.com/trade-journals/cannabis-weakens-immune-system-may-cause-mental/docview/228747678/se-2?accountid=11530)ental/docview/228747678/se-2?accountid=11530(https://www.proquest.com/trade-journals/cannabis-weakens-immune-system-may-cause-mental/docview/228747678/se-2?accountid=11530) Bryant, A. L., Schulenberg, J. E., O'Malley, P. M., Bachman, J. G., & Johnston, L. D. (2003). How academic achievement, attitudes, and behaviors relate to the course of substance use during adolescence: A 6-year, multiwave national longitudinal study. Journal of Research on Adolescence, 13(3), 361-397. https://doi.org/10.1111/1532-7795.1303005(https://doi.org/10.1111/1532-7795.1303005) Bryant, A. L., & Zimmerman, M. A. (2002). Examining the effects of academic beliefs and behaviors on changes in substance use among urban adolescents. Journal of Educational Psychology, 94, 621-637. https://doi.org/10.1037/0022-0663.94.3.621(https://doi.org/10.1037/0022-0663.94.3.621) Campolongo, P., Trezza, V., Cassano, T., Gaetani, S., Morgese, M. G., Ubaldi, M., Soverchia, L., Antonelli, T., Ferraro, L., Massi, M., Ciccocioppo, R., & Cuomo, V. (2007). Perinatal exposure to delta-9-tetrahydrocannabinol causes enduring cognitive deficits associated with alteration of cortical gene expression and neurotransmission in rats. Addiction Biology, 12(3). 485-495. https://doi.org/10.1111/j.1369-1600.2007.00074.x(https://doi.org/10.1111/j.1369-1600.2007.00074.x) Carney, R., Cotter, J., Firth, J., Bradshaw, T., & Yung, A. R. (2017). Cannabis use and symptom severity in individuals at ultra high risk for psychosis: A meta‐analysis. Acta Psychiatrica Scandinavica, 136(1), 5-15. https://doi.org/10.1111/acps.12699(https://doi.org/10.1111/acps.12699) Compton, D. R., Dewey, W. L., & Martin, B. R. (1990). Cannabis dependence and tolerance production. Advances in Alcohol & Substance Abuse, 9(1-2), 129-147. https://doi.org/10.1300/J251v09n01_08(https://doi.org/10.1300/J251v09n01_08) Cox, R. G., Zhang, L., Johnson, W. D., & Bender, D. R. (2007). Academic performance and substance use: From a state survey of public high school students. Journal of School Health, 77(3), 109-115. https://doi.org/10.1111/j.1746-1561.2007.00179.x(https://doi.org/10.1111/j.1746-1561.2007.00179.x) Degenhardt, L., Chiu, W. T., Sampson, N., Kessler, R. C., Anthony, J. C. (2007). Epidemiological patterns of extra-medical drug use in the united states: Evidence from the national comorbidity survey replication, 2001–2003. Drug and Alcohol Dependence, 90(2), 210–23. https://doi.org/10.1016/j.drugalcdep.2007.03.007(https://doi.org/10.1016/j.drugalcdep.2007.03.007) Dreher, M. (2002). Crack heads and roots daughters: The therapeutic use of cannabis in jamaica. Journal of Cannabis Therapeutics, 2(3-4), 121-133. https://doi.org/10.1300/J175v02n03_08(https://doi.org/10.1300/J175v02n03_08) Dryfoos, J. G. (1990). Adolescents at risk: Prevalence and prevention. New York: Oxford University Press. https://doi.org/10.1093/oso/9780195072686.001.0001(https://doi.org/10.1093/oso/9780195072686.001.0001) Duncan, D. F. (1987). Lifetime prevalence of “amotivational syndrome” among users and nonusers of hashish. Psychology of Addictive Behaviors, 1(2), 114-119. https://doi.org/10.1037/0893-164X.1.2.114(https://doi.org/10.1037/0893-164X.1.2.114) Farris, M. S., Shakeel, M. K., & Addington, J. (2020). Cannabis use in individuals at clinical high-risk for psychosis: A comprehensive review. Social Psychiatry and Psychiatric Epidemiology, 55(5), 527-537. https://doi.org/10.1007/s00127-019-01810-x(https://doi.org/10.1007/s00127-019-01810-x) Fergusson, D. M., & Boden, J. M. (2008). Cannabis use and later life outcomes. Addiction (Abingdon, England), 103(6), 969-976. https://doi.org/10.1111/j.1360-0443.2008.02221.x(https://doi.org/10.1111/j.1360-0443.2008.02221.x) Fergusson, D. M., Horwood, L. J., & Beautrais, A. L. (2003). Cannabis and educational achievement. Addiction (Abingdon, England), 98(12), 1681–1692. https://doi.org/10.1111/j.1360-0443.2003.00573.x(https://doi.org/10.1111/j.1360-0443.2003.00573.x) Finn, K. V. (2012). Marijuana use at school and achievement-linked behaviors. The High School Journal, 95(3), 3-13. https://doi.org/10.1353/hsj.2012.0005(https://doi.org/10.1353/hsj.2012.0005) Freeman, T. P., & Winstock, A. R. (2015). Examining the profile of high-potency cannabis and its association with severity of cannabis dependence. Psychological Medicine, 45(15), 3181-3189. https://doi.org/10.1017/S0033291715001178(https://doi.org/10.1017/S0033291715001178) Gerard, A. (2014). Medical cannabis and the myth of amotivational syndrome. Substance Abuse Policy. https://substanceabusepolicy.biomedcentral.com/articles/10.1186/1747-597X-1-2(https://substanceabusepolicy.biomedcentral.com/articles/10.1186/1747-597X-1-2) Grewal, J. K., & Loh, L. C. (2020). Health considerations of the legalization of cannabis edibles. Canadian Medical Association Journal (CMAJ), 192(1), E1-E2. https://doi.org/10.1503/cmaj.191217(https://doi.org/10.1503/cmaj.191217) Grewal, S., & George. T. (2017). Cannabis-induced psychosis: A review. Psychiatric Times, 34(7). https://www.psychiatrictimes.com/view/cannabis-induced-psychosis-review(https://www.psychiatrictimes.com/view/cannabis-induced-psychosis-review) Guimarães, F. S., Chiaretti, T. M., Graeff, F. G., and Zuardi, A. W. (1990). Antianxiety effect of cannabidiol in the elevated plus-maze. Psychopharmacology, 100(4), 558–559. https://doi.org/10.1007/BF02244012(https://doi.org/10.1007/BF02244012) Hall, W. (2015). What has research over the past two decades revealed about the adverse health effects of recreational cannabis use? Addiction (Abingdon, Endlang), 110(1), 19-35. https://doi.org/10.1111/add.12703(https://doi.org/10.1111/add.12703) Hartney, E. (2021). Recognize the symptoms of marijuana addiction. VeryWellMind. https://www.verywellmind.com/characteristics-of-marijuana-addiction-22298(https://www.verywellmind.com/characteristics-of-marijuana-addiction-22298) Hasin, D. S., O'Brien, C. P., Auriacombe, M., Borges, G., Bucholz, K., Budney, A., Compton, W. M., Crowley, T., Ling, W., Petry, N. M., Schuckit, M., & Grant, B. F. (2013). Dsm-5 criteria for substance use disorders: Recommendations and rationale. The American Journal of Psychiatry, 170(8), 834-851. https://doi.org/10.1176/appi.ajp.2013.12060782(https://doi.org/10.1176/appi.ajp.2013.12060782) Hasin, D. S., Saha, T. D., Kerridge, B. T., Goldstein, R. B., Chou, S. P., Zhang, H., Jung, J., Pickering, R. P., Ruan, W. J., Smith, S. M., Huang, B., & Grant, B. F. (2015). Prevalence of marijuana use disorders in the united states between 2001-2002 and 2012-2013. JAMA Psychiatry, 72(12), 1235-1242. https://doi.org/10.1001/jamapsychiatry.2015.1858(https://doi.org/10.1001/jamapsychiatry.2015.1858) Hawkins, J. D., Catalano, R. F., & Miller, J. Y. (1992). Risk and protective factors for alcohol and other drug problems in adolescence and early adulthood: Implications for substance abuse prevention. Psychological Bulletin, 112(1), 64-105. https://doi.org/10.1037/0033-2909.112.1.64(https://doi.org/10.1037/0033-2909.112.1.64) Henry, K. L. (2010). Academic achievement and adolescent drug use: An examination of reciprocal effects and correlated growth trajectories. Journal of School Health, 80, 38-43. https://doi.org/10.1111/j.1746-1561.2009.00455.x(https://doi.org/10.1111/j.1746-1561.2009.00455.x) Jafari, S., & Tang, T. (2016). Diagnosis and treatment of marijuana dependence. British Columbia Medical Journal, 58(6), 315-317. https://bcmj.org/articles/diagnosis-and-treatment-marijuana-dependence(https://bcmj.org/articles/diagnosis-and-treatment-marijuana-dependence) Joo, S. H., Durband, D. B., & Grable, J. (2008). The academic impact of financial stress on college students. Journal of College Student Retention: Research, Theory & Practice, 10(3), 287-305. https://doi.org/10.2190/CS.10.3.c(https://doi.org/10.2190/CS.10.3.c) Kouri, E., Pope Jr, H. G., Yurgelun-Todd, D., & Gruber, S. (1995). Attributes of heavy vs. occasional marijuana smokers in a college population. Biological Psychiatry (1969), 38(7), 475-481. https://doi.org/10.1016/0006-3223(94)00325-W(https://doi.org/10.1016/0006-3223(94)00325-W) Krumrei-Mancuso, E. J., Newton, F. B., Kim, E., & Wilcox, D. (2013). Psychosocial factors predicting first-year college student success. Journal of College Student Development, 54(3), 247-266. https://doi.org/10.1353/csd.2013.0034(https://doi.org/10.1353/csd.2013.0034) Ksir, C., & Hart, C. L. (2016). Cannabis and psychosis: A critical overview of the relationship. Current Psychiatry Reports, 18(2), 1-11. https://doi.org/10.1007/s11920-015-0657-y(https://doi.org/10.1007/s11920-015-0657-y) Lac, A., & Luk, J. W. (2018). Testing the amotivational syndrome: Marijuana use longitudinally predicts lower self-efficacy even after controlling for demographics, personality, and alcohol and cigarette use. Prevention Science, 19(2), 117-126. https://doi.org/10.1007/s11121-017-0811-3(https://doi.org/10.1007/s11121-017-0811-3) Lachenmeier, D. W., & Rehm, J. (2015). Comparative risk assessment of alcohol, tobacco, cannabis and other illicit drugs using the margin of exposure approach. Scientific Reports, 5(1), 8126. https://doi.org/10.1038/srep08126(https://doi.org/10.1038/srep08126) Linscott, R. J., & van Os, J. (2013). An updated and conservative systematic review and meta-analysis of epidemiological evidence on psychotic experiences in children and adults: On the pathway from proneness to persistence to dimensional expression across mental disorders. Psychological Medicine, 43(6), 1133-1149. https://doi.org/10.1017/S0033291712001626(https://doi.org/10.1017/S0033291712001626) Lucas, P. (2012). Cannabis as an adjunct to or substitute for opiates in the treatment of chronic pain. Journal of Psychoactive Drugs, 44(2), 125-133. https://doi.org/10.1080/02791072.2012.684624(https://doi.org/10.1080/02791072.2012.684624) Lucas, P., Reiman, A., Earleywine, M., McGowan, S. K., Oleson, M., Coward, M. P., & Thomas, B. (2013). Cannabis as a substitute for alcohol and other drugs: A dispensary-based survey of substitution effect in Canadian medical cannabis patients. Addiction Research & Theory, 21(5), 435-442. https://doi.org/10.3109/16066359.2012.733465(https://doi.org/10.3109/16066359.2012.733465) Lynskey, M. T., & Hall, W. (2000). The effects of adolescent cannabis use on educational achievement: A review. Addiction (Abingdon, England), 95(11), 1621-1630. https://doi.org/10.1046/j.1360-0443.2000.951116213.x(https://doi.org/10.1046/j.1360-0443.2000.951116213.x) Mattern, K. D., & Shaw, E. J. (2010). A look beyond cognitive predictors of academic success: Understanding the relationship between academic self-beliefs and outcomes. Journal of College Student Development, 51(6), 665-678. https://doi.org/10.1353/csd.2010.0017(https://doi.org/10.1353/csd.2010.0017) Marconi, A., Di Forti, M., Lewis, C. M., Murray, R. M., & Vassos, E. (2016). Meta-analysis of the association between the level of cannabis use and risk of psychosis. Schizophrenia Bulletin, 42(5), 1262-1269. https://doi.org/10.1093/schbul/sbw003(https://doi.org/10.1093/schbul/sbw003) Media Relations. (2017). Marijuana use tied to poorer school performance. University of Waterloo. https://uwaterloo.ca/news/news/marijuana-use-tied-poorer-school-performance(https://uwaterloo.ca/news/news/marijuana-use-tied-poorer-school-performance) Mikuriya, T. H. (2004). Cannabis as a substitute for alcohol: A harm-reduction approach. Journal of Cannabis Therapeutics, 4(1), 79-93. https://doi.org/10.1300/J175v04n01_04(https://doi.org/10.1300/J175v04n01_04) Mikuriya, T., & Mandel, J. (2001). Cannabis substitution: Harm reduction treatment for alcoholism and drug dependence. https://www.mikuriya.com/cw_cansub.html(https://www.mikuriya.com/cw_cansub.html) Miller, B. (2021). Does cannabis cause psychosis? Psychiatric Times, 38(3). https://www.psychiatrictimes.com/view/cannabis-cause-psychosis(https://www.psychiatrictimes.com/view/cannabis-cause-psychosis) Mundell, E., J. (2020). One joint may cause psychotic symptoms: Study. A Family Pharmacy Apple Valley. https://www.afamilypharmacy.com/patient-resources/article/755848/one-joint-may-cause-(https://www.afamilypharmacy.com/patient-resources/article/755848/one-joint-may-cause-psychotic-symptoms-study)psychotic-symptoms-study(https://www.afamilypharmacy.com/patient-resources/article/755848/one-joint-may-cause-psychotic-symptoms-study) Musty, R. E., & Kaback, L. (1995). Relationships between motivation and depression in chronic marijuana users. Life Sciences, 56(23-24), 2151-2158. https://doi.org/10.1016/0024-3205(95)00202-h(https://doi.org/10.1016/0024-3205(95)00202-h) Newcomb, M. D., Bentler, P. M. (1988). Impact of adolescent drug use and social support on problems of young adults: a longitudinal study. Journal of Abnormal Psychology (1965), 97(1), 64–75. https://doi.org/10.1037/0021-843X.97.1.64(https://doi.org/10.1037/0021-843X.97.1.64) Patton G. C., Coffey C., Lynskey M. T., Reid S., Hemphill S., Carlin J. B., & Hall, W. (2007). Trajectories of adolescent alcohol and cannabis use into young adulthood. Addiction (Abingdon, England), 102(4), 607–15. https://doi.org/10.1111/j.1360-0443.2006.01728.x(https://doi.org/10.1111/j.1360-0443.2006.01728.x) Petrucci, A. S., LaFrance, E. M., & Cuttler, C. (2020). A comprehensive examination of the links between cannabis use and motivation. Substance Use & Misuse, 55(7), 1155-1164. https://doi.org/10.1080/10826084.2020.1729203(https://doi.org/10.1080/10826084.2020.1729203) Pike, G. R., Kuh, G. D., & Massa-McKinley, R. C. (2008). First-year students' employment, engagement, and academic achievement: Untangling the relationship between work and grades. NASPA Journal, 45(4), 560-582. https://doi.org/10.2202/1949-6605.2011(https://doi.org/10.2202/1949-6605.2011) Radhakrishnan, R., Wilkinson, S. T., D'Souza, D. C. (2014). Gone to pot—A review of the association between cannabis and psychosis. Frontiers in Psychiatry, 5, 54. https://doi.org/10.3389/fpsyt.2014.00054(https://doi.org/10.3389/fpsyt.2014.00054) Ramo, D. E., Delucchi, K. L., Hall, S. M., Liu, H., & Prochaska, J. J. (2013). Marijuana and tobacco co-use in young adults: Patterns and thoughts about use. Journal of Studies on Alcohol and Drugs, 74(2), 301-310. https://doi.org/10.15288/jsad.2013.74.301(https://doi.org/10.15288/jsad.2013.74.301) Register, C. A., Williams, D. R., & Grimes, P. W. (2001). Adolescent drug use and educational attainment. Education Economics, 9(1), 1-18. https://doi.org/10.1080/09645290124529(https://doi.org/10.1080/09645290124529) Reilly, D., Didcott, P., Swift, W., & Hall, W. (1998). Long‐term cannabis use: Characteristics of users in an australian rural area. Addiction (Abingdon, England), 93(6), 837-846. https://doi.org/10.1046/j.1360-0443.1998.9368375.x(https://doi.org/10.1046/j.1360-0443.1998.9368375.x) Reiman, A. (2007). Medical cannabis patients: Patient profiles and health care utilization patterns. Complementary Health Practice Review, 12(1), 31-50. https://doi.org/10.1177/1533210107301834(https://doi.org/10.1177/1533210107301834) Reiman, A. (2009). Cannabis as a substitute for alcohol and other drugs. Harm Reduction Journal, 6(1), 35. https://doi.org/10.1186/1477-7517-6-35(https://doi.org/10.1186/1477-7517-6-35) Robb, C. A., Moody, B., & Abdel-Ghany, M. (2012). College student persistence to degree: The burden of debt. Journal of College Student Retention: Research, Theory & Practice, 13(4), 431-456. https://doi.org/10.2190/CS.13.4.b(https://doi.org/10.2190/CS.13.4.b) Rubinstein, M. L., Rait, M. A., & Prochaska, J. J. (2014). Frequent marijuana use is associated with greater nicotine addiction in adolescent smokers. Drug and Alcohol Dependence, 141, 159-162. https://doi.org/10.1016/j.drugalcdep.2014.05.015(https://doi.org/10.1016/j.drugalcdep.2014.05.015) Schmidt, L., Weisner, C., & Wiley J. (1998). Substance abuse and the course of welfare dependency. American Journal of Public Health (1971), 88(11), 1616–22. https://doi.org/10.2105/AJPH.88.11.1616(https://doi.org/10.2105/AJPH.88.11.1616) Semple, D. M., McIntosh, A. M., & Lawrie, S. M. (2005). Cannabis as a risk factor for psychosis: Systematic review. Sage Publications. https://doi.org/10.1177/0269881105049040(https://doi.org/10.1177/0269881105049040) Smith, D. E. (1968). Acute and chronic toxicity of marijuana. Journal of Psychedelic Drugs, 2(1), 37-48. https://doi.org/10.1080/02791072.1968.10524399(https://doi.org/10.1080/02791072.1968.10524399) Studies from washington university yield new information about marijuana/cannabis (A large-scale genome-wide association study meta-analysis of cannabis use disorder). (2021). Psychology & Psychiatry Journal, 503. https://link.gale.com/apps/doc/A646718700/AONE?u=humber&sid=summon&xid=bc33d(https://link.gale.com/apps/doc/A646718700/AONE?u=humber&sid=summon&xid=bc33d18f)18f(https://link.gale.com/apps/doc/A646718700/AONE?u=humber&sid=summon&xid=bc33d18f) Subbaraman, M. S. (2014). Can cannabis be considered a substitute medication for alcohol? Alcohol and Alcoholism (Oxford), 49(3), 292-298. https://doi.org/10.1093/alcalc/agt182(https://doi.org/10.1093/alcalc/agt182) Suresh, K. (2011). An overview of randomization techniques: An unbiased assessment of outcome in clinical research. Journal of Human Reproductive Sciences, 4(1), 8-11. https://doi.org/10.4103/0974-1208.82352(https://doi.org/10.4103/0974-1208.82352) Szoke, A., Galliot, A., Richard, J., Ferchiou, A., Baudin, G., Leboyer, M., & Schürhoff, F. (2014). Association between cannabis use and schizotypal dimensions –A meta-analysis of cross-sectional studies. Psychiatry Research, 219(1), 58-66. https://doi.org/10.1016/j.psychres.2014.05.008(https://doi.org/10.1016/j.psychres.2014.05.008) Timmins, B. (2017). Cannabis users are more successful and satisfied, finds new study. Independent. https://www.independent.co.uk/life-style/cannabis-users-success-satisfied-marijuana-weed(https://www.independent.co.uk/life-style/cannabis-users-success-satisfied-marijuana-weed-study-well-adjusted-rich-a7792991.htmlV)-study-well-adjusted-rich-a7792991.html(https://www.independent.co.uk/life-style/cannabis-users-success-satisfied-marijuana-weed-study-well-adjusted-rich-a7792991.htmlV) Voelkl, K. E., & Frone, M. R. (2000). Predictors of substance use at school among high school students. Journal of Educational Psychology, 92(3), 583-592. https://doi.org/10.1037//0022-0663.92.3.583(https://doi.org/10.1037/0022-0663.92.3.583) Watkins. M., (2020). Marijuana (Weed, cannabis) Overdose symptoms, signs & treatment. American Addictions Centers. https://drugabuse.com/drugs/marijuana/overdose/(https://drugabuse.com/drugs/marijuana/overdose/) Wiesbeck, G. A., Schuckit, M. A., Kalmijn, J. A., Tipp, J. E., Bucholz, K. K., & Smith, T. L. (1996). An evaluation of the history of a marijuana withdrawal syndrome in a large population. Addiction (Abingdon, England), 91(10), 1469-1478. https://pubmed.ncbi.nlm.nih.gov/8917915/(https://pubmed.ncbi.nlm.nih.gov/8917915/) World Health Organization. (2016). The health and social effects of nonmedical cannabis use. https://apps.who.int/iris/handle/10665/251056(https://apps.who.int/iris/handle/10665/251056) World Health Organization (WHO). (2016). International statistical classification of diseases and related health problems - Tenth revision (ICD-10). https://apps.who.int/iris/bitstream/handle/10665/246208/9789241549165-V3-eng.pdf?sequence=3&isAllowed=y(https://apps.who.int/iris/bitstream/handle/10665/246208/9789241549165-V3-eng.pdf?sequence=3&isAllowed=y)

Adlaf, E. M., Hamilton, H. A., Wu, F., & Noh, S. (2009). Adolescent stigma towards drug addiction: Effects of age and drug use behaviour. Addictive Behaviors, 34(4), 360–364. https://doi.org/10.1016/j.addbeh.2008.11.012(https://doi.org/10.1016/j.addbeh.2008.11.012) Botvin, G. J., & Griffin, K. W. (2007). School-based programmes to prevent alcohol, tobacco and other drug use. International Review of Psychiatry (Abingdon, England), 19(6), 607–615. https://doi.org/10.1080/09540260701797753(https://doi.org/10.1080/09540260701797753) Bränström, R., Sjöström, E., & Andréasson, S. (2007). Individual, group and community risk and protective factors for alcohol and drug use among swedish adolescents. European Journal of Public Health, 18(1), 12–18. https://doi.org/10.1093/eurpub/ckm038(https://doi.org/10.1093/eurpub/ckm038) Chaloupka, F. J., Grossman, M., & Saffer, H. (2002). The effects of price on alcohol consumption and alcohol-related problems. Alcohol Research & Health: The Journal of the National Institute on Alcohol Abuse and Alcoholism, 26(1), 22–34. https://pubmed.ncbi.nlm.nih.gov/12154648/(https://pubmed.ncbi.nlm.nih.gov/12154648/) Chaloupka, F. J., & Wechsler, H. (1996). Binge drinking in college: The impact of price, availability, and alcohol control policies. Contemporary Economic Policy, 14(4), 112–124. https://doi.org/10.1111/j.1465-7287.1996.tb00638.x(https://doi.org/10.1111/j.1465-7287.1996.tb00638.x) Farrelly, M. C., Bray, J. W., Zarkin, G. A., & Wendling, B. W. (2001). The joint demand for cigarettes and marijuana: Evidence from the national household surveys on drug abuse. Journal of Health Economics, 20(1), 51–68. https://doi.org/10.1016/S0167-6296(00)00067-9(https://doi.org/10.1016/S0167-6296(00)00067-9) Grossman, M. (2005). Individual behaviours and substance use: The role of price. In B. lindgren & M. grossman (Eds.), Substance Use: Individual Behaviour, Social Interactions, Markets and Politics. https://doi.org/10.1016/S0731-2199(05)16002-6(https://doi.org/10.1016/S0731-2199(05)16002-6) Grossman, M., Chaloupka, F. J., Saffer, H., & Laixuthai, A. (1994). Effects of alcohol price policy on youth: A summary of economic research. Journal of Research on Adolescence (Lawrence Erlbaum), 4(2), 347–364. https://doi.org/10.3386/w4385(https://doi.org/10.3386/w4385) Hathaway, A. D., Comeau, N. C., & Erickson, P. G. (2011). Cannabis normalization and stigma: Contemporary practices of moral regulation. Criminology & Criminal Justice, 11(5), 451–469. https://doi.org/10.1177/1748895811415345(https://doi.org/10.1177/1748895811415345) Kuo, M., Wechsler, H., Greenberg, P., & Lee, H. (2003). The marketing of alcohol to college students: The role of low prices and special promotions. American Journal of Preventive Medicine, 25(3), 204–211. https://doi.org/10.1016/s0749-3797(03)00200-9(https://doi.org/10.1016/s0749-3797(03)00200-9) Leverett, M., Ashe, M., Gerard, S., Jenson, J., & Woollery, T. (2002). Tobacco use: The impact of prices. The Journal of Law, Medicine & Ethics, 30(3), 88–95. https://pubmed.ncbi.nlm.nih.gov/12508509/(https://pubmed.ncbi.nlm.nih.gov/12508509/) Parker, H., & Egginton, R. (2002). Adolescent recreational alcohol and drugs careers gone wrong: developing a strategy for reducing risks and harms. International Journal of Drug Policy, 13(5), 419–432. https://doi.org/https://doi.org/10.1016/S0955-3959(02)00154-8(https://doi.org/https:/doi.org/10.1016/S0955-3959(02)00154-8) Rhodes, W., Johnston, P., Han, S., McMullen, Q., & Hozik, L. (2000). Illicit drugs: Price elasticity of demand and supply. Abt Associates. Stockwell, T., Zhao, J., Giesbrecht, N., Macdonald, S., Thomas, G., & Wettlaufer, A. (2012). The raising of minimum alcohol prices in saskatchewan, canada: Impacts on consumptionand implications for public health. American Journal of Public Health, 102(12), e103–e110. https://doi.org/10.2105/AJPH.2012.301094(https://doi.org/10.2105/AJPH.2012.301094) van Ours, J. C., & Williams, J. (2007). Cannabis prices and dynamics of cannabis use. Journal of Health Economics, 26(3), 578–596. https://doi.org/10.1016/j.jhealeco.2006.10.001(https://doi.org/10.1016/j.jhealeco.2006.10.001) Xu, X., & Chaloupka, F. J. (2011). The effects of prices on alcohol use and its consequences. Alcohol Research & Health : The Journal of the National Institute on Alcohol Abuse and Alcoholism, 34(2), 236–245. https://pubmed.ncbi.nlm.nih.gov/22330223(https://pubmed.ncbi.nlm.nih.gov/22330223)

Alcohol and Gaming Commission of Ontario. (n.d.). First allocation of stores - Expression of interest lottery. https://www.agco.ca/cannabis/cannabis-retail-lottery (https://www.agco.ca/cannabis/cannabis-retail-lottery) Cannabis Act (S.C. 2018, c. 16). https://laws-lois.justice.gc.ca/eng/acts/c-24.5/ (https://laws-lois.justice.gc.ca/eng/acts/c-24.5/) Cannabis Regulations (SOR/2018-144). https://laws-lois.justice.gc.ca/eng/Regulations/SOR-2018-144/index.html (https://laws-lois.justice.gc.ca/eng/Regulations/SOR-2018-144/index.html) CDPE. (2020, October 14). Canada’s legal cannabis industry lacks diversity, a new policy brief by the centre on drug policy evaluation and the university of toronto finds. https://cdpe.org/canadas-legal-cannabis-industry-lacks-diversity/#:~:text=The%20new%20(https://cdpe.org/canadas-legal-cannabis-industry-lacks-diversity/#:~:text=The%20new%20policy%20brief%20found,%2C%20and%201%25%20Latinx)policy%20brief%20found,%2C%20and%201%25%20Latinx)(https://cdpe.org/canadas-legal-cannabis-industry-lacks-diversity/#:~:text=The%20new%20policy%20brief%20found,%2C%20and%201%25%20Latinx). Government of Canada. (2016, December 13). A framework for the legalization and regulation of cannabis in canada. https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/laws-regulati(https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/laws-regulations/task-force-cannabis-legalization-regulation/framework-legalization-regulation-cannabis-in-canada.html#a2.2)ons/task-force-cannabis-legalization-regulation/framework-legalization-regulation-cannab(https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/laws-regulations/task-force-cannabis-legalization-regulation/framework-legalization-regulation-cannabis-in-canada.html#a2.2)is-in-canada.html#a2.2 (https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/laws-regulations/task-force-cannabis-legalization-regulation/framework-legalization-regulation-cannabis-in-canada.html#a2.2) Government of Canada. (2019). Final regulations: Edible cannabis, cannabis extracts, cannabis topicals. https://www.canada.ca/content/dam/hc-sc/documents/services/drugs-medication/cannabis/(https://www.canada.ca/content/dam/hc-sc/documents/services/drugs-medication/cannabis/resources/final-regulations-edible-cannabis-extracts-topical-eng.pdf)resources/final-regulations-edible-cannabis-extracts-topical-eng.pdf (https://www.canada.ca/content/dam/hc-sc/documents/services/drugs-medication/cannabis/resources/final-regulations-edible-cannabis-extracts-topical-eng.pdf) Government of Canada. (2019, December 23). Summary of results for the canadian student tobacco, alcohol and drugs survey 2018-19. https://www.canada.ca/en/health-canada/services/canadian-student-tobacco-alcohol-drugs-(https://www.canada.ca/en/health-canada/services/canadian-student-tobacco-alcohol-drugs-survey/2018-2019-summary.html)survey/2018-2019-summary.html (https://www.canada.ca/en/health-canada/services/canadian-student-tobacco-alcohol-drugs-survey/2018-2019-summary.html) Government of Canada. (2019, June 14). Directory of nutrition facts table formats for edible cannabis. https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/laws-regulati(https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/laws-regulations/regulations-support-cannabis-act/directory-nutrition-facts-table-formats-edible.html)ons/regulations-support-cannabis-act/directory-nutrition-facts-table-formats-edible.html (https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/laws-regulations/regulations-support-cannabis-act/directory-nutrition-facts-table-formats-edible.html) Government of Canada. (2019, November 5). The cannabis act and cannabis regulations: Promotion prohibitions. https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/laws-regulati(https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/laws-regulations/promotion-prohibitions.html)ons/promotion-prohibitions.html (https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/laws-regulations/promotion-prohibitions.html) Government of Canada. (2020). Canadian cannabis survey 2020: Summary. https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/research-data/canadian-cannabis-survey-2020-summary.html#a4(https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/research-data/canadian-cannabis-survey-2020-summary.html#a4) Government of Canada. (2021). Authorized cannabis retailers in the provinces and territories. https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/laws-regulati(https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/laws-regulations/provinces-territories.html)ons/provinces-territories.html(https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/laws-regulations/provinces-territories.html) Government of Canada. (2021, February 3). Cannabis legalization and regulation. https://www.justice.gc.ca/eng/cj-jp/cannabis/ (https://www.justice.gc.ca/eng/cj-jp/cannabis/) Health Canada. (2018). Cannabis public education activities. Government of Canada. https://www.canada.ca/en/health-canada/news/2018/06/cannabis-public-education-activitie(https://www.canada.ca/en/health-canada/news/2018/06/cannabis-public-education-activities.html)s.html(https://www.canada.ca/en/health-canada/news/2018/06/cannabis-public-education-activities.html) Health Canada, Cannabis Legalization and Regulation Branch. (2018). Promotion prohibitions under the cannabis act. https://commb.ca/wp-content/uploads/2018/09/25152254/Cannabis_Act_Promotion_Prohi(https://commb.ca/wp-content/uploads/2018/09/25152254/Cannabis_Act_Promotion_Prohibitions_EN.pdf)bitions_EN.pdf (https://commb.ca/wp-content/uploads/2018/09/25152254/Cannabis_Act_Promotion_Prohibitions_EN.pdf) Lisdahl, K. M., Gilbart, E. R., Wright, N. E., & Shollenbarger, S. (2013). Dare to delay? The impacts of adolescent alcohol and marijuana use onset on cognition, brain structure, and function. Frontiers in psychiatry, 4, 53. https://doi.org/10.3389/fpsyt.2013.00053(https://doi.org/10.3389/fpsyt.2013.00053) Pfeffer, A. (2019, November 13). Pot producers implore ontario to open more stores. CBC News. https://www.cbc.ca/news/canada/ottawa/pot-producers-implore-ontario-open-stores-1.5357101(https://www.cbc.ca/news/canada/ottawa/pot-producers-implore-ontario-open-stores-1.5357101) Rotermann, M. (2020, February 19). What has changed since cannabis was legalized? Statistics Canada. https://www150.statcan.gc.ca/n1/pub/82-003-x/2020002/article/00002-eng.htm (https://www150.statcan.gc.ca/n1/pub/82-003-x/2020002/article/00002-eng.htm) Solowij, N., Jones, K. A., Rozman, M. E., Davis, S. M., Ciarrochi, J., Heaven, P. C., Lubman, D. I., & Yücel, M. (2011). Verbal learning and memory in adolescent cannabis users, alcohol users and non-users. Psychopharmacology, 216(1), 131–144.https://doi.org/10.1007/s00213-011-2203-x (https://doi.org/10.1007/s00213-011-2203-x) Tobacco and Vaping Products Act, S.C. 1997, c. 13. https://laws-lois.justice.gc.ca/eng/acts/t-11.5/(https://laws-lois.justice.gc.ca/eng/acts/t-11.5/)

Abelman, D. D. (2017). Mitigating risks of students use of study drugs through understanding motivations for use & applying harm reduction theory: A literature review. Harm Reduction Journal, 14(1), 68. https://doi.org/10.1186/s12954-017-0194-6 (https://doi.org/10.1186/s12954-017-0194-6) Ali, S., Mouton, C. P., Jabeen, S., Ofoemezie, E. K., Bailey, R. K., Shahid, M., & Zeng, Q. (2011). Early detection of illicit drug use in teenagers. Innovations in Clinical Neuroscience, 8(12), 24–28. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3257983/(https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3257983/) Arria, A. M., & DuPont, R. L. (2010). Nonmedical prescription stimulant use among college students: Why we need to do something and what we need to do. Journal of Addictive Diseases, 29(4), 417-426. https://doi.org/10.1080/10550887.2010.509273 (https://doi.org/10.1080/10550887.2010.509273) Canadian Centre on Substance Abuse. (n.d.). Canadian centre on substance abuse. https://www.ccsa.ca/(https://www.ccsa.ca/) Canadian Centre on Substance Abuse. (2014). The canadian standards for youth substance abuse prevention: An overview. https://www.ccsa.ca/sites/default/files/2019-05/2014-CCSA-Canadian-Standards-Youth-Substance-Abuse-Prevention-Overview-en.pdf(https://www.ccsa.ca/sites/default/files/2019-05/2014-CCSA-Canadian-Standards-Youth-Substance-Abuse-Prevention-Overview-en.pdf) Department of Justice. (2018, September 26). National anti-drug strategy evaluation. https://www.justice.gc.ca/eng/rp-pr/cp-pm/eval/rep-rap/12/nas-sna/p4.html(https://www.justice.gc.ca/eng/rp-pr/cp-pm/eval/rep-rap/12/nas-sna/p4.html) Fischer, B. (2005). Substance abuse in canada: Current challenges and choices. Canadian Centre on Substance Abuse, 11–12. https://www.ccsa.ca/sites/default/files/2019-04/ccsa-004032-2005.pdf (https://www.ccsa.ca/sites/default/files/2019-04/ccsa-004032-2005.pdf) Gaetz, S. (2014). Harm reduction. Homeless Hub. https://www.homelesshub.ca/solutions/supports/harm-reduction (https://www.homelesshub.ca/solutions/supports/harm-reduction) Mitra, S., & Globerman, J. (2016). Engaging law enforcement in harm reduction programs for people who inject drugs. Ontario HIV Treatment Network. http://www.ohtn.on.ca/wp-content/uploads/2016/08/rr109_law-enforcement-harm-reduction.pdf (http://www.ohtn.on.ca/wp-content/uploads/2016/08/rr109_law-enforcement-harm-reduction.pdf) Public Health England. (2015). The international evidence on the prevention of drug and alcohol use. https://healtheducationresources.unesco.org/library/documents/international-evidence-prevention-drug-and-alcohol-use-summary-and-examples(https://healtheducationresources.unesco.org/library/documents/international-evidence-prevention-drug-and-alcohol-use-summary-and-examples) Shaw, A., Egan, J., & Gillespie, M. (2007). Drugs and poverty: A literature review. Scottish Drugs Forum. http://www.dldocs.stir.ac.uk/documents/drugpovertylitrev.pdf (http://www.dldocs.stir.ac.uk/documents/drugpovertylitrev.pdf) Spooner, C., & Hetherington, K. (2004). Social Determinants of Drug Use. National Drug and Alcohol Research Centre. https://ndarc.med.unsw.edu.au/sites/default/files/ndarc/resources/TR.228.pdf(https://ndarc.med.unsw.edu.au/sites/default/files/ndarc/resources/TR.228.pdf) United Nations International Drug Control Programme (UNDCP). (1995). The social impact of drug abuse. https://www.unodc.org/pdf/technical_series_1995-03-01_1.pdf(https://www.unodc.org/pdf/technical_series_1995-03-01_1.pdf) Vancouver Police Department. (2006). Vancouver police department drug policy. https://vancouver.ca/police/assets/pdf/reports-policies/vpd-policy-drug.pdf(https://vancouver.ca/police/assets/pdf/reports-policies/vpd-policy-drug.pdf) Warren, F. (2016, December). 'What works' in drug education and prevention? Scottish Government. http://www.edex.es/wp-content/uploads/What-works-in-prevention.pdf(http://www.edex.es/wp-content/uploads/What-works-in-prevention.pdf)

Becvar, D. S. (2007). Families that flourish: Facilitating resilience in clinical practice. WW Norton & Company. Birtchnell, J. (1975). Psychiatric breakdown following recent parent death. British Journal of Medical Psychology, 48(4), 379–390. https://doi.org/10.1111/j.2044-8341.1975.tb02346.x(https://doi.org/10.1111/j.2044-8341.1975.tb02346.x) Bonanno, G. A., Wortman, C. B., Lehman, D. R., Tweed, R. G., Haring, M., Sonnega, J., Carr, D., & Nesse, R. M. (2002). Resilience to loss and chronic grief: A prospective study from preloss to 18-months postloss. Journal of Personality and Social Psychology, 83(5), 1150-1164. https://doi.org/10.1037//0022-3514.83.5.1150(https://doi.org/10.1037/0022-3514.83.5.1150) Brent, D. A., Perper, J. A., Moritz, G., Liotus, L., Schweers, J., & Canobbio, R. (1994). Major depression or uncomplicated bereavement? A follow-up of youth exposed to suicide. Journal of the American Academy of Child & Adolescent Psychiatry, 33(2), 231–239. https://doi.org/10.1097/00004583-199402000-00012(https://doi.org/10.1097/00004583-199402000-00012) Brewer, N. T., Weinstein, N. D., Cuite, C. L., & Herrington, J. E. (2004). Risk perceptions and their relation to risk behavior. Annals of Behavioral Medicine, 27(2), 125–130. https://doi.org/10.1207/s15324796abm2702_7(https://doi.org/10.1207/s15324796abm2702_7) Burton, A. M., Haley, W. E., & Small, B. J. (2006). Bereavement after caregiving or unexpected death: Effects on elderly spouses. Aging and Mental Health, 10(3), 319–326. https://doi.org/10.1080/13607860500410045(https://doi.org/10.1080/13607860500410045) Bush, J., Phillimore, P., Pless-Mulloli, T., & Thompson, C. (2005). Carcass disposal and siting controversy: Risk, dialogue and confrontation in the 2001 foot-and-mouth outbreak. Local Environment, 10(6), 649–664. https://doi.org/10.1080/13549830500321907(https://doi.org/10.1080/13549830500321907) Carey, M. P., Braaten, L. S., Jaworski, B. C., Durant, L. E., & Forsyth, A. D. (1999). Hiv and aids relative to other health, social, and relationship concerns among low-income urban women: A brief report. Journal of Women’s Health and Gender-Based Medicine, 8(5), 657–661. https://doi.org/10.1089/jwh.1.1999.8.657(https://doi.org/10.1089/jwh.1.1999.8.657) Carr, D. (2004). Gender, preloss marital dependence, and older adults’ adjustment to widowhood. Journal of Marriage and Family, 66(1), 220–235. https://doi.org/10.1111/j.0022-2445.2004.00016.x(https://doi.org/10.1111/j.0022-2445.2004.00016.x) Conner, M., & Norman, P. (2005). Predicting health behaviour. UK: McGraw-Hill Education. De Cock, K. M., Jaffe, H. W., & Curran, J. W. (2011). Reflections on 30 years of aids. Emerging Infectious Diseases, 17(6), 1044-1048. https://doi.org/10.3201/eid/1706.100184(https://doi.org/10.3201/eid/1706.100184) Drew, S. (2007). Having cancer changed my life, and changed my life forever’: Survival, illness legacy and service provision following cancer in childhood. Chronic Illness, 3(4), 278–295. https://doi.org/10.1177/1742395307085236(https://doi.org/10.1177/1742395307085236) Egnew, T. R. (2005). The meaning of healing: Transcending suffering. The Annals of Family Medicine, 3(3), 255–262. https://doi.org/10.1370/afm.313(https://doi.org/10.1370/afm.313) Elwert, F., & Christakis, N. A. (2008). The effect of widowhood on mortality by the causes of death of both spouses. American Journal of Public Health, 98(11), 2092–2098. https://doi.org/10.2105/AJPH.2007.114348(https://doi.org/10.2105/AJPH.2007.114348) Fauci, A. S., & Morens, D. M. (2012). The perpetual challenge of infectious diseases. New England Journal of Medicine, 366(5), 454–461. https://doi.org/10.1056/NEJMra1108296(https://doi.org/10.1056/NEJMra1108296) Folkman, S., & Greer, S. (2000). Promoting psychological well-being in the face of serious illness: When theory, research and practice inform each other. Psycho-Oncology: Journal of the Psychological, Social and Behavioural Dimensions of Cancer, 9(1), 11–19. https://doi.org/10.1002/(sici)1099-1611(200001/02)9:1<11::aid-pon424>3.0.co;2-z(https://doi.org/10.1002/(sici)1099-1611(200001/02)9:1%3c11::aid-pon424%3e3.0.co;2-z) Gallacher, J., Bronstering, K., Palmer, S., Fone, D., & Lyons, R. (2007). Symptomatology attributable to psychological exposure to a chemical incident: A natural experiment. Journal of Epidemiology & Community Health, 61(6), 506–512. https://doi.org/10.1136/jech.2006.046987(https://doi.org/10.1136/jech.2006.046987) Greene, G., Turley, R., Mann, M., Amlôt, R., Page, L., & Palmer, S. (2014). Differing community responses to similar public health threats: A cross-disciplinary systematic literature review. Science of the Total Environment, 470, 759–767. https://doi.org/10.1016/j.scitotenv.2013.10.031(https://doi.org/10.1016/j.scitotenv.2013.10.031) Greyson, B., & Khanna, S. (2014). Spiritual transformation after near-death experiences. Spirituality in Clinical Practice, 1(1), 43-45. https://doi.org/10.1037/scp0000010(https://doi.org/10.1037/scp0000010) Guidotti, T. L., & Jacobs, P. (1993). The implications of an epidemiological mistake: A community’s response to a perceived excess cancer risk. American Journal of Public Health, 83(2), 233–239. https://doi.org/10.2105/AJPH.83.2.233(https://doi.org/10.2105/AJPH.83.2.233) Horowitz, M. J., Krupnick, J., Kaltreider, N., Wilner, N., Leong, A., & Marmar, C. (1981). Initial psychological response to parental death. Archives of General Psychiatry, 38(3), 316–323. https://doi.org/10.1001/archpsyc.1981.01780280084010(https://doi.org/10.1001/archpsyc.1981.01780280084010) Hughes, M. E., & Waite, L. J. (2009). Marital biography and health at mid-life. Journal of Health and Social Behavior, 50(3), 344–358. https://doi.org/10.1177/002214650905000307(https://doi.org/10.1177/002214650905000307) Kilpatrick, A. M., & Randolph, S. E. (2012). Drivers, dynamics, and control of emerging vector-borne zoonotic diseases. The Lancet, 380(9857), 1946–1955. https://doi.org/10.1016/S0140-6736(12)61151-9(https://doi.org/10.1016/S0140-6736(12)61151-9) Lau, J. T., Yang, X., Pang, E., Tsui, H. Y., Wong, E., & Wing, Y. K. (2005). Sars-related perceptions in hong kong. Emerging Infectious Diseases, 11(3), 417-424. https://pubmed.ncbi.nlm.nih.gov/15757557/(https://pubmed.ncbi.nlm.nih.gov/15757557/) Lee, G. R., & DeMaris, A. (2007). Widowhood, gender, and depression: A longitudinal analysis. Research on Aging, 29(1), 56–72. https://doi.org/10.1177/0164027506294098(https://doi.org/10.1177/0164027506294098) Leung, G. M., Quah, S., Ho, L. M., Ho, S. Y., Hedley, A. J., Lee, H. P., & Lam, T. H. (2004). A tale of two cities: Community psychobehavioral surveillance and related impact on outbreak control in hong kong and singapore during the severe acute respiratory syndrome epidemic. Infection Control & Hospital Epidemiology, 25(12), 1033–1041. https://doi.org/10.1086/502340(https://doi.org/10.1086/502340) Liu, W.-M., Forbat, L., & Anderson, K. (2019). Correction: Death of a close friend: Short and long-term impacts on physical, psychological and social well-being. PloS One, 14(5), e0218026. https://doi.org/10.1371/journal.pone.0218026(https://doi.org/10.1371/journal.pone.0218026) Lucas, R. E., Clark, A. E., Georgellis, Y., & Diener, E. (2003). Reexamining adaptation and the set point model of happiness: reactions to changes in marital status. Journal of Personality and Social Psychology, 84(3), 527-539. https://doi.org/10.1037//0022-3514.84.3.527(https://doi.org/10.1037/0022-3514.84.3.527) Melhem, N. M., Porta, G., Shamseddeen, W., Payne, M. W., & Brent, D. A. (2011). Grief in children and adolescents bereaved by sudden parental death. Archives of General Psychiatry, 68(9), 911–919. https://doi.org/10.1001/archgenpsychiatry.2011.101(https://doi.org/10.1001/archgenpsychiatry.2011.101) Morens, D. M., & Fauci, A. S. (2013). Emerging infectious diseases: threats to human health and global stability. PLoS Pathogens, 9(7), e1003467. https://doi.org/10.1371/journal.ppat.1003467(https://doi.org/10.1371/journal.ppat.1003467) Moskowitz, J. T., Hult, J. R., Bussolari, C., & Acree, M. (2009). What works in coping with hiv? A meta-analysis with implications for coping with serious illness. Psychological Bulletin, 135(1), 121-141. https://doi.org/10.1037/a0014210(https://doi.org/10.1037/a0014210) Ong, A. D., Fuller-Rowell, T. E., & Bonanno, G. A. (2010). Prospective predictors of positive emotions following spousal loss. Psychology and Aging, 25(3), 653-660. https://doi.org/10.1037/a0018870(https://doi.org/10.1037/a0018870) Perrins, J., King, N., & Collings, J. (1998). Assessment of long-term psychological well-being following intensive care. Intensive and Critical Care Nursing, 14(3), 108–116. https://doi.org/10.1016/s0964-3397(98)80351-0(https://doi.org/10.1016/s0964-3397(98)80351-0) Rowan, K. M. (1992). Outcome comparisons of intensive care units in Great Britain and Ireland using the APACHE II method. Oxford: University of Oxford. Rubin, G. J., Amlôt, R., Page, L., & Wessely, S. (2009). Public perceptions, anxiety, and behaviour change in relation to the swine flu outbreak: Cross sectional telephone survey. BMJ: British Medical Journal, 339(7713), 156. https://doi.org/10.1136/bmj.b2651(https://doi.org/10.1136/bmj.b2651) Rubin, G. J., Finn, Y., Potts, H. W. W., & Michie, S. (2015). Who is sceptical about emerging public health threats? Results from 39 national surveys in the united kingdom. Public Health, 129(12), 1553–1562. https://doi.org/10.1016/j.puhe.2015.09.004(https://doi.org/10.1016/j.puhe.2015.09.004) Rubin, G. J., Potts, H. W. W., & Michie, S. (2010). The impact of communications about swine flu (influenza a h1n1v) on public responses to the outbreak: Results from 36 national telephone surveys in the uk. Health Technology Assessment, 14(34), 183–266. https://doi.org/10.3310/hta14340-03(https://doi.org/10.3310/hta14340-03) Schulz, R., & Beach, S. R. (1999). Caregiving as a risk factor for mortality: The caregiver health effects study. JAMA, 282(23), 2215–2219. https://doi.org/10.1001/jama.282.23.2215(https://doi.org/10.1001/jama.282.23.2215) Setbon, M., & Raude, J. (2009). Population response to the risk of vector-borne diseases: Lessons learned from socio-behavioural research during large-scale outbreaks. Emerging Health Threats Journal, 2, e6. https://pubmed.ncbi.nlm.nih.gov/22460287/(https://pubmed.ncbi.nlm.nih.gov/22460287/) Smith, R. D. (2006). Responding to global infectious disease outbreaks: Lessons from sars on the role of risk perception, communication and management. Social Science & Medicine (1982), 63(12), 3113–3123. https://doi.org/10.1016/j.socscimed.2006.08.004(https://doi.org/10.1016/j.socscimed.2006.08.004) Stroebe, M., Schut, H., & Stroebe, W. (2007). Health outcomes of bereavement. The Lancet (British Edition), 370(9603), 1960–1973. https://doi.org/10.1016/S0140-6736(07)61816-9(https://doi.org/10.1016/S0140-6736(07)61816-9) Stroebe, W., & Stroebe, M. S. (1987). Bereavement and health: The psychological and physical consequences of partner loss. Cambridge University Press. Sutton, S. (1987). Social-psychological approaches to understanding addictive behaviours: Attitude-behaviour and decision-making models. British Journal of Addiction, 82(4), 355–370. https://doi.org/10.1111/j.1360-0443.1987.tb01492.x(https://doi.org/10.1111/j.1360-0443.1987.tb01492.x) Taylor, S. (2020). Transformation through loss and grief: A study of personal transformation following bereavement. The Humanistic Psychologist, 49(3), 381-399. https://doi.org/10.1037/hum0000172(https://doi.org/10.1037/hum0000172) Tedlie Moskowitz, J., & Wrubel, J. (2005). Coping with hiv as a chronic illness: A longitudinal analysis of illness appraisals. Psychology & Health, 20(4), 509–531. https://doi.org/10.1080/08870440412331337075(https://doi.org/10.1080/08870440412331337075) Tyson, J. (2013). Turning a tragedy into a tribute: A literature review of creating meaning after loss of a loved one. Illness, Crisis & Loss, 21(4), 325–340. https://doi.org/10.2190/IL.21.4.e(https://doi.org/10.2190/IL.21.4.e) Umberson, D., & Chen, M. D. (1994). Effects of a parent’s death on adult children: Relationship salience and reaction to loss. American Sociological Review, 59(1), 152–168. https://doi.org/10.2307/2096138(https://doi.org/10.2307/2096138) Umberson, D., Wortman, C. B., & Kessler, R. C. (1992). Widowhood and depression:Explaining long-term gender differences in vulnerability. Journal of Health and Social Behavior, 33(1), 10–24. https://doi.org/10.2307/2136854(https://doi.org/10.2307/2136854) van Eys, J. (1988). Is all well with the young man, Absalom. Springfield, IL: Charles C. Thomas. Weinstein, N. D. (1993). Testing four competing theories of health-protective behavior. Health Psychology, 12(4), 324-333. https://doi.org/10.1037/0278-6133.12.4.324(https://doi.org/10.1037/0278-6133.12.4.324) Williams, K. (2003). Has the future of marriage arrived? A contemporary examination of gender, marriage, and psychological well-being. Journal of Health and Social Behavior,44(4), 470-487. https://doi.org/10.2307/1519794(https://doi.org/10.2307/1519794) Wurm, S., Tomasik, M. J., & Tesch-Römer, C. (2008). Serious health events and their impact on changes in subjective health and life satisfaction: The role of age and a positive view on ageing. European Journal of Ageing, 5(2), 117–127. https://doi.org/10.1007/s10433-008-0077-5(https://doi.org/10.1007/s10433-008-0077-5) Zisook, S., Chentsova-Dutton, Y., & Shuchter, S. R. (1998). Ptsd following bereavement. Annals of Clinical Psychiatry, 10(4), 157–163. https://doi.org/10.1023/a:1022342028750(https://doi.org/10.1023/a:1022342028750)